Processing 00000000.tx.1: Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection Chee Yeun Chung1,2, Hyemyung Seo1,, Kai Christian Sonntag1, Andrew Brooks3, Ling Lin1 and Ole Isacson1,2,* 1Neuroregeneration Laboratories, Harvard Medical School, McLean Hospital, 115 Mill Street, Belmont, MA 02478, USA, 2Harvard Center for Neurodegeneration and Repair, Boston, MA 02114, USA and 3Department of Environmental Medicine, Aab Institute of Biomedical Sciences, University of Rochester Medical Center, Rochester, NY 14642, USA * To whom correspondence should be addressed. 

Phrase: "Cell type-specific gene expression of midbrain dopaminergic neurons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0017262:Gene Expression [Genetic Function]
   762   C0314611:Gene type [Genetic Function]
   762   C1861886:CELL Gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]

Phrase: "involved in their vulnerability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1314939:Involved [Functional Concept]

Phrase: "and"

Phrase: "protection Chee Yeun Chung1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Hyemyung Seo1,"

Phrase: ", Kai Christian Sonntag1,"

Phrase: "Andrew Brooks3,"

Phrase: "Ling Lin1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413217:LIN1 [Gene or Genome]

Phrase: "and"

Phrase: "Ole Isacson1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "* 1Neuroregeneration Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "McLean Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "115 Mill Street,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0442658:Street [Manufactured Object]
   827   C1301826:Street [Finding]

Phrase: "Belmont,"

Phrase: "MA 02478,"

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "2Harvard Center for Neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "Repair,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043240:Repair, NOS [Organism Function]
  1000   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA 02114,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "and"

Phrase: "3Department of Environmental Medicine,"

Phrase: "Aab Institute of Biomedical Sciences,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "University of Rochester Medical Center,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   911   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0041740:University [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]

Phrase: "Rochester,"

Phrase: "NY 14642,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027976:NY [Geographic Area]
   861   C1879958:NY [Intellectual Product]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.2: Tel: +1 6178553283; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+1 6178553283"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.3: Fax: +1 6178553284; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+1 6178553284"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.4: Email: isacson{at}hms.harvard.edu Received April 1, 2005; 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "isacson{at}hms.harvard.edu Received April 1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
   793   C0262500:hms [Health Care Activity]
   793   C1514756:Received [Qualitative Concept]
   793   C1855627:HMS [Disease or Syndrome]

Phrase: "2005"

Phrase: ";"
Processing 00000000.tx.5: Accepted May 2, 2005  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES  Molecular differences between dopamine (DA) neurons may explain why the mesostriatal DA neurons in the A9 region preferentially degenerate in Parkinson's disease (PD) and toxic models, whereas the adjacent A10 region mesolimbic and mesocortical DA neurons are relatively spared. 

Phrase: "Accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "May 2,"

Phrase: "2005  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS SUPPLEMENTARY MATERIAL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Molecular differences between dopamine (DA) neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "may"

Phrase: "explain"

Phrase: "why"

Phrase: "the mesostriatal DA neurons in the A9 region preferentially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1512035:dopamine neurons [Cell]
   742   C0027882:Neurons [Cell]

Phrase: "degenerate in Parkinson's disease"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   770   C0011164:degenerate [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1880269:Degenerate [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(PD)"

Phrase: "and"

Phrase: "toxic models,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]

Phrase: "whereas"

Phrase: "the adjacent A10 region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "mesolimbic"

Phrase: "and"

Phrase: "mesocortical DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "are"

Phrase: "relatively"

Phrase: "spared."
Processing 00000000.tx.6: To characterize innate physiological differences between A9 and A10 DA neurons, we determined gene expression profiles in these neurons in the adult mouse by laser capture microdissection, microarray analysis and real-time PCR. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "characterize"

Phrase: "innate physiological differences between A9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "A10 DA neurons,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "we"

Phrase: "determined"

Phrase: "gene expression profiles in these neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C1956267:Gene Expression Profiles [Quantitative Concept]
   816 E C1449575:gene expression profile [Laboratory Procedure]
   719   C1979963:Profile [Laboratory Procedure]
   719   C2003903:Profile [Functional Concept]

Phrase: "in the adult mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "by laser capture microdissection,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1113652:Laser Capture Microdissection [Laboratory Procedure]
   827   C0023089:Laser [Manufactured Object]
   827   C0458142:Laser [Phenomenon or Process]
   827   C0598304:Microdissection [Laboratory Procedure]
   827   C1023865:Laser [Plant]
   827   C1706315:Laser [Medical Device]

Phrase: "microarray analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1449575:Microarray Analysis [Laboratory Procedure]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "real-time PCR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   734   C1550177:Real Time [Idea or Concept]
Processing 00000000.tx.7: We found 42 genes relatively elevated in A9 DA neurons, whereas 61 genes were elevated in A10 DA neurons [>2-fold; false discovery rate (FDR) <1%]. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "42 genes relatively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "elevated in A9 DA neurons,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1512035:dopamine neurons [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0027882:Neurons [Cell]
   760   C0205250:Elevated [Qualitative Concept]
   760   C0933647:A9 [Body Part, Organ, or Organ Component]
   760   C3163633:Elevated [Qualitative Concept]

Phrase: "whereas"

Phrase: "61 genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "were"

Phrase: "elevated in A10 DA neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1512035:dopamine neurons [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0027882:Neurons [Cell]
   760   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]
   760   C0205250:Elevated [Qualitative Concept]
   760   C3163633:Elevated [Qualitative Concept]

Phrase: "["

Phrase: ">2-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "; false discovery rate (FDR)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1880720:False Discovery Rate [Quantitative Concept]
   901   C0205557:False Discovery [Laboratory or Test Result]
   827   C0205237:False [Qualitative Concept]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
   827   C1880355:Discovery [Activity]

Phrase: "<1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "]."
Processing 00000000.tx.8: Genes of interest for further functional analysis were selected by criteria of (i) fold differences in gene expression, (ii) real-time PCR validation and (iii) potential roles in neurotoxic or protective biochemical pathways. 

Phrase: "Genes of interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017337:Genes [Gene or Genome]

Phrase: "for further functional analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0558024:Functional analysis [Health Care Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "selected by criteria of (i) fold differences"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0021966:I- [Inorganic Chemical]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0243161:criteria [Intellectual Product]
   748   C0332462:Fold [Spatial Concept]
   748   C1880834:FOLD [Phenomenon or Process]
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]
   714   C1707391:Select [Activity]

Phrase: "in gene expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(ii"

Phrase: ")"

Phrase: "real-time PCR validation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1519941:Validation [Research Activity]
   756   C1709846:Real-Time PCR [Molecular Biology Research Technique]

Phrase: "and ("

Phrase: "iii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "potential roles in neurotoxic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "or"

Phrase: "protective biochemical pathways."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0243123:biochemical pathways [Qualitative Concept]
   867 E C1704259:Biochemical Pathway [Molecular Function]
           Pathways
   827   C0205474:Biochemical [Functional Concept]
   827   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.9: Three A9-elevated molecules [G-protein coupled inwardly rectifying K channel 2 (GIRK2), adenine nucleotide translocator 2 (ANT-2) and the growth factor IGF-1] and three A10-elevated peptides (GRP, CGRP and PACAP) were further examined in both -synuclein overexpressing PC12 (PC12-Syn) cells and rat primary ventral mesencephalic (VM) cultures exposed to MPP+ neurotoxicity. 

Phrase: "Three A9-elevated molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0567416:molecules [Substance]
   729 E C1521991:Molecular [Qualitative Concept]

Phrase: "[G-protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439267:g% [Quantitative Concept]

Phrase: "coupled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1948027:Coupled [Functional Concept]
   966 E C0010222:couple [Family Group]

Phrase: "inwardly"

Phrase: "rectifying"

Phrase: "K channel 2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439799:Channel [Spatial Concept]
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1706095:Channel [Conceptual Entity]
   827   C1708601:K' [Quantitative Concept]

Phrase: "(GIRK2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416588:GIRK2 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "adenine nucleotide translocator 2 (ANT-2)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0600150:Adenine Nucleotide Translocator 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335834:ADENINE NUCLEOTIDE TRANSLOCATOR 2 [Gene or Genome]
  1000   C1442882:Adenine Nucleotide Translocator-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   812   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the growth factor IGF-1"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0220844:growth [Physiologic Function]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "]"

Phrase: "and"

Phrase: "three A10-elevated peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(GRP,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0061132:Gastrin releasing peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1333714:gastrin-releasing peptide [Gene or Genome]
   827   C0017151:Gastrin [Amino Acid, Peptide, or Protein,Hormone]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0376180:Gastrin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1283071:Releasing [Functional Concept]
   793 E C0030685:Release [Health Care Activity]
   793 E C0391871:Release [Functional Concept]
   793 E C0439180:% release [Quantitative Concept]
   793 E C0680255:release [Health Care Activity]
   793 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "CGRP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0439095:Alpha [Intellectual Product]
   804   C2003941:Alpha [Intellectual Product]
   804   C2350010:Alpha [Qualitative Concept]
   771   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   771   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]

Phrase: "and"

Phrase: "PACAP)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0071163:PACAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412228:PACAP [Gene or Genome]
  1000   C1836172:PACAP [Gene or Genome]

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "examined in both -synuclein overexpressing PC12"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0085262:PC-12 [Cell]
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332128:Examined [Finding]
   753   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   719   C1514559:overexpress [Genetic Function]

Phrase: "(PC12-Syn) cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0085262:PC12 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "rat primary ventral mesencephalic (VM) cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0010453:Cultures [Idea or Concept]
   771 E C0220814:culture [Functional Concept]
   771 E C0430400:Culture [Laboratory Procedure]
   771 E C2242979:Culture [Laboratory Procedure]

Phrase: "exposed to MPP+ neurotoxicity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0000098:MPP+ [Hazardous or Poisonous Substance,Organic Chemical]
   770   C0235032:Neurotoxicity [Injury or Poisoning]
   770   C1417248:MPP [Gene or Genome]
Processing 00000000.tx.10: GIRK2-positive DA neurons were more vulnerable to MPP+ toxicity and overexpression of GIRK2 increased the vulnerability of PC12-Syn cells to the toxin. 

Phrase: "GIRK2-positive DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1512035:dopamine neurons [Cell]
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "more vulnerable to MPP+ toxicity"

Phrase: "and"

Phrase: "overexpression of GIRK2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514559:Overexpression [Genetic Function]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the vulnerability of PC12-Syn cells"

Phrase: "to the toxin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
Processing 00000000.tx.11: Blocking of ANT decreased vulnerability to MPP+ in both cell culture systems. 

Phrase: "Blocking of ANT"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   862   C1141015:Adenine Nucleotide Translocase [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   862   C1153238:adenine nucleotide translocase [Molecular Function]
   806   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   806   C1135982:Nucleotide Translocase [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0233660:Blocking [Mental or Behavioral Dysfunction]
   760   C0332206:Blocking [Functional Concept]
   760   C0582119:Translocase [Amino Acid, Peptide, or Protein,Enzyme]
   726 E C0028778:Block [Pathologic Function]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "vulnerability to MPP+"

Phrase: "in both cell culture systems."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   966   C1516329:Cell Culture System [Molecular Biology Research Technique]
   901   C0007585:Cell Culture [Laboratory Procedure]
   827   C0007634:Cell [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.12: Exposing cells to IGF-1, GRP and PACAP decreased vulnerability of both cell types to MPP+, whereas CGRP protected PC12-Syn cells but not primary VM DA neurons. 

Phrase: "Exposing cells to IGF-1,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   774   C0007595:cells growth [Cell Function]
   757   C0030281:Insulin Cell [Cell]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "GRP"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0061132:Gastrin releasing peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1333714:gastrin-releasing peptide [Gene or Genome]
   827   C0017151:Gastrin [Amino Acid, Peptide, or Protein,Hormone]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0376180:Gastrin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1283071:Releasing [Functional Concept]
   793 E C0030685:Release [Health Care Activity]
   793 E C0391871:Release [Functional Concept]
   793 E C0439180:% release [Quantitative Concept]
   793 E C0680255:release [Health Care Activity]
   793 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "PACAP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0071163:PACAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412228:PACAP [Gene or Genome]
  1000   C1836172:PACAP [Gene or Genome]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "vulnerability of both cell types"

Phrase: "to MPP+,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000098:MPP+ [Hazardous or Poisonous Substance,Organic Chemical]
  1000   C1417248:MPP [Gene or Genome]

Phrase: "whereas"

Phrase: "CGRP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0439095:Alpha [Intellectual Product]
   804   C2003941:Alpha [Intellectual Product]
   804   C2350010:Alpha [Qualitative Concept]
   771   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   771   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]

Phrase: "protected"

Phrase: "PC12-Syn cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0085262:PC12 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "not primary VM DA neurons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1512035:dopamine neurons [Cell]
   799   C0027882:Neurons [Cell]
   716 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.13: These results indicate that certain differentially expressed molecules in A9 and A10 DA neurons may play key roles in their relative vulnerability to toxins and PD.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that certain differentially expressed molecules in A9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0567416:molecules [Substance]

Phrase: "and"

Phrase: "A10 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "key roles in their relative vulnerability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0035820:Roles [Social Behavior]
   719 E C1705810:Role [Conceptual Entity]

Phrase: "to toxins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040549:Toxins [Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "and"

Phrase: "PD."
Processing 00000000.tx.14: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES  Major unsolved problems for most neurodegenerative diseases include determining specific factors that cause relative vulnerabilities of neuronal populations. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS SUPPLEMENTARY MATERIAL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Major unsolved problems for most neurodegenerative diseases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1546466:Problems [Idea or Concept]
   714 E C0033213:Problem [Finding]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "determining"

Phrase: "specific factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "relative vulnerabilities of neuronal populations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0949366:Vulnerable Population [Population Group]
Processing 00000000.tx.15: This problem is exemplified by Parkinson's disease (PD), in which there is relative vulnerability even among neighboring midbrain populations of neurons releasing the same neurotransmitter, dopamine (DA). 

Phrase: "This problem"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033213:Problem [Finding]

Phrase: "is"

Phrase: "exemplified by Parkinson's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(PD"

Phrase: ")"

Phrase: ","

Phrase: "in which there"

Phrase: "is"

Phrase: "relative vulnerability even among neighboring midbrain populations of neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0949366:Vulnerable Population [Population Group]

Phrase: "releasing"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1283071:Releasing [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0391871:Release [Functional Concept]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "the same neurotransmitter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027908:Neurotransmitter [Neuroreactive Substance or Biogenic Amine]

Phrase: "dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "(DA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.16: DA neurons in the ventral midbrain consist of two main groups: the A9 group in the substantia nigra (SN) and the A10 group in the medial and ventral tegmentum (1). 

Phrase: "DA neurons in the ventral midbrain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1512035:dopamine neurons [Cell]
   753   C0027882:Neurons [Cell]

Phrase: "consist of two main groups"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0205225:Main [Qualitative Concept]
   760   C0205448:Two [Quantitative Concept]
   760   C0332529:CONSIST [Qualitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1542147:Main [Qualitative Concept]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: ":"

Phrase: "the A9 group in the substantia nigra (SN)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1552516:Group [Health Care Related Organization]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "the A10 group in the medial"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "ventral tegmentum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039441:tegmentum [Body Part, Organ, or Organ Component]
   861   C1704448:Ventral [Spatial Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.17: A9 and A10 DA neurons project to different anatomical structures and are involved in distinct functions. 

Phrase: "A9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0933647:A9 [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "A10 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "project to different anatomical structures"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0700276:anatomical structures [Anatomical Structure]
   760   C0220784:Anatomical [Qualitative Concept]
   760   C0678594:structures [Spatial Concept]
   760   C1705242:Different [Qualitative Concept]
   760   C1709701:Project [Conceptual Entity]

Phrase: "and"

Phrase: "are"

Phrase: "involved in distinct functions."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0542341:Functions [Functional Concept]
   770   C1314939:Involved [Functional Concept]
   737 E C0031843:function [Physiologic Function]
   737 E C0700205:FUNCTION [Classification]
   737 E C1705273:Function [Intellectual Product]
Processing 00000000.tx.18: A9 DA neurons mainly project to the dorsolateral striatum, involved in the control of motor functions, whereas A10 DA neurons provide connections to the ventromedial striatum, limbic and cortical regions, involved in reward and emotional behavior. 

Phrase: "A9 DA neurons mainly"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1512035:dopamine neurons [Cell]
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "project to the dorsolateral striatum,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0010097:Striatum [Body Part, Organ, or Organ Component]
   760   C0162512:Striatum [Body Part, Organ, or Organ Component]
   760   C1709701:Project [Conceptual Entity]
   760   C2983598:Dorsolateral [Spatial Concept]

Phrase: "involved in the control of motor functions,"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   774   C0234130:functions motor [Functional Concept]
   757   C2587213:Control function [Functional Concept]
           Control
   748   C0243148:control [Qualitative Concept]
   748   C0542341:Functions [Functional Concept]
   748   C1314939:Involved [Functional Concept]
   748   C1513492:Motor [Functional Concept]
   748   C1550141:Control [Substance]
   748   C1705994:Motor [Manufactured Object]
   748   C1882979:Control [Conceptual Entity]
   748   C3274648:Control [Qualitative Concept]
   714 E C0031843:function [Physiologic Function]
   714 E C0700205:FUNCTION [Classification]
   714 E C1705273:Function [Intellectual Product]

Phrase: "whereas"

Phrase: "A10 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "connections to the ventromedial striatum,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449379:connections [Intellectual Product]

Phrase: "limbic"

Phrase: "and"

Phrase: "cortical regions,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "involved in reward"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035397:Reward [Mental Process]
   790   C1314939:Involved [Functional Concept]

Phrase: "and"

Phrase: "emotional behavior."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0004927:Behavior [Individual Behavior]
   861   C0013987:Emotional [Mental Process]
   861   C0849912:Emotional [Finding]
   861   C2707008:Behavior [Clinical Attribute]
   789 E C2986890:Behavioral [Idea or Concept]
Processing 00000000.tx.19: In addition to the distinct axonal projections and differences in synaptic connectivity, these groups of DA neurons exhibit differences in neurochemistry and electrophysiological properties (2,3), illustrating the functional differences despite similar neurotransmitter identity. 

Phrase: "In addition to the distinct axonal projections"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016538:projections [Intellectual Product]
   827   C0033363:projections [Mental Process]
   827   C0348018:projections [Spatial Concept]

Phrase: "and"

Phrase: "differences in synaptic connectivity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "these groups of DA neurons"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "differences in neurochemistry"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "and"

Phrase: "electrophysiological properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "illustrating"

Phrase: "the functional differences despite similar neurotransmitter identity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.20: The most prominent neuropathology of PD is degeneration or dysfunction of midbrain DA neurons. 

Phrase: "The most prominent neuropathology of PD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   753   C1540677:neuropathology [Pathologic Function]
   753   C1555824:Neuropathology [Intellectual Product]

Phrase: "is"

Phrase: "degeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011164:Degeneration [Pathologic Function]
  1000   C1880269:Degeneration [Functional Concept]

Phrase: "or"

Phrase: "dysfunction of midbrain DA neurons."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0031847:dysfunction [Functional Concept]
   760   C0277785:Dysfunction, NOS [Qualitative Concept]
   704 E C0231174:Malfunction [Functional Concept]
   704 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.21: Most PD cases are sporadic, for which a combination of environmental and genetic factors is the proposed etiology (4,5). 

Phrase: "Most PD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "are"

Phrase: "sporadic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205422:Sporadic [Temporal Concept]

Phrase: "for which"

Phrase: "a combination of environmental"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205195:Combination [Qualitative Concept]
   770   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "genetic factors"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "is"

Phrase: "the proposed etiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0015127:aetiology [Functional Concept]
   861   C1314792:Aetiology [Functional Concept]
   861   C1524003:Etiology [Conceptual Entity]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.22: The remaining cases are familial PD and caused by monogenic mutations on molecules such as -synuclein (6) ubiquitin C-terminal hydrolase-1 (7), parkin (8), DJ-1 (9) and PINK1 (10) or, in the case of -synuclein, also by triplication of the wild-type gene (11). 

Phrase: "The remaining cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "are"

Phrase: "familial PD"

Phrase: "and"

Phrase: "caused by monogenic mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0026882:Mutations [Genetic Function]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "on molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]

Phrase: "such as -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(6"

Phrase: ")"

Phrase: "ubiquitin C-terminal hydrolase-1"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   804   C0007634:Cells [Cell]
   804   C0020289:Hydrolase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0205088:Terminal [Temporal Concept]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(7"

Phrase: ")"

Phrase: ","

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(8"

Phrase: ")"

Phrase: ","

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "(9"

Phrase: ")"

Phrase: "and"

Phrase: "PINK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422771:PINK1 [Gene or Genome]

Phrase: "(10"

Phrase: ")"

Phrase: "or"

Phrase: ","

Phrase: "in the case of -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "also by triplication of the wild-type gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1883559:Wild Type [Organism Attribute]
   767   C0314611:Gene type [Genetic Function]
   744   C0017337:Gene [Gene or Genome]
   744   C0332307:Type [Qualitative Concept]
   744   C0445392:Wild [Intellectual Product]
   744   C1547052:*Type [Quantitative Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.23: Strikingly, and independent of specific etiology, 9 DA neurons are preferentially affected in PD and A10 DA neurons relatively spared (1215). 

Phrase: "Strikingly,"

Phrase: "and independent of specific etiology,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0332291:Independent of [Functional Concept]
   760   C0015127:aetiology [Functional Concept]
   760   C0085862:Independent [Idea or Concept]
   760   C0205369:Specific [Qualitative Concept]
   760   C1299583:Independent [Finding]
   760   C1314792:Aetiology [Functional Concept]
   760   C1515981:And [Idea or Concept]
   760   C1524003:Etiology [Conceptual Entity]
   760   C1552740:specific [Intellectual Product]

Phrase: "9 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "are"

Phrase: "preferentially"

Phrase: "affected in PD"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]

Phrase: "and"

Phrase: "A10 DA neurons relatively"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1512035:dopamine neurons [Cell]
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "spared"

Phrase: "(1215"

Phrase: ")."
Processing 00000000.tx.24: Similar patterns of degeneration appear in rodents and primate models of PD (13,16,17), indicating that the physiological differences between A9 and A10 DA neurons may be conserved between species. 

Phrase: "Similar patterns of degeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449774:Patterns [Spatial Concept]

Phrase: "appear in rodents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035804:Rodents [Mammal]
   790   C0700364:APPEAR [Qualitative Concept]

Phrase: "and"

Phrase: "primate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033147:Primate [Mammal]

Phrase: "models of PD (13,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3161035:Model [Intellectual Product]

Phrase: "16,"

Phrase: "17"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "the physiological differences between A9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "A10 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "may"

Phrase: "be"

Phrase: "conserved between species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.25: Postmortem analyses of human PD brains demonstrate a selective cell loss of the A9 DA neuron group with a survival rate of 10% (14,1820), whereas the A10 group is largely spared with a survival rate of 60% even in severe cases (14,21,22). 

Phrase: "Postmortem analyses of human PD brains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "demonstrate"

Phrase: "a selective cell loss of the A9 DA neuron group"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   757   C0598940:neuron loss [Finding]
           Loss of neurons
   739   C1517945:Loss [Quantitative Concept]
   722 E C1850496:Neuronal loss [Finding]

Phrase: "with a survival rate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038954:Survival Rate [Quantitative Concept]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "of 10%"

Phrase: "(14,"

Phrase: "1820"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the A10 group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "is"

Phrase: "largely"

Phrase: "spared with a survival rate of 60% even"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0038954:Survival Rate [Quantitative Concept]
   744   C0038952:Survival [Activity]
   744   C0220921:survival [Functional Concept]
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]

Phrase: "in severe cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "(14,"

Phrase: "21,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.26: This indicates that A9 DA neurons are more vulnerable to intrinsic and/or extrinsic factors causing degeneration in PD. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that A9 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "are"

Phrase: "more vulnerable to intrinsic"

Phrase: "and/or"

Phrase: "extrinsic factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205101:Extrinsic [Spatial Concept]
   861   C0595947:Extrinsic [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "degeneration in PD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011164:Degeneration [Pathologic Function]
   790   C1880269:Degeneration [Functional Concept]
Processing 00000000.tx.27: In addition, three regional gradients of neurodegeneration in the dorso-ventral/rostro-caudal/medio-lateral axis have been reported in PD. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "three regional gradients of neurodegeneration"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0812409:gradients [Quantitative Concept]
   726 E C0439182:% gradient [Quantitative Concept]

Phrase: "in the dorso-ventral/rostro-caudal/medio-lateral axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0004457:Axis [Body Part, Organ, or Organ Component]
   795   C0999597:Axis [Mammal]
   795   C1522496:Axis [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "reported in PD."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.28: Caudally and laterally located ventral DA cells within A9 DA neurons are the most vulnerable cells in PD (14,15). 

Phrase: "Caudally"

Phrase: "and"

Phrase: "laterally"

Phrase: "located"

Phrase: "ventral DA cells within A9 DA neurons"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C3496153:A9 dopamine cells [Cell]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "the most vulnerable cells in PD (14,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   757   C0007634:THE CELL [Cell]
           Cells
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.29: In contrast, the medial and rostral part of DA cell subgroups within A10 DA neurons (i.e. rostral linear nucleus, RLi) are the least affected (525% cell loss) (14,22). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the medial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205098:Medial [Spatial Concept]

Phrase: "and"

Phrase: "rostral part of DA cell subgroups"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1292711:Part of [Spatial Concept]
   783   C1178969:Cell part [Cell Component]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: "within A10 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(i.e. rostral linear nucleus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0175404:Linear nucleus [Body Part, Organ, or Organ Component]
   804   C0007610:Nucleus [Cell Component]

Phrase: "RLi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412092:RLI [Gene or Genome]

Phrase: ")"

Phrase: "are"

Phrase: "the least affected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392760:Affected [Functional Concept]
   861   C1314939:Affected [Functional Concept]

Phrase: "(525% cell loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517945:Loss [Quantitative Concept]

Phrase: ")"

Phrase: "(14,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.30: Certain proteins differentially expressed in A9 and A10 DA neurons may play critical roles in susceptibility to or protection against neurodegenerative processes in PD. 

Phrase: "Certain proteins differentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "expressed in A9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0933647:A9 [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "A10 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "critical roles in susceptibility"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "to"

Phrase: "or"

Phrase: "protection against neurodegenerative processes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1545588:Protection [Finding]

Phrase: "in PD."
Processing 00000000.tx.31: Previous studies have reported several proteins that are differentially expressed in A9 and A10 DA neurons. 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "reported several proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "are"

Phrase: "differentially"

Phrase: "expressed in A9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0933647:A9 [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "A10 DA neurons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.32: For example, calbindin D28K, an intracellular calcium binding protein has been used to distinguish resistant from vulnerable DA neurons in PD patient brain and animal models of PD, because it is colocalized in the resistant DA population (mostly A10 DA neurons) (2325). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "calbindin D28K,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "an intracellular calcium binding protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   923   C0006732:Calcium-binding protein [Amino Acid, Peptide, or Protein,Receptor]
   923   C1822659:calcium binding protein [Gene or Genome]
   875   C0805431:Calcium/Protein [Quantitative Concept]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1516144:Calcium Binding [Molecular Function]
   812   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0006726:Calcium [Inorganic Chemical]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C2936886:Calcium [Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "distinguish"

Phrase: "resistant from vulnerable DA neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332325:Resistant [Functional Concept]
   760   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "in PD patient brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "animal models of PD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0599779:Models, Animal [Animal]
   770   C0003062:Animal [Animal]
   770   C3161035:Models [Intellectual Product]

Phrase: "because"

Phrase: "it"

Phrase: "is"

Phrase: "colocalized in the resistant DA population"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   753   C0032659:Population [Quantitative Concept]
   753   C0332325:Resistant [Functional Concept]
   753   C1257890:Population [Population Group]
   753   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "(mostly A10 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1512035:dopamine neurons [Cell]
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: ")"

Phrase: "(2325"

Phrase: ")."
Processing 00000000.tx.33: Another of these proteins is G-protein-gated inwardly rectifying K+ channel (GIRK), which generates a slow inhibitory postsynaptic potential (IPSP) in DA neurons via activation of D2 or GABAB receptors and controls the membrane excitability of DA neurons. 

Phrase: "Another of these proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "G-protein-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439267:g% [Quantitative Concept]

Phrase: "gated inwardly rectifying K+ channel (GIRK),"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   937   C0214230:INWARDLY RECTIFYING K CHANNEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0439799:Channel [Spatial Concept]
   804   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C1706095:Channel [Conceptual Entity]
   804   C1708601:K' [Quantitative Concept]

Phrase: "which"

Phrase: "generates"

Phrase: "a slow inhibitory postsynaptic potential (IPSP) in DA neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C1720982:Postsynaptic Potential, Inhibitory [Organ or Tissue Function]
   770   C2350339:Potential, Postsynaptic [Organ or Tissue Function]
   767   C0234122:Inhibitory potential [Organ or Tissue Function]
   767   C0597474:slow potential [Cell Function]
   744   C3245505:Potential [Qualitative Concept]
   744   C3463820:Inhibitory [Activity]

Phrase: "via activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of D2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1414052:D2 [Gene or Genome]
  1000   C1415944:D2 [Gene or Genome]

Phrase: "or"

Phrase: "GABAB receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the membrane excitability of DA neurons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0235169:Excitability [Sign or Symptom]
Processing 00000000.tx.34: This can modulate the release of DA from synaptic terminals of DA neurons to the striatum. 

Phrase: "This"

Phrase: "can"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the release of DA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from synaptic terminals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0206181:Synaptic Terminals [Cell Component]
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]

Phrase: "of DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1512035:dopamine neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "to the striatum."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010097:Striatum [Body Part, Organ, or Organ Component]
  1000   C0162512:Striatum [Body Part, Organ, or Organ Component]
Processing 00000000.tx.35: Among four isoforms of GIRK, only GIRK2 is exclusively expressed in the vulnerable DA neurons (mostly A9 neurons) (26,27), and it has been implicated in A9 DA neuron pathology in weaver mice (2830). 

Phrase: "Among four isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "of GIRK,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0214230:INWARDLY RECTIFYING K CHANNEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0332285:Of [Spatial Concept]
   799   C0439799:Channel [Spatial Concept]
   799   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   799   C1706095:Channel [Conceptual Entity]
   799   C1708601:K' [Quantitative Concept]

Phrase: "only GIRK2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416588:GIRK2 [Gene or Genome]

Phrase: "is"

Phrase: "exclusively"

Phrase: "expressed in the vulnerable DA neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1512035:dopamine neurons [Cell]
   753   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   753   C0027882:Neurons [Cell]

Phrase: "(mostly A9 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: ")"

Phrase: "(26,"

Phrase: "27"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "implicated in A9 DA neuron pathology"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1512035:dopamine neuron [Cell]
   753   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   753   C0027882:Neuron [Cell]
   753   C0030664:Pathology [Biomedical Occupation or Discipline]
   753   C0205469:pathology [Functional Concept]
   753   C0677042:pathology [Pathologic Function]
   753   C0933647:A9 [Body Part, Organ, or Organ Component]

Phrase: "in weaver mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0043086:Weaver Mice [Mammal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0326812:Weaver [Bird]

Phrase: "(2830"

Phrase: ")."
Processing 00000000.tx.36: The general hypothesis for this kind of exploration is that idiopathic, environmental and genetically driven processes culminating in neurodegenerative diseases are present in most cellular systems, but only reach a pathological threshold in very specific and characteristic neuronal populations (31,32). 

Phrase: "The general hypothesis for this kind of exploration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "that idiopathic, environmental"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014406:Environmental [Spatial Concept]

Phrase: "and"

Phrase: "genetically"

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]

Phrase: "culminating in neurodegenerative diseases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   770   C0012634:Diseases [Disease or Syndrome]
   770   C0205260:Culminating [Qualitative Concept]

Phrase: "are"

Phrase: "present in most cellular systems,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "but"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "a pathological threshold in very specific"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449864:Threshold [Qualitative Concept]

Phrase: "and"

Phrase: "characteristic neuronal populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.37: To determine the critical molecular differences that could result in vulnerability or provide opportunities for neuroprotection, we characterized the gene expression profiles of A9 and A10 DA neurons from adult mouse midbrain by laser capture microdissection (LCM) followed by microarray analysis and validation using real-time PCR. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the critical molecular differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1705241:*Difference [Quantitative Concept]
   793   C1705242:Difference [Qualitative Concept]
   743 E C0443199:Differential [Qualitative Concept]

Phrase: "that"

Phrase: "could"

Phrase: "result in vulnerability"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]

Phrase: "or"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "opportunities for neuroprotection,"

Phrase: "we"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "the gene expression profiles of A9"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C1956267:Gene Expression Profiles [Quantitative Concept]
   816 E C1449575:gene expression profile [Laboratory Procedure]
   719   C1979963:Profile [Laboratory Procedure]
   719   C2003903:Profile [Functional Concept]

Phrase: "and"

Phrase: "A10 DA neurons from adult mouse midbrain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1512035:dopamine neurons [Cell]
   748   C0027882:Neurons [Cell]

Phrase: "by laser capture microdissection (LCM)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1113652:Laser Capture Microdissection [Laboratory Procedure]
   827   C0023089:Laser [Manufactured Object]
   827   C0458142:Laser [Phenomenon or Process]
   827   C0598304:Microdissection [Laboratory Procedure]
   827   C1023865:Laser [Plant]
   827   C1706315:Laser [Medical Device]

Phrase: "followed by microarray analysis"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0332283:Followed by [Temporal Concept]
           followed
   833   C1449575:Microarray Analysis [Laboratory Procedure]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C1709016:Microarray [Manufactured Object]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "validation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519941:Validation [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "real-time PCR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   734   C1550177:Real Time [Idea or Concept]
Processing 00000000.tx.38: Some of the molecules from this analysis were then examined for functional relevance using PD-related in vitro cellular bioassays.  

Phrase: "Some of the molecules"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205392:Some [Quantitative Concept]
   770   C0567416:molecules [Substance]
   770   C3540770:Some [Intellectual Product]

Phrase: "from this analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "examined for functional relevance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205245:Functional [Functional Concept]
   770   C0332128:Examined [Finding]
   770   C0542341:Functional [Functional Concept]
   770   C2347946:Relevance [Qualitative Concept]
   770   C2700217:Functional [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PD-related in vitro cellular bioassays."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0005507:Bioassays [Laboratory Procedure]
   766 E C1704780:Bioassay [Conceptual Entity]
Processing 00000000.tx.39: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES  Gene expression profiles of A9 and A10 DA neurons based on LCM and microarray analysis In our experiments, midbrain A9 and A10 DA neuronal groups were identified by rapid TH-immunostaining designed to minimize RNA degradation in tissue sections and microdissected by LCM using anatomical criteria (Fig.1A1D) as described in Materials and Methods. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS SUPPLEMENTARY MATERIAL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Gene expression profiles of A9"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   862   C1956267:Gene Expression Profiles [Quantitative Concept]
   845 E C1449575:gene expression profile [Laboratory Procedure]
   726   C1979963:Profile [Laboratory Procedure]
   726   C2003903:Profile [Functional Concept]

Phrase: "and"

Phrase: "A10 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "based on LCM"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   862   C1113652:Laser Capture Microdissection [Laboratory Procedure]
   760   C0023089:Laser [Manufactured Object]
   760   C0458142:Laser [Phenomenon or Process]
   760   C0598304:Microdissection [Laboratory Procedure]
   760   C1023865:Laser [Plant]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C1706315:Laser [Medical Device]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "microarray analysis In our experiments,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1449575:Microarray Analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "midbrain A9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0933647:A9 [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "A10 DA neuronal groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1552839:groups [Idea or Concept]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "identified by rapid TH-"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0039725:TH [Geographic Area]
   770   C0039738:Th [Element, Ion, or Isotope]
   770   C0205396:Identified [Qualitative Concept]
   770   C0439831:Rapid [Qualitative Concept]
   770   C1420718:TH [Gene or Genome]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "immunostaining"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "minimize"

Phrase: "RNA degradation in tissue sections"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1257756:RNA Degradation [Genetic Function]
   806   C2984321:RNA degradation [Functional Concept]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "microdissected by LCM"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C1113652:Laser Capture Microdissection [Laboratory Procedure]
   760   C0023089:Laser [Manufactured Object]
   760   C0458142:Laser [Phenomenon or Process]
   760   C0598304:Microdissection [Laboratory Procedure]
   760   C1023865:Laser [Plant]
   760   C1706315:Laser [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anatomical criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243161:criteria [Intellectual Product]

Phrase: "(Fig.1A1D"

Phrase: ")"

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.40: Using real-time PCR, we validated the quality of the extracted RNA samples by confirming the mRNA levels of GIRK2 known to be elevated in A9 DA neurons (26,27) and calbindin D28K known to be elevated in A10 DA neurons (2325) (Fig.1E). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "real-time PCR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   734   C1550177:Real Time [Idea or Concept]

Phrase: "we"

Phrase: "validated"

Phrase: "the quality of the extracted RNA samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332306:Quality [Qualitative Concept]

Phrase: "by confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the mRNA levels of GIRK2"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elevated in A9 DA neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1512035:dopamine neurons [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0027882:Neurons [Cell]
   760   C0205250:Elevated [Qualitative Concept]
   760   C0933647:A9 [Body Part, Organ, or Organ Component]
   760   C3163633:Elevated [Qualitative Concept]

Phrase: "(26,"

Phrase: "27"

Phrase: ")"

Phrase: "and"

Phrase: "calbindin D28K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elevated in A10 DA neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1512035:dopamine neurons [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0027882:Neurons [Cell]
   760   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]
   760   C0205250:Elevated [Qualitative Concept]
   760   C3163633:Elevated [Qualitative Concept]

Phrase: "(2325"

Phrase: ")"

Phrase: "(Fig.1E"

Phrase: ")."
Processing 00000000.tx.41: Glial fibrillary acidic protein (GFAP) was undetectable in both A9 and A10 samples, demonstrating the purity of the LCM samples (data not shown). 

Phrase: "Glial fibrillary acidic protein (GFAP)"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0017626:Glial Fibrillary Acidic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1325793:glial fibrillary acidic protein [Cell Component]
  1000   C1415042:GLIAL FIBRILLARY ACIDIC PROTEIN [Gene or Genome]
   812   C0001128:Acidic [Chemical]
   812   C0027836:Glial [Cell]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741 E C0202406:Acid [Laboratory Procedure]
   741 E C1087003:Glia [Plant]

Phrase: "was"

Phrase: "undetectable in both A9"

Phrase: "and"

Phrase: "A10 samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "demonstrating"

Phrase: "the purity of the LCM samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1882508:Purity [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.42: To investigate the molecular differences between DA neurons located in the A9 and A10 midbrain regions, we performed microarray analysis to compare the gene expression profiles of A9 and A10 DA neurons. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the molecular differences between DA neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "located in the A9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0933647:A9 [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "A10 midbrain regions,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "microarray analysis to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1449575:Microarray Analysis [Laboratory Procedure]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the gene expression profiles of A9"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C1956267:Gene Expression Profiles [Quantitative Concept]
   816 E C1449575:gene expression profile [Laboratory Procedure]
   719   C1979963:Profile [Laboratory Procedure]
   719   C2003903:Profile [Functional Concept]

Phrase: "and"

Phrase: "A10 DA neurons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.43: In total, five biological replicates from A9 and six biological replicates from A10 regions of mouse brain were analyzed on an Affymetrix Murine 430A high-density oligonucleotide array, which currently queries 22000 murine probe sets. 

Phrase: "In total,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "five biological"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0205460:biological [Qualitative Concept]

Phrase: "replicates from A9"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205173:Replicate [Functional Concept]
   790   C0205341:Replicate [Functional Concept]
   790   C0933647:A9 [Body Part, Organ, or Organ Component]
   790   C1883725:Replicate [Qualitative Concept]

Phrase: "and"

Phrase: "six biological"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0205460:biological [Qualitative Concept]

Phrase: "replicates from A10 regions of mouse brain"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C1521713:Mouse Brain [Tissue]
   774   C1273723:brain regions [Body Location or Region]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]
   748   C0205173:Replicate [Functional Concept]
   748   C0205341:Replicate [Functional Concept]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1883725:Replicate [Qualitative Concept]
   714   C0017446:Region [Geographic Area]
   714   C0205147:Region [Spatial Concept]

Phrase: "were"

Phrase: "analyzed on an Affymetrix Murine 430A high-density oligonucleotide array,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0600597:Oligonucleotide Array [Medical Device,Research Device]
   739   C0026809:Murine [Mammal]
   739   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0178587:density [Quantitative Concept]
   739   C0205250:High [Qualitative Concept]
   739   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   739   C0936012:Analyzed [Research Activity]
   739   C1299351:High [Qualitative Concept]
   739   C1510941:Array [Spatial Concept]
   739   C2700149:HIGH [Intellectual Product]

Phrase: "which currently queries 22000 murine probe sets."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0036849:Set [Mental Process]
   799   C0182400:Probe [Medical Device]
   799   C1442518:Set [Functional Concept]
   799   C1704681:Probe [Gene or Genome]
   799   C1705195:Set [Conceptual Entity]
   799   C2347609:Probe [Chemical Viewed Functionally]
   799   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.44: Paired hybridization results between replicates of A9 (Fig.1F) and A10 (Fig.1G) samples demonstrated the reproducibility between the biological replicates. 

Phrase: "Paired hybridization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020202:Hybridisation [Genetic Function]
   861   C1300517:Hybridization [Laboratory Procedure]

Phrase: "results between"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1274040:Result [Functional Concept]
   833   C1546471:Result [Idea or Concept]
   833   C2825142:Result [Finding]

Phrase: "replicates of A9"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205173:Replicate [Functional Concept]
   790   C0205341:Replicate [Functional Concept]
   790   C0933647:A9 [Body Part, Organ, or Organ Component]
   790   C1883725:Replicate [Qualitative Concept]

Phrase: "(Fig.1F"

Phrase: ")"

Phrase: "and"

Phrase: "A10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]

Phrase: "(Fig.1G"

Phrase: ")"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "demonstrated"

Phrase: "the reproducibility between the biological"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514863:Reproducibility [Qualitative Concept]

Phrase: "replicates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Replicate [Functional Concept]
  1000   C0205341:Replicate [Functional Concept]
  1000   C1883725:Replicate [Qualitative Concept]
Processing 00000000.tx.45: The distribution of gene expression signals from the combined data of the A9 and A10 series displayed similarity and even distribution of A9-elevated and A10-elevated genes in the plot (Fig.1H). 

Phrase: "The distribution of gene expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "signals from the combined data of the A9"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0205195:Combined [Qualitative Concept]
   744   C0933647:A9 [Body Part, Organ, or Organ Component]
   744   C1511726:Data [Idea or Concept]
   744   C1710082:Signal [Phenomenon or Process]
   744   C3245479:data [Medical Device]
   711 E C0336789:Combine [Manufactured Object]

Phrase: "and"

Phrase: "A10 series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205549:Series [Quantitative Concept]
   861   C2348044:Series [Intellectual Product]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "similarity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similarity [Qualitative Concept]

Phrase: "and"

Phrase: "even distribution of A9-elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "A10-elevated genes in the plot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017337:Genes [Gene or Genome]

Phrase: "(Fig.1H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442450:1H [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.46: Only a small number of genes were differentially expressed. 

Phrase: "Only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a small number of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "were"

Phrase: "differentially"

Phrase: "expressed."
Processing 00000000.tx.47: Forty-two genes had >2.0-fold elevation of mRNA levels in A9 compared with A10 DA neurons (Table1) and 221 genes had >1.5-fold elevation (FDR<1%) (Supplementary Material, TableS1). 

Phrase: "Forty-two genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "had >"

Phrase: "2.0-fold elevation of mRNA levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439775:Elevation [Therapeutic or Preventive Procedure]
   748   C0702240:Elevation [Spatial Concept]

Phrase: "in A9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0933647:A9 [Body Part, Organ, or Organ Component]

Phrase: "compared with A10 DA neurons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1512035:dopamine neurons [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0027882:Neurons [Cell]
   760   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]
   760   C1707455:Compared [Activity]

Phrase: "(Table1"

Phrase: ")"

Phrase: "and"

Phrase: "221 genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "had >"

Phrase: "1.5-fold elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439775:Elevation [Therapeutic or Preventive Procedure]
   812   C0702240:Elevation [Spatial Concept]

Phrase: "(FDR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1880720:False Discovery Rate [Quantitative Concept]
   901   C0205557:False Discovery [Laboratory or Test Result]
   827   C0205237:False [Qualitative Concept]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
   827   C1880355:Discovery [Activity]

Phrase: "<1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(Supplementary Material,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936424:Supplementary Material [Intellectual Product]
   861   C0520510:Material [Substance]

Phrase: "TableS1"

Phrase: ")."
Processing 00000000.tx.48: Sixty-one genes had >2.0-fold elevation of mRNA levels in A10 compared with A9 DA neurons (Table1) and 167 genes had >1.5-fold elevation (FDR<1%) (Supplementary Material, TableS1). 

Phrase: "Sixty-one genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "had >"

Phrase: "2.0-fold elevation of mRNA levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439775:Elevation [Therapeutic or Preventive Procedure]
   748   C0702240:Elevation [Spatial Concept]

Phrase: "in A10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]

Phrase: "compared with A9 DA neurons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1512035:dopamine neurons [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0027882:Neurons [Cell]
   760   C0933647:A9 [Body Part, Organ, or Organ Component]
   760   C1707455:Compared [Activity]

Phrase: "(Table1"

Phrase: ")"

Phrase: "and"

Phrase: "167 genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "had >"

Phrase: "1.5-fold elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439775:Elevation [Therapeutic or Preventive Procedure]
   812   C0702240:Elevation [Spatial Concept]

Phrase: "(FDR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1880720:False Discovery Rate [Quantitative Concept]
   901   C0205557:False Discovery [Laboratory or Test Result]
   827   C0205237:False [Qualitative Concept]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
   827   C1880355:Discovery [Activity]

Phrase: "<1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(Supplementary Material,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936424:Supplementary Material [Intellectual Product]
   861   C0520510:Material [Substance]

Phrase: "TableS1"

Phrase: ")."
Processing 00000000.tx.49: We validated the microarray analysis in two ways. 

Phrase: "We"

Phrase: "validated"

Phrase: "the microarray analysis in two ways."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1449575:Microarray Analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
Processing 00000000.tx.50: First, we verified previously reported gene expression differences reported between A9 and A10 DA neurons. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "we"

Phrase: "verified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verified [Functional Concept]

Phrase: "previously reported gene expression differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   771   C1705241:*Difference [Quantitative Concept]
   771   C1705242:Difference [Qualitative Concept]
   721 E C0443199:Differential [Qualitative Concept]

Phrase: "reported between A9"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C0933647:A9 [Body Part, Organ, or Organ Component]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "A10 DA neurons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.51: For example, Raldh1 (33) was elevated in A9 neurons and calbindin D28K (2325) and cholecystokinin (34,35) were elevated in A10 DA neurons (Supplementary Material, TableS1). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "Raldh1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412333:RALDH1 [Gene or Genome]

Phrase: "(33"

Phrase: ")"

Phrase: "was"

Phrase: "elevated in A9 neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0027882:Neurons [Cell]
   770   C0205250:Elevated [Qualitative Concept]
   770   C0933647:A9 [Body Part, Organ, or Organ Component]
   770   C3163633:Elevated [Qualitative Concept]

Phrase: "and"

Phrase: "calbindin D28K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(2325"

Phrase: ")"

Phrase: "and"

Phrase: "cholecystokinin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008328:Cholecystokinin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1413167:CHOLECYSTOKININ [Gene or Genome]

Phrase: "(34,"

Phrase: "35"

Phrase: ")"

Phrase: "were"

Phrase: "elevated in A10 DA neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1512035:dopamine neurons [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0027882:Neurons [Cell]
   760   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]
   760   C0205250:Elevated [Qualitative Concept]
   760   C3163633:Elevated [Qualitative Concept]

Phrase: "(Supplementary Material,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936424:Supplementary Material [Intellectual Product]
   861   C0520510:Material [Substance]

Phrase: "TableS1"

Phrase: ")."
Processing 00000000.tx.52: The known A9-elevated molecule, GIRK2, was confirmed only by real-time PCR as mentioned earlier [2.78-fold more expressed in A9 DA neurons (SEM0.94)], because GIRK2 gene is not represented in the microarray chips used in this study. 

Phrase: "The known A9-elevated molecule,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0567416:Molecule [Substance]
   741 E C1521991:Molecular [Qualitative Concept]

Phrase: "GIRK2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416588:GIRK2 [Gene or Genome]

Phrase: "was"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "only by real-time PCR"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   862   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   806   C1550177:Real Time [Idea or Concept]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0040223:Time [Temporal Concept]
   760   C0205171:Only [Quantitative Concept]
   760   C0237400:Real [Qualitative Concept]
   760   C0677874:pCR [Finding]
   760   C1720467:Only [Intellectual Product]
   760   C3272377:REAL [Intellectual Product]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "as"

Phrase: "mentioned"

Phrase: "earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "[2.78-fold more"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332462:Fold [Spatial Concept]
   812   C1880834:FOLD [Phenomenon or Process]

Phrase: "expressed in A9 DA neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1512035:dopamine neurons [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0027882:Neurons [Cell]
   760   C0933647:A9 [Body Part, Organ, or Organ Component]

Phrase: "(SEM0.94"

Phrase: ")"

Phrase: "],"

Phrase: "because"

Phrase: "GIRK2 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "represented in the microarray chips"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0349380:chips [Food]
   760   C1510451:Chips [Food]
   760   C1709016:Microarray [Manufactured Object]
   726 E C0600596:Chip [Research Device]
   726   C1882932:Represent [Activity]

Phrase: "used in this study."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.53: Secondly, using real-time PCR of laser-captured RNA samples, we quantified the mRNA levels of several genes from our microarray analysis to confirm gene expression patterns (Table2). 

Phrase: "Secondly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205436:Secondly [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "real-time PCR of laser-captured RNA samples,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   744   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0677874:pCR [Finding]

Phrase: "we"

Phrase: "quantified"

Phrase: "the mRNA levels of several genes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "from our microarray analysis to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1449575:Microarray Analysis [Laboratory Procedure]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "gene expression patterns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449774:Patterns [Spatial Concept]
   734   C0017262:Gene Expression [Genetic Function]

Phrase: "(Table2"

Phrase: ")."
Processing 00000000.tx.54: We chose to validate genes from various functional categories with potential association to relative vulnerability. 

Phrase: "We"

Phrase: "chose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Choose [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "validate"

Phrase: "genes from various functional categories"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017337:Genes [Gene or Genome]

Phrase: "with potential association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "to relative vulnerability."
Processing 00000000.tx.55: Among the 16 genes tested, none failed validation by quantitative PCR. 

Phrase: "Among the 16 genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ","

Phrase: "none failed validation by quantitative PCR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1519941:Validation [Research Activity]
Processing 00000000.tx.56: To gain insight into the biological relevance of differential A9/A10 gene expression, we analyzed genes that exhibited significant differences (FDR<1%) with Onto-Express (OE) software, which systematically translates genetic input into functional profiles (36). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "gain"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "insight into the biological relevance of differential A9/A10 gene expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0233820:Insight [Mental Process]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "that"

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "significant differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "(FDR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1880720:False Discovery Rate [Quantitative Concept]
   901   C0205557:False Discovery [Laboratory or Test Result]
   827   C0205237:False [Qualitative Concept]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
   827   C1880355:Discovery [Activity]

Phrase: "<1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "with"

Phrase: "Onto-"

Phrase: "Express"

Phrase: "(OE) software,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "which systematically"

Phrase: "translates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040710:translate [Occupational Activity]

Phrase: "genetic input into functional profiles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1708517:Input [Conceptual Entity]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.57: Genes from several categories showed interesting differences among cell groups. 

Phrase: "Genes from several categories"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017337:Genes [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "interesting differences among cell groups."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.58: Genes related to metabolism (Fig.2A) and genes encoding mitochondrial proteins (Fig.2B) were elevated in A9 DA neurons compared with A10 DA neurons. 

Phrase: "Genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "related to metabolism"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0025519:Metabolism [Organism Function]
   790   C0025520:metabolism [Functional Concept]
   790   C0439849:Related [Qualitative Concept]
   790   C0445223:Related [Finding]
   756 E C0163712:Relate [Organic Chemical]

Phrase: "(Fig.2A"

Phrase: ")"

Phrase: "and"

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "mitochondrial proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0949610:Mitochondrial Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig.2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: "were"

Phrase: "elevated in A9 DA neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1512035:dopamine neurons [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0027882:Neurons [Cell]
   760   C0205250:Elevated [Qualitative Concept]
   760   C0933647:A9 [Body Part, Organ, or Organ Component]
   760   C3163633:Elevated [Qualitative Concept]

Phrase: "compared with A10 DA neurons."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1512035:dopamine neurons [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0027882:Neurons [Cell]
   760   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]
   760   C1707455:Compared [Activity]
Processing 00000000.tx.59: Genes involved in protein, lipid and vesicle-mediated transport, but not ion transport, were also elevated in A9 DA neurons (Fig.2C). 

Phrase: "Genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "involved in protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1314939:Involved [Functional Concept]

Phrase: "lipid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipid [Lipid]

Phrase: "and"

Phrase: "vesicle-mediated transport,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1325417:vesicle-mediated transport [Cell Function]
           vesicle transport
   827   C0005528:Transport, NOS [Cell Function]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]

Phrase: "but"

Phrase: "not ion transport,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0162585:Ion Transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]

Phrase: "were"

Phrase: "also"

Phrase: "elevated in A9 DA neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1512035:dopamine neurons [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0027882:Neurons [Cell]
   760   C0205250:Elevated [Qualitative Concept]
   760   C0933647:A9 [Body Part, Organ, or Organ Component]
   760   C3163633:Elevated [Qualitative Concept]

Phrase: "(Fig.2C"

Phrase: ")."
Processing 00000000.tx.60: Several genes related to small GTPase-mediated signaling and synaptic vesicle recycling, including RAB and RAS proteins (37), were elevated in A9 DA neurons (Supplementary Material, TableS1) and genes related to neuropeptide and hormone activity and axon guidance were elevated in A10 cells (Table3). 

Phrase: "Several genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "related to small GTPase-mediated signaling"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0018296:GTPase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0037083:Signaling [Cell Function]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   753   C0700321:Small [Quantitative Concept]
   753   C3537152:signaling [Biologic Function]
   719 E C0163712:Relate [Organic Chemical]

Phrase: "and"

Phrase: "synaptic vesicle recycling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0282114:Recycling [Human-caused Phenomenon or Process]
   734   C0039065:Synaptic vesicle [Cell Component]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "RAB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415715:RAB [Gene or Genome]

Phrase: "and"

Phrase: "RAS proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242853:ras Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(37"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "elevated in A9 DA neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1512035:dopamine neurons [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0027882:Neurons [Cell]
   760   C0205250:Elevated [Qualitative Concept]
   760   C0933647:A9 [Body Part, Organ, or Organ Component]
   760   C3163633:Elevated [Qualitative Concept]

Phrase: "(Supplementary Material,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936424:Supplementary Material [Intellectual Product]
   861   C0520510:Material [Substance]

Phrase: "TableS1"

Phrase: ")"

Phrase: "and"

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "related to neuropeptide"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   790   C0439849:Related [Qualitative Concept]
   790   C0445223:Related [Finding]
   756 E C0163712:Relate [Organic Chemical]

Phrase: "and"

Phrase: "hormone activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1149475:hormone activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "axon guidance"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C2984268:Axon guidance [Cell Function]
   964 E C0598948:axonal guidance [Cell Function]
   861   C0150600:Guidance [Health Care Activity]
   861   C1959633:Guidance [Clinical Attribute]

Phrase: "were"

Phrase: "elevated in A10 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]
   770   C0205250:Elevated [Qualitative Concept]
   770   C3163633:Elevated [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Table3"

Phrase: ")."
Processing 00000000.tx.61: Intriguingly, certain opposing molecular functional categories exhibited inverse expression patterns in A9 and A10 DA neurons. 

Phrase: "Intriguingly,"

Phrase: "certain opposing molecular functional categories"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0683312:Categories [Intellectual Product]
   771 E C1555713:category [Idea or Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "inverse expression patterns in A9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Patterns [Spatial Concept]

Phrase: "and"

Phrase: "A10 DA neurons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.62: For example, gene expression of proteases and phosphatases was elevated in A9 DA neurons, whereas inhibitors of proteases and phosphatases were elevated in A10 DA neurons (Table3). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "gene expression of proteases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0017262:Gene Expression [Genetic Function]
   802   C1335528:Protease Gene [Gene or Genome]
   770   C0017337:Gene [Gene or Genome]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "phosphatases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031678:Phosphatases [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C1149880:phosphatase [Molecular Function]

Phrase: "was"

Phrase: "elevated in A9 DA neurons,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1512035:dopamine neurons [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0027882:Neurons [Cell]
   760   C0205250:Elevated [Qualitative Concept]
   760   C0933647:A9 [Body Part, Organ, or Organ Component]
   760   C3163633:Elevated [Qualitative Concept]

Phrase: "whereas"

Phrase: "inhibitors of proteases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   841   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   824 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   790   C0243077:inhibitors [Chemical Viewed Functionally]
   756 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "phosphatases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031678:Phosphatases [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C1149880:phosphatase [Molecular Function]

Phrase: "were"

Phrase: "elevated in A10 DA neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1512035:dopamine neurons [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0027882:Neurons [Cell]
   760   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]
   760   C0205250:Elevated [Qualitative Concept]
   760   C3163633:Elevated [Qualitative Concept]

Phrase: "(Table3"

Phrase: ")."
Processing 00000000.tx.63: Two pro-apoptotic genes, caspase 7 and Bcl2-like 11 (38), were elevated in A9 neurons (Table3). 

Phrase: "Two pro-apoptotic genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Genes [Gene or Genome]

Phrase: "caspase 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0537969:caspase-7 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Bcl2-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376515:BCL2 [Gene or Genome]
  1000   C0597712:BCL2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "like 11"

Phrase: "(38"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "elevated in A9 neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0027882:Neurons [Cell]
   770   C0205250:Elevated [Qualitative Concept]
   770   C0933647:A9 [Body Part, Organ, or Organ Component]
   770   C3163633:Elevated [Qualitative Concept]

Phrase: "(Table3"

Phrase: ")."
Processing 00000000.tx.64: View larger version (39K): [in this window] [in a new window]  Figure1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(39K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure1."
Processing 00000000.tx.65: LCM and microarray on A9 and A10 DA neurons. 

Phrase: "LCM"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1113652:Laser Capture Microdissection [Laboratory Procedure]
   827   C0023089:Laser [Manufactured Object]
   827   C0458142:Laser [Phenomenon or Process]
   827   C0598304:Microdissection [Laboratory Procedure]
   827   C1023865:Laser [Plant]
   827   C1706315:Laser [Medical Device]

Phrase: "and"

Phrase: "microarray on A9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709016:Microarray [Manufactured Object]

Phrase: "and"

Phrase: "A10 DA neurons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.66: (A) Coronal section of the mouse midbrain after quick TH immunostaining. 

Phrase: "(A) Coronal section of the mouse midbrain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205123:Coronal [Spatial Concept]
   748   C0205155:Section [Spatial Concept]
   748   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   748   C1522472:Section [Substance]
   748   C1552923:Section [Quantitative Concept]
   748   C1705191:Section [Physical Object]

Phrase: "after quick TH immunostaining."
Processing 00000000.tx.67: A9 DA neurons are located in the SN pars reticulata (SNr) and the lateral part of SN pars compacta (SNc) marked by a red dotted line. 

Phrase: "A9 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "are"

Phrase: "located in the SN pars reticulata"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   853   C0175413:Substantia nigra pars reticulata [Body Part, Organ, or Organ Component]
           Pars reticulata
   778   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   778   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
   748   C0032405:PARS [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1414437:PARS [Gene or Genome]
   714 E C1417826:PAR [Gene or Genome]
   714 E C1514229:PAR [Quantitative Concept]
   714 E C1705885:PAR [Gene or Genome]

Phrase: "(SNr)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986823:SNR [Quantitative Concept]

Phrase: "and"

Phrase: "the lateral part of SN pars compacta"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   869   C2326281:Lateral part of substantia nigra [Body Part, Organ, or Organ Component]
   770   C0442055:Lateral part [Spatial Concept]
   770   C1292711:Part of [Spatial Concept]
   744   C0205093:Lateral [Spatial Concept]
   744   C0449719:Part [Spatial Concept]
   744   C1709471:Part [Quantitative Concept]

Phrase: "(SNc)"

Phrase: "marked by a red dotted line."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0205132:Line [Spatial Concept]
   753   C0332575:Red [Finding]
   753   C0522501:Marked [Qualitative Concept]
   753   C1260956:Red [Qualitative Concept]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]
   753   C1706089:Marked [Qualitative Concept]
   719   C0872145:DOT [Therapeutic or Preventive Procedure]
Processing 00000000.tx.68: A10 DA neurons are located in the medial part of the ventral tegmental area (VTA), the nucleus PN and the interfascicular nucleus (IF) marked by a green dotted line. 

Phrase: "A10 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "are"

Phrase: "located in the medial part of the ventral tegmental area (VTA),"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   782   C0175405:Ventral Tegmental Area [Body Part, Organ, or Organ Component]
   760   C0442056:Medial part [Spatial Concept]
   760   C1292711:Part of [Spatial Concept]
   757   C0442053:Ventral part [Spatial Concept]
   739   C0017446:Area [Geographic Area]
   739   C0205098:Medial [Spatial Concept]
   739   C0205146:Area [Spatial Concept]
   739   C0449719:Part [Spatial Concept]
   739   C1704448:Ventral [Spatial Concept]
   739   C1709471:Part [Quantitative Concept]

Phrase: "the nucleus PN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2330526:Nucleus paranigralis [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the interfascicular nucleus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2331355:Interfascicular nucleus [Body Part, Organ, or Organ Component]
   861   C0007610:Nucleus [Cell Component]

Phrase: "("

Phrase: "IF)"

Phrase: "marked by a green dotted line."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205132:Line [Spatial Concept]
   753   C0332583:Green [Qualitative Concept]
   753   C0522501:Marked [Qualitative Concept]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]
   753   C1706089:Marked [Qualitative Concept]
   719   C0872145:DOT [Therapeutic or Preventive Procedure]
Processing 00000000.tx.69: (BD) LCM of the midbrain DA neurons. 

Phrase: "(BD) LCM of the midbrain DA neurons."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1113652:Laser Capture Microdissection [Laboratory Procedure]
   742   C0023089:Laser [Manufactured Object]
   742   C0458142:Laser [Phenomenon or Process]
   742   C0598304:Microdissection [Laboratory Procedure]
   742   C1023865:Laser [Plant]
   742   C1706315:Laser [Medical Device]
Processing 00000000.tx.70: Selection of DA neurons was guided by quick TH immunostaining. 

Phrase: "Selection of DA neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0036576:selection [Genetic Function]

Phrase: "was"

Phrase: "guided by quick TH immunostaining."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0039725:TH [Geographic Area]
   760   C0039738:Th [Element, Ion, or Isotope]
   760   C0439831:quick [Qualitative Concept]
   760   C1420718:TH [Gene or Genome]
   726   C0181090:Guide [Professional or Occupational Group]
   726   C0302614:Guide [Medical Device]
   726   C1706050:Guide [Manufactured Object]
Processing 00000000.tx.71: (B) TH-positive neurons in SNc before laser capture. 

Phrase: "(B) TH-positive neurons in SNc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0027882:Neurons [Cell]

Phrase: "before laser capture."
Processing 00000000.tx.72: (C) The TH-positive cells were targeted for laser capture with a 7.5M laser diameter. 

Phrase: "(C"

Phrase: ")"

Phrase: "The TH-positive cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0439178:% positive cells [Quantitative Concept]
   896   C0018894:Th cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "targeted for laser capture"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0023089:Laser [Manufactured Object]
   770   C0458142:Laser [Phenomenon or Process]
   770   C1023865:Laser [Plant]
   770   C1521840:Targeted [Functional Concept]
   770   C1706315:Laser [Medical Device]
   737 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "with a 7.5M laser diameter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1301886:Diameter [Quantitative Concept]
Processing 00000000.tx.73: (D) Captured cells on the thermoplastic film were visualized before processing for RNA extraction. 

Phrase: "("

Phrase: "D)"

Phrase: "Captured cells on the thermoplastic film"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "visualized before processing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0234621:Visualized [Functional Concept]
   790   C1709694:Processing [Activity]

Phrase: "for RNA extraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185115:Extraction [Therapeutic or Preventive Procedure]
   861   C0684295:extraction [Laboratory Procedure]
Processing 00000000.tx.74: (E) Validation of GIRK2 and calbindin D28K mRNA levels in LCM samples by real-time PCR. 

Phrase: "(E) Validation of GIRK2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1519941:Validation [Research Activity]

Phrase: "and"

Phrase: "calbindin D28K mRNA levels in LCM samples"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   742   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "by real-time PCR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   734   C1550177:Real Time [Idea or Concept]
Processing 00000000.tx.75: The transcript level of GIRK2 was 2.78-fold (SEM0.94) higher in A9 and that of calbindin was 2.90-fold (SEM0.64) higher in A10 DA neurons. 

Phrase: "The transcript level of GIRK2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "2.78-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(SEM0.94"

Phrase: ")"

Phrase: "higher in A9"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "and"

Phrase: "that of calbindin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0054444:Calbindin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "2.90-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(SEM0.64"

Phrase: ")"

Phrase: "higher in A10 DA neurons."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.76: (F and G) Gene expression profiles of A9 and A10 DA neurons determined by microarray analysis. 

Phrase: "(F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "G) Gene expression profiles of A9"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C1956267:Gene Expression Profiles [Quantitative Concept]
   816 E C1449575:gene expression profile [Laboratory Procedure]
   719   C1979963:Profile [Laboratory Procedure]
   719   C2003903:Profile [Functional Concept]

Phrase: "and"

Phrase: "A10 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "determined by microarray analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1449575:Microarray Analysis [Laboratory Procedure]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C1709016:Microarray [Manufactured Object]
Processing 00000000.tx.77: There is a high reproducibility between A9 (F) and A10 (G) microarray replicates. 

Phrase: "There"

Phrase: "is"

Phrase: "a high reproducibility between A9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514863:Reproducibility [Qualitative Concept]

Phrase: "(F)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "A10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]

Phrase: "(G) microarray"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709016:Microarray [Manufactured Object]

Phrase: "replicates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Replicate [Functional Concept]
  1000   C0205341:Replicate [Functional Concept]
  1000   C1883725:Replicate [Qualitative Concept]
Processing 00000000.tx.78: (H) Differential gene expression between A9 and A10 replicates showed genes with differential expression. 

Phrase: "(H) Differential gene expression between A9"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1519516:Differential Gene Expression [Genetic Function]
   790   C0017262:Gene Expression [Genetic Function]
   753   C0017337:Gene [Gene or Genome]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "A10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]

Phrase: "replicates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Replicate [Functional Concept]
  1000   C0205341:Replicate [Functional Concept]
  1000   C1883725:Replicate [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "genes with differential expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   856   C1519516:Differential Gene Expression [Genetic Function]
   802   C0017262:Gene Expression [Genetic Function]
   770   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.79: All genes were plotted on a log scale and represent a comparison between microdissected samples of A9 and A10. 

Phrase: "All genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "were"

Phrase: "plotted on a log scale"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0175659:Scale [Medical Device]
   760   C0349674:Scale [Intellectual Product]
   760   C1708728:Log [Intellectual Product]
   760   C1947916:Scale [Activity]
   760   C2986775:log [Occupational Activity]
   760   C3536777:Scale [Manufactured Object]

Phrase: "and"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a comparison between microdissected samples of A9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "A10."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.80: Five A9 replicates are plotted against six A10 replicates to determine the differential gene expression between the groups. 

Phrase: "Five A9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0933647:A9 [Body Part, Organ, or Organ Component]

Phrase: "replicates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Replicate [Functional Concept]
  1000   C0205341:Replicate [Functional Concept]
  1000   C1883725:Replicate [Qualitative Concept]

Phrase: "are"

Phrase: "plotted against six A10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]
   770   C0205452:Six [Quantitative Concept]

Phrase: "replicates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Replicate [Functional Concept]
  1000   C0205341:Replicate [Functional Concept]
  1000   C1883725:Replicate [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the differential gene expression between the groups."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C1519516:Differential Gene Expression [Genetic Function]
   778   C0017262:Gene Expression [Genetic Function]
   748   C0017337:Gene [Gene or Genome]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.81: The distance from the midline infers increasing levels of differential gene expression. 

Phrase: "The distance from the midline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0012751:Distance [Quantitative Concept]

Phrase: "infers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679201:Infer [Mental Process]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "levels of differential gene expression."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C3244092:expression level [Idea or Concept]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.82: All data were normalized using the probe level Robust Multi-Chip Analysis (RMA) algorithm.  

Phrase: "All data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the probe level Robust Multi-Chip Analysis (RMA) algorithm."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0002045:algorithm [Intellectual Product]
   795   C1553907:algorithm [Laboratory Procedure]
Processing 00000000.tx.83: View this table: [in this window] [in a new window]  Table1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table1."
Processing 00000000.tx.84: The differentially expressed genes between A9 and A10 DA neurons (>2-fold, FDR<1%)  View this table: [in this window] [in a new window]  Table2. 

Phrase: "The differentially expressed genes between A9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "A10 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "("

Phrase: ">2-fold,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "FDR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1880720:False Discovery Rate [Quantitative Concept]
   901   C0205557:False Discovery [Laboratory or Test Result]
   827   C0205237:False [Qualitative Concept]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
   827   C1880355:Discovery [Activity]

Phrase: "<1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table2."
Processing 00000000.tx.85: Validation of microarray results by real-time PCR on RNA samples collected by LCM  View larger version (46K): [in this window] [in a new window]  Figure2. 

Phrase: "Validation of microarray results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1519941:Validation [Research Activity]

Phrase: "by real-time PCR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   734   C1550177:Real Time [Idea or Concept]

Phrase: "on RNA samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "collected by LCM"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C1113652:Laser Capture Microdissection [Laboratory Procedure]
   760   C0023089:Laser [Manufactured Object]
   760   C0458142:Laser [Phenomenon or Process]
   760   C0598304:Microdissection [Laboratory Procedure]
   760   C1023865:Laser [Plant]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]
   760   C1706315:Laser [Medical Device]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(46K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure2."
Processing 00000000.tx.86: Functional profiles of microarray data. 

Phrase: "Functional profiles of microarray data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1979963:Profile [Laboratory Procedure]
   726   C2003903:Profile [Functional Concept]
Processing 00000000.tx.87: A9- and A10-elevated genes were categorized based on biological functions and cellular components by Onto-Express (36). 

Phrase: "A9-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0933647:A9 [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "A10-elevated genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "were"

Phrase: "categorized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871968:categorized [Activity]

Phrase: "based on biological functions"
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   799   C0031845:Biological function, NOS [Physiologic Function]
   770   C0005532:Biological [Biomedical Occupation or Discipline]
   770   C0205460:biological [Qualitative Concept]
   770   C0542341:Functions [Functional Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0031843:function [Physiologic Function]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C0700205:FUNCTION [Classification]
   737 E C1705273:Function [Intellectual Product]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "cellular components by"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   866   C1166607:cellular component [Cell Component]
   790   C0449432:Components [Manufactured Object]
   756 E C1705248:Component [Conceptual Entity]

Phrase: "Onto-"

Phrase: "Express"

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.88: Genes with significant differences (FDR<1%) were distributed into different categories of metabolisms (A), cellular components in cytoplasm (B) and transport mechanisms (C).  

Phrase: "Genes with significant differences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017337:Genes [Gene or Genome]

Phrase: "(FDR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1880720:False Discovery Rate [Quantitative Concept]
   901   C0205557:False Discovery [Laboratory or Test Result]
   827   C0205237:False [Qualitative Concept]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
   827   C1880355:Discovery [Activity]

Phrase: "<1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "were"

Phrase: "distributed into different categories of metabolisms"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0025519:metabolisms [Organism Function]
   753   C0683312:Categories [Intellectual Product]
   753   C1704711:Distributed [Functional Concept]
   753   C1705242:Different [Qualitative Concept]
   719 E C0025520:metabolism [Functional Concept]
   719 E C1555713:category [Idea or Concept]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "cellular components in cytoplasm"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   816   C1166607:cellular component [Cell Component]
   802   C1820050:cytoplasm component [Cell Component]
   770   C0449432:Components [Manufactured Object]
   737 E C1705248:Component [Conceptual Entity]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "transport mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "(C"

Phrase: ")."
Processing 00000000.tx.89: View this table: [in this window] [in a new window]  Table3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table3."
Processing 00000000.tx.90: Comparison of genetic profiles in A9 and A10 DA neurons from microarray analyses (>1.5-fold, FDR<1%)  Altered vulnerability of -synuclein overexpressing PC12 cells and primary VM cultures by molecules elevated in A9 DA neurons To investigate and to efficiently screen candidate genes with functional relevance to PD-related vulnerability, we used inducible -synuclein overexpressing PC12 cells (PC12-Syn) (39) in combination with MPP+ treatment. 

Phrase: "Comparison of genetic profiles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "in A9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0933647:A9 [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "A10 DA neurons from microarray analyses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1512035:dopamine neurons [Cell]
   753   C0027882:Neurons [Cell]

Phrase: "("

Phrase: ">1.5-fold,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0450316:1/5 [Quantitative Concept]

Phrase: "FDR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1880720:False Discovery Rate [Quantitative Concept]
   901   C0205557:False Discovery [Laboratory or Test Result]
   827   C0205237:False [Qualitative Concept]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
   827   C1880355:Discovery [Activity]

Phrase: "<1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "Altered vulnerability of -synuclein overexpressing PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   818   C0085262:PC12 Cells [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "primary VM cultures by molecules"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0010453:Cultures [Idea or Concept]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C2242979:Culture [Laboratory Procedure]

Phrase: "elevated in A9 DA neurons To"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1512035:dopamine neurons [Cell]
   753   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   753   C0027882:Neurons [Cell]
   753   C0205250:Elevated [Qualitative Concept]
   753   C0933647:A9 [Body Part, Organ, or Organ Component]
   753   C3163633:Elevated [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "and"

Phrase: "to efficiently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "screen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220908:screen [Health Care Activity]
  1000   C1305399:screen [Functional Concept]
  1000   C1705053:Screen [Medical Device]

Phrase: "candidate genes with functional relevance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1332838:Candidate Genes [Gene or Genome]
   760   C0017337:Genes [Gene or Genome]

Phrase: "to PD-related vulnerability,"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "inducible -synuclein overexpressing PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C0085262:PC12 Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(PC12-Syn) (39"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085262:PC-12 [Cell]
   827   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "with MPP+ treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.91: This cell culture model combines two features of PD-related pathogenetic mechanisms: MPP+-induced mitochondrial complex I inhibition (40) and -synuclein overexpression (11). 

Phrase: "This cell culture model"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C0007585:Cell Culture [Laboratory Procedure]
   827   C0007634:Cell [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]
   827   C3161035:Model [Intellectual Product]

Phrase: "combines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336789:Combine [Manufactured Object]

Phrase: "two features of PD-related pathogenetic mechanisms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   714   C1521970:Feature [Qualitative Concept]
   714   C1706388:Feature [Conceptual Entity]
   714   C2346469:Feature [Qualitative Concept]
   714   C2348519:Feature [Qualitative Concept]

Phrase: ":"

Phrase: "MPP+-induced mitochondrial complex I inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   799   C0021467:Inhibition [Mental Process]
   799   C0021469:Inhibition [Molecular Function]
   799   C1628982:% inhibition [Quantitative Concept]
   799   C3463820:Inhibition [Activity]
   727 E C0311403:Inhibited [Qualitative Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "and -"

Phrase: "synuclein overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514559:Overexpression [Genetic Function]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.92: We first established that overexpression of -synuclein increased the susceptibility of PC12 cells to MPP+. 

Phrase: "We first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that overexpression of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the susceptibility of PC12 cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "to MPP+."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000098:MPP+ [Hazardous or Poisonous Substance,Organic Chemical]
  1000   C1417248:MPP [Gene or Genome]
Processing 00000000.tx.93: There were 32% (SEM2.6), 66% (SEM3.8) and 20% (SEM3.8) increases in LDH release at 1, 2.5, and 5mM MPP+, respectively, when compared with control PC12 cells (P<0.05; n=4). 

Phrase: "There"

Phrase: "were"

Phrase: "32%"

Phrase: "(SEM2.6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1822673:sem2 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "66%"

Phrase: "(SEM3.8"

Phrase: ")"

Phrase: "and"

Phrase: "20%"

Phrase: "(SEM3.8"

Phrase: ")"

Phrase: "increases in LDH release at 1,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   804   C0023165:lactate dehydrogenase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   763   C0151754:Increased lactate dehydrogenase [Finding]
   748   C0022924:lactate [Organic Chemical]
   748   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0030685:Release [Health Care Activity]
   748   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0442805:Increase [Functional Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "2.5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0450346:2 5 [Quantitative Concept]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "5mM MPP+,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0000098:MPP+ [Hazardous or Poisonous Substance,Organic Chemical]
   861   C1417248:MPP [Gene or Genome]

Phrase: "respectively,"

Phrase: "when"

Phrase: "compared with control PC12 cells"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   806   C0085262:PC12 Cells [Cell]
           PC-12
   760   C0007634:Cells [Cell]
   760   C0243148:control [Qualitative Concept]
   760   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.94: We then investigated GIRK2, which is known to be elevated in A9 DA neurons (26,27) and linked to the degeneration of A9 DA neurons in the weaver mouse (26,41,42). 

Phrase: "We then investigated GIRK2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1416588:GIRK2 [Gene or Genome]

Phrase: "which"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "elevated in A9 DA neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1512035:dopamine neurons [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0027882:Neurons [Cell]
   760   C0205250:Elevated [Qualitative Concept]
   760   C0933647:A9 [Body Part, Organ, or Organ Component]
   760   C3163633:Elevated [Qualitative Concept]

Phrase: "(26,"

Phrase: "27"

Phrase: ")"

Phrase: "and"

Phrase: "linked to the degeneration of A9 DA neurons"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C1512035:dopamine neurons [Cell]
   767   C0027746:degeneration neurons [Cell or Molecular Dysfunction]
   744   C0011164:Degeneration [Pathologic Function]
   744   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   744   C0027882:Neurons [Cell]
   744   C0933647:A9 [Body Part, Organ, or Organ Component]
   744   C1880269:Degeneration [Functional Concept]
   711   C1517892:Link [Intellectual Product]
   711   C1704666:Link [Intellectual Product]

Phrase: "in the weaver mouse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0043086:Weaver Mouse [Mammal]
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]
   861   C0326812:Weaver [Bird]

Phrase: "(26,"

Phrase: "41,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.95: We tested whether an increase in GIRK2 expression levels could modulate vulnerability to MPP+ in PC12-Syn. 

Phrase: "We"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "whether"

Phrase: "an increase in GIRK2 expression levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "could"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "vulnerability to MPP+"

Phrase: "in PC12-Syn."
Processing 00000000.tx.96: Lentivirus-mediated overexpression of GIRK2 in PC12-Syn (Fig.3A and 3B) resulted in significantly increased vulnerability at low (1mM) and high (5mM) concentrations of MPP+ when compared with control (eGFP-transduced) cells (Fig.3C). 

Phrase: "Lentivirus-mediated overexpression of GIRK2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "in PC12-Syn (Fig.3A"

Phrase: "and"

Phrase: "3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450365:3b [Intellectual Product]
  1000   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: "resulted in significantly increased vulnerability"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "at low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "(1mM"

Phrase: ")"

Phrase: "and"

Phrase: "high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "(5mM"

Phrase: ")"

Phrase: "concentrations of MPP+"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0086045:Concentrations [Mental Process]
   756 E C1446561:Concentration [Quantitative Concept]
   706 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "when"

Phrase: "compared with control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "(eGFP-transduced"

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig.3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.97: Then, we characterized GIRK2 expression in TH-positive cells of primary VM cultures (Fig.3D and 3E). 

Phrase: "Then,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "we"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "GIRK2 expression in TH-positive cells of primary VM cultures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450363:3D [Spatial Concept]
  1000   C2986797:3D [Functional Concept]

Phrase: "and"

Phrase: "3E"

Phrase: ")."
Processing 00000000.tx.98: These cultures contained a mixed cell population of A9- and A10-like DA neurons and 40% of the TH-positive neurons at 5 days in vitro were GIRK2-positive by immunocytochemistry (Fig.3E). 

Phrase: "These cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "a mixed cell population of A9-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0032659:Population [Quantitative Concept]
   753   C1257890:Population [Population Group]

Phrase: "and"

Phrase: "A10-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]

Phrase: "like DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1512035:dopamine neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "40% of the TH-positive neurons"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0027882:Neurons [Cell]
   753   C0039725:TH [Geographic Area]
   753   C0039738:Th [Element, Ion, or Isotope]
   753   C0439178:% Positive [Quantitative Concept]
   753   C0439509:/40 [Temporal Concept]
   753   C1420718:TH [Gene or Genome]
   753   C1446409:Positive [Qualitative Concept]
   753   C1514241:Positive [Finding]
   753   C2825490:Positive [Qualitative Concept]

Phrase: "at 5 days in vitro"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0021135:In Vitro [Intellectual Product]
   861   C1442466:5 Days [Temporal Concept]
   861   C1533691:in vitro [Qualitative Concept]
           vitro
   861   C2827718:In Vitro [Functional Concept]
   812   C0439228:days [Temporal Concept]
   779 E C0332173:/day [Temporal Concept]
   779 E C0439505:/day [Temporal Concept]

Phrase: "were"

Phrase: "GIRK2-positive by immunocytochemistry"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439178:% Positive [Quantitative Concept]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C2825490:Positive [Qualitative Concept]

Phrase: "(Fig.3E"

Phrase: ")."
Processing 00000000.tx.99: The number of TH-positive/GIRK2-positive cells was reduced following MPP+ treatment, presumably reflecting vulnerability to this mitochondrial toxin when compared with TH-positive/GIRK2-negative cells (Fig.3E). 

Phrase: "The number of TH-positive/GIRK2-positive cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   750   C0007584:Cell Number [Laboratory Procedure]
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "MPP+ treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "presumably"

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "vulnerability to this mitochondrial toxin"

Phrase: "when"

Phrase: "compared with TH-positive/GIRK2-negative cells"
Meta Candidates (Total=20; Excluded=3; Pruned=0; Remaining=17)
   774   C0439178:% positive cells [Quantitative Concept]
           % Positive
   757   C0018894:Th cell [Cell]
   748   C0007634:Cells [Cell]
   748   C0039725:TH [Geographic Area]
   748   C0039738:Th [Element, Ion, or Isotope]
   748   C0205160:Negative [Qualitative Concept]
   748   C1416588:GIRK2 [Gene or Genome]
   748   C1420718:TH [Gene or Genome]
   748   C1446409:Positive [Qualitative Concept]
   748   C1513916:Negative [Finding]
   748   C1514241:Positive [Finding]
   748   C1707455:Compared [Activity]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825490:Positive [Qualitative Concept]
   748   C2825491:Negative [Qualitative Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig.3E"

Phrase: ")."
Processing 00000000.tx.100: We also examined a role of a mitochondrial protein, adenine nucleotide translocase (ANT) 2, which was elevated in A9 neurons (Table2) on MPP+ induced toxicity. 

Phrase: "We also"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "a role of a mitochondrial protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "adenine nucleotide translocase (ANT) 2,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C1141015:Adenine Nucleotide Translocase [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1153238:adenine nucleotide translocase [Molecular Function]
   861   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C1135982:Nucleotide Translocase [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0582119:Translocase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "which"

Phrase: "was"

Phrase: "elevated in A9 neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0027882:Neurons [Cell]
   770   C0205250:Elevated [Qualitative Concept]
   770   C0933647:A9 [Body Part, Organ, or Organ Component]
   770   C3163633:Elevated [Qualitative Concept]

Phrase: "(Table2"

Phrase: ")"

Phrase: "on MPP+ induced toxicity."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   827   C0040539:toxicity [Qualitative Concept]
   827   C0600688:Toxicity [Injury or Poisoning]
   755 E C1407029:Toxic [Qualitative Concept]
   734 E C0032346:Poison [Hazardous or Poisonous Substance]
   734 E C1548769:Poison [Intellectual Product]
   734 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.101: ANTs appear to have an essential role in regulating permeability transition of mitochondria (43), which may in turn induce apoptosis (44). 

Phrase: "ANTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003455:Ants [Eukaryote]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "an essential role in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "regulating"

Phrase: "permeability transition of mitochondria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0031164:Permeability [Natural Phenomenon or Process]
   770   C0599156:Transition [Cell or Molecular Dysfunction]
   770   C2700061:Transition [Activity]

Phrase: "(43"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "may"

Phrase: "in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.102: As ANT-2 mRNA was abundant in PC12 cells (data not shown), we inhibited the activity of ANT-2 by applying its inhibitor, bongkrekic acid (BA) in the presence of MPP+. 

Phrase: "As ANT-2 mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771   C0600150:Adenine Nucleotide Translocator 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1335834:ADENINE NUCLEOTIDE TRANSLOCATOR 2 [Gene or Genome]
   771   C1442882:Adenine Nucleotide Translocator-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "abundant in PC12 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2346714:Abundant [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the activity of ANT-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "by applying"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0185125:Apply [Health Care Activity]
   966   C1632850:Apply [Functional Concept]
   966   C1879355:Apply [Functional Concept]

Phrase: "its inhibitor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999216:Inhibitor [Qualitative Concept]

Phrase: "bongkrekic acid (BA) in the presence of MPP+."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0005982:Bongkrekic Acid [Organic Chemical,Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.103: BA was able to decrease MPP+-induced LDH release in a dose-dependent manner (Fig.3F), indicating that higher expression of ANT-2 may increase susceptibility to MPP+ toxicity. 

Phrase: "BA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005982:Bongkrekic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "MPP+-induced LDH release in a dose-dependent manner"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0030685:Release [Health Care Activity]
   739   C0391871:Release [Functional Concept]
   739   C0439180:% release [Quantitative Concept]
   739   C0680255:release [Health Care Activity]
   739   C1283071:Release [Functional Concept]
   739   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(Fig.3F"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that higher expression of ANT-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "susceptibility to MPP+ toxicity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]
Processing 00000000.tx.104: In primary VM cultures, BA showed a significant protective effect on both GIRK2-negative and GIRK2-positive DA neurons (Fig.3G). 

Phrase: "In primary VM cultures,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "BA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005982:Bongkrekic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a significant protective effect on both GIRK2-negative"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "GIRK2-positive DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1512035:dopamine neurons [Cell]
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(Fig.3G"

Phrase: ")."
Processing 00000000.tx.105: Interestingly, GIRK2-negative DA neurons appeared to be more sensitive to BA, as these A10-like DA neurons were maximally protected at lower doses than GIRK2-positive DA neurons (Fig.3G). 

Phrase: "Interestingly,"

Phrase: "GIRK2-negative DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1512035:dopamine neurons [Cell]
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "more sensitive to BA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332324:Sensitive to [Functional Concept]
           Sensitive
   760   C1550474:sensitive [Idea or Concept]

Phrase: "as"

Phrase: "these A10-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]

Phrase: "like DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1512035:dopamine neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "maximally"

Phrase: "protected at lower doses"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0178602:Doses [Quantitative Concept]
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]
   737 E C0869039:Dose [Quantitative Concept]
   737 E C1114758:Dose # [Clinical Attribute]
   737 E C1428722:DOS [Gene or Genome]

Phrase: "than GIRK2-positive DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1512035:dopamine neurons [Cell]
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(Fig.3G"

Phrase: ")."
Processing 00000000.tx.106: View larger version (44K): [in this window] [in a new window]  Figure3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(44K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure3."
Processing 00000000.tx.107: Altered vulnerability of PC12-Syn cells and primary VM cultures by A9-elevated molecules. 

Phrase: "Altered vulnerability of PC12-Syn cells"

Phrase: "and"

Phrase: "primary VM cultures by A9-elevated molecules."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0010453:Cultures [Idea or Concept]
   711 E C0220814:culture [Functional Concept]
   711 E C0430400:Culture [Laboratory Procedure]
   711 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.108: (AC) Effects of GIRK2 overexpression in PC12-Syn cells. 

Phrase: "(AC) Effects of GIRK2 overexpression"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "in PC12-Syn cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0085262:PC12 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.109: Cells were transduced with either eGFP or GIRK2-expressing lentiviruses at an MOI of 5 and higher GIRK2 expression was achieved in GIRK2-transduced cells (B) when compared with untransduced cells (A). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transduced with either eGFP"

Phrase: "or"

Phrase: "GIRK2-expressing lentiviruses at an MOI of 5"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0079679:Lentiviruses [Virus]
   711 E C0206037:Lentivirus [Virus]

Phrase: "and"

Phrase: "higher GIRK2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "achieved in GIRK2-transduced cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C1416588:GIRK2 [Gene or Genome]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "when"

Phrase: "compared with untransduced cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(A"

Phrase: ")."
Processing 00000000.tx.110: Red staining represents GIRK2 and cell nuclei were visualized by DAPI staining (blue). 

Phrase: "Red staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "GIRK2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416588:GIRK2 [Gene or Genome]

Phrase: "and"

Phrase: "cell nuclei"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007610:Cell Nuclei [Cell Component]
           Nucleus
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "visualized by DAPI staining"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0057142:DAPI [Organic Chemical,Pharmacologic Substance]
   770   C0234621:Visualized [Functional Concept]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: "(blue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260957:Blue [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.111: There was higher MPP+ toxicity in GIRK2 overexpressing PC12-Syn cells (1 and 5mM) when compared with eGFP-expressing control cells (C). 

Phrase: "There"

Phrase: "was"

Phrase: "higher MPP+ toxicity in GIRK2 overexpressing PC12-Syn cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0040539:toxicity [Qualitative Concept]
   742   C0600688:Toxicity [Injury or Poisoning]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "5mM"

Phrase: ")"

Phrase: "when"

Phrase: "compared with eGFP-expressing control cells (C)."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0007634:Cells [Cell]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1707455:Compared [Activity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.112: Cell viability was measured by LDH release, which was significantly increased in GIRK2 overexpressing cells when compared with control eGFP-expressing cells (*P<0.05 between groups). 

Phrase: "Cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "measured by LDH release,"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   806   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0022924:lactate [Organic Chemical]
   760   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0030685:Release [Health Care Activity]
   760   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "which"

Phrase: "was"

Phrase: "significantly"

Phrase: "increased in GIRK2 overexpressing cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0007634:Cells [Cell]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1416588:GIRK2 [Gene or Genome]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726   C1514559:overexpress [Genetic Function]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "when"

Phrase: "compared with control eGFP-expressing cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0007634:Cells [Cell]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1707455:Compared [Activity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "*P<0.05 between groups"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   797   C0441849:Group P [Intellectual Product]
   797   C1959644:P group [Clinical Attribute]
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.113: (DE) Differential vulnerability of primary VM cells to MPP+. 

Phrase: "(DE) Differential vulnerability of primary VM cells"

Phrase: "to MPP+."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000098:MPP+ [Hazardous or Poisonous Substance,Organic Chemical]
  1000   C1417248:MPP [Gene or Genome]
Processing 00000000.tx.114: (D) Immunostaining of primary VM cultures demonstrated TH(+), GIRK2(+) and TH(+)/GIRK2(+) cells. 

Phrase: "("

Phrase: "D)"

Phrase: "Immunostaining of primary VM cultures"

Phrase: "demonstrated"

Phrase: "TH(+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039725:TH [Geographic Area]
  1000   C0039738:Th [Element, Ion, or Isotope]
  1000   C1420718:TH [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "GIRK2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416588:GIRK2 [Gene or Genome]

Phrase: "(+"

Phrase: ")"

Phrase: "and"

Phrase: "TH(+)/GIRK2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416588:GIRK2 [Gene or Genome]

Phrase: "(+"

Phrase: ")"

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.115: (E) TH(+)/GIRK2(+) or TH(+)/GIRK2() cells were counted after MPP+ treatment and were presented as percentage of total TH(+) neurons of non-treated control conditions. 

Phrase: "(E) TH(+)/GIRK2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1416588:GIRK2 [Gene or Genome]

Phrase: "(+"

Phrase: ")"

Phrase: "or"

Phrase: "TH(+)/GIRK2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416588:GIRK2 [Gene or Genome]

Phrase: "("

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "counted after MPP+ treatment"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0000098:MPP+ [Hazardous or Poisonous Substance,Organic Chemical]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1417248:MPP [Gene or Genome]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]

Phrase: "and"

Phrase: "were"

Phrase: "presented as percentage of total TH(+) neurons"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   748   C0027882:Neurons [Cell]
   748   C0039725:TH [Geographic Area]
   748   C0039738:Th [Element, Ion, or Isotope]
   748   C0439165:Percentage [Quantitative Concept]
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C0449450:Presented [Idea or Concept]
   748   C1420718:TH [Gene or Genome]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]
   714 E C0150312:Present [Quantitative Concept]

Phrase: "of non-treated control conditions."
Meta Candidates (Total=17; Excluded=9; Pruned=0; Remaining=8)
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
   779   C0012634:condition [Disease or Syndrome]
   779   C0348080:Condition [Qualitative Concept]
   779   C1705253:Condition [Conceptual Entity]
   756 E C0040607:Training [Educational Activity]
   756 E C0220931:Training [Educational Activity]
   756 E C0336809:Train [Manufactured Object]
   756 E C1552514:Train [Manufactured Object]
   756 E C2673163:training [Qualitative Concept]
   729 E C0009647:Conditioned [Mental Process]
   729 E C1701901:Conditional [Qualitative Concept]
   729 E C1963686:Conditional [Functional Concept]
   706 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.116: TH(+)/GIRK2(+) cells were more vulnerable to MPP+ than TH(+)/GIRK2() cells [*P<0.05 in comparison with the control (no MPP+) condition]. 

Phrase: "TH(+)/GIRK2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416588:GIRK2 [Gene or Genome]

Phrase: "(+"

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "more vulnerable to MPP+"

Phrase: "than TH(+)/GIRK2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416588:GIRK2 [Gene or Genome]

Phrase: "("

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "["

Phrase: "*P<0.05 in comparison"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1707455:Comparison [Activity]
   760   C2603361:P' [Clinical Attribute]

Phrase: "with the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "("

Phrase: "no MPP+) condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0012634:condition [Disease or Syndrome]
   861   C0348080:Condition [Qualitative Concept]
   861   C1705253:Condition [Conceptual Entity]
   789 E C0009647:Conditioned [Mental Process]
   789 E C1701901:Conditional [Qualitative Concept]
   789 E C1963686:Conditional [Functional Concept]
   761 E C1519605:Conditionality [Conceptual Entity]

Phrase: "]."
Processing 00000000.tx.117: (FI) The effects of an ANT blocker, BA and IGF-1 in PC12 Syn cells (F and H) and in primary VM cultures (G and I). 

Phrase: "(FI)"

Phrase: "The effects of an ANT blocker,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "BA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005982:Bongkrekic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "IGF-1 in PC12 Syn cells"
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0007595:cells growth [Cell Function]
   767   C0085262:PC12 Cells [Cell]
           PC-12
   767   C1309046:SYN-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C0030281:Insulin Cell [Cell]
   744   C0007634:Cells [Cell]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0220844:growth [Physiologic Function]
   744   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   744   C1521761:Factor [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "H)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and in primary VM cultures"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   753   C0010453:Cultures [Idea or Concept]
   753   C0025462:Mesencephalic [Body Part, Organ, or Organ Component]
   753   C0205225:Primary [Qualitative Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   753   C1515981:And [Idea or Concept]
   753   C1704448:Ventral [Spatial Concept]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C2242979:Culture [Laboratory Procedure]

Phrase: "(G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.118: In PC12 Syn cells (F and H), cells were pretreated with BA (F) and IGF-1 (H) at concentrations indicated under the bar graph for 2h prior to treatment with 1mM MPP+ for 24h. 

Phrase: "In PC12 Syn cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0085262:PC12 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pretreated with BA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0005982:Bongkrekic Acid [Organic Chemical,Pharmacologic Substance]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]

Phrase: "(F)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "IGF-1"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(H) at concentrations"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   841   C0020283:H+ concentration [Quantitative Concept]
   790   C0033727:H+ [Element, Ion, or Isotope]
   790   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0441932:H+ [Classification]
   790   C0564385:/h [Quantitative Concept]

Phrase: "indicated under the bar graph"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0681493:Graph [Intellectual Product]
   760   C1444656:Indicated [Finding]
   760   C2698021:Graph [Conceptual Entity]

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "prior to treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with 1mM MPP+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0000098:MPP+ [Hazardous or Poisonous Substance,Organic Chemical]
   861   C1417248:MPP [Gene or Genome]

Phrase: "for 24h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]
Processing 00000000.tx.119: The levels of LDH release were presented as percentage of control group without treatment. 

Phrase: "The levels of LDH release"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   804   C0202113:Lactate dehydrogenase level [Laboratory Procedure]
   783   C0428445:lactate levels [Laboratory Procedure]
   783   C1304767:lactate levels [Laboratory or Test Result]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "presented as percentage of control group"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   790   C0009932:Control Group [Group]
   753   C0243148:control [Qualitative Concept]
   753   C0439165:Percentage [Quantitative Concept]
   753   C0441833:Group [Idea or Concept]
   753   C0449450:Presented [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1549488:Percentage [Idea or Concept]
   753   C1550141:Control [Substance]
   753   C1552516:Group [Health Care Related Organization]
   753   C1561533:Percentage [Idea or Concept]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719 E C0150312:Present [Quantitative Concept]

Phrase: "without treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.120: LDH releases were significantly reduced by addition of these protective molecules [*P<0.01 in comparison with the group of MPP+ only treatment (black bar graph); Student's t-test]. 

Phrase: "LDH releases"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C1963578:releases [Therapeutic or Preventive Procedure]
   793 E C0030685:Release [Health Care Activity]
   793 E C0391871:Release [Functional Concept]
   793 E C0439180:% release [Quantitative Concept]
   793 E C0680255:release [Health Care Activity]
   793 E C1283071:Release [Functional Concept]
   734   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "significantly"

Phrase: "reduced by addition of these protective molecules"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0392756:Reduced [Qualitative Concept]
   748   C0567416:molecules [Substance]
   748   C1883712:Addition [Functional Concept]

Phrase: "["

Phrase: "*P<0.01 in comparison"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1707455:Comparison [Activity]
   760   C2603361:P' [Clinical Attribute]

Phrase: "with the group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "of MPP+ only treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "(black bar graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0681493:Graph [Intellectual Product]
   827   C2698021:Graph [Conceptual Entity]

Phrase: ")"

Phrase: "; Student's t-test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.121: In primary VM cultures (G and I), the ANT blocker (G) and IGF-1 (I) were added to the cultures at 5 days in vitro 2h prior treatment with 10M MPP+. 

Phrase: "In primary VM cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "(G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "the ANT blocker"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1141015:Adenine Nucleotide Translocase [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1153238:adenine nucleotide translocase [Molecular Function]

Phrase: "(G)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "IGF-1"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(I)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "were"

Phrase: "added to the cultures"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0010453:Cultures [Idea or Concept]
   770   C1524062:Added [Functional Concept]
   737 E C0220814:culture [Functional Concept]
   737 E C0430400:Culture [Laboratory Procedure]
   737 E C1883712:Add [Functional Concept]
   737 E C2242979:Culture [Laboratory Procedure]

Phrase: "at 5 days in vitro 2h prior treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   818   C1514463:Prior Treatment [Clinical Attribute]
   795   C0039798:treatment [Functional Concept]
   795   C0087111:Treatment [Therapeutic or Preventive Procedure]
   795   C1522326:Treatment [Functional Concept]
   795   C1533734:Treatment [Therapeutic or Preventive Procedure]
   795   C1705169:Treatment [Conceptual Entity]
   795   C3538994:TREATMENT [Research Activity]

Phrase: "with 10M MPP+."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0000098:MPP+ [Hazardous or Poisonous Substance,Organic Chemical]
   861   C1417248:MPP [Gene or Genome]
Processing 00000000.tx.122: After 48h, TH(+)/GIRK2(+) and TH(+)/GIRK2() neurons were counted and presented as percentage of total TH(+) neurons of control (no MPP+) conditions [*P<0.05 in the comparison with the group of MPP+ only treatment (black bar graph)]. 

Phrase: "After 48h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "TH(+)/GIRK2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416588:GIRK2 [Gene or Genome]

Phrase: "(+"

Phrase: ")"

Phrase: "and"

Phrase: "TH(+)/GIRK2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416588:GIRK2 [Gene or Genome]

Phrase: "("

Phrase: ")"

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "and"

Phrase: "presented as percentage of total TH(+) neurons of control"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   742   C0027882:Neurons [Cell]
   742   C0039725:TH [Geographic Area]
   742   C0039738:Th [Element, Ion, or Isotope]
   742   C0243148:control [Qualitative Concept]
   742   C0439165:Percentage [Quantitative Concept]
   742   C0439175:% total [Quantitative Concept]
   742   C0439810:Total [Qualitative Concept]
   742   C0449450:Presented [Idea or Concept]
   742   C1420718:TH [Gene or Genome]
   742   C1549488:Percentage [Idea or Concept]
   742   C1550141:Control [Substance]
   742   C1561533:Percentage [Idea or Concept]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]
   708 E C0150312:Present [Quantitative Concept]

Phrase: "("

Phrase: "no MPP+) conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "["

Phrase: "*P<0.05 in the comparison"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C1707455:Comparison [Activity]
   753   C2603361:P' [Clinical Attribute]

Phrase: "with the group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "of MPP+ only treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "(black bar graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0681493:Graph [Intellectual Product]
   827   C2698021:Graph [Conceptual Entity]

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.123: Student's t-test was used to obtain statistical significance.  

Phrase: "Student's t-test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "statistical significance."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.124: On the basis of our comparative genetic profiles (Table3), many growth factor-related genes were differentially expressed. 

Phrase: "On the basis of our comparative genetic profiles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C2986505:genetic profile [Laboratory Procedure]
   793   C1979963:Profile [Laboratory Procedure]
   793   C2003903:Profile [Functional Concept]

Phrase: "(Table3"

Phrase: ")"

Phrase: ","

Phrase: "many growth factor-related genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   906   C0812325:Growth Factor Gene [Gene or Genome]
   812   C0017337:Genes [Gene or Genome]

Phrase: "were"

Phrase: "differentially"

Phrase: "expressed."
Processing 00000000.tx.125: Among these, we analyzed IGF-1 in both PC12-Syn cells and primary VM cultures. 

Phrase: "Among these,"

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "IGF-1 in both PC12-Syn cells"
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0007595:cells growth [Cell Function]
   762   C0085262:PC12 Cells [Cell]
           PC-12
   762   C1309046:SYN-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   745   C0030281:Insulin Cell [Cell]
   742   C0007634:Cells [Cell]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0220844:growth [Physiologic Function]
   742   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   742   C1521761:Factor [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "primary VM cultures."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.126: IGF-1 was able to exert protective effects against MPP+ toxicity in both PC12-Syn cells (Fig.3H) and GIRK2-positive DA neurons of primary VM culture (Fig.3I) in a dose-dependent manner. 

Phrase: "IGF-1"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "protective effects against MPP+ toxicity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C1280500:effects [Qualitative Concept]
   745   C0600688:Toxic effect [Injury or Poisoning]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "in both PC12-Syn cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0085262:PC12 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig.3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "GIRK2-positive DA neurons of primary VM culture"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1512035:dopamine neurons [Cell]
   742   C0027882:Neurons [Cell]

Phrase: "(Fig.3I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552167:3i [Medical Device]

Phrase: ")"

Phrase: "in a dose-dependent manner."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]
Processing 00000000.tx.127: Altered vulnerability of -synuclein overexpressing PC12 cells and primary VM cultures by molecules elevated in A10 DA neurons We also analyzed molecules that were more highly expressed in A10 DA neurons. 

Phrase: "Altered vulnerability of -synuclein overexpressing PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   818   C0085262:PC12 Cells [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "primary VM cultures by molecules"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0010453:Cultures [Idea or Concept]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C2242979:Culture [Laboratory Procedure]

Phrase: "elevated in A10 DA neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1512035:dopamine neurons [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0027882:Neurons [Cell]
   760   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]
   760   C0205250:Elevated [Qualitative Concept]
   760   C3163633:Elevated [Qualitative Concept]

Phrase: "We also analyzed molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "more highly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0205250:Highly [Qualitative Concept]

Phrase: "expressed in A10 DA neurons."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1512035:dopamine neurons [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0027882:Neurons [Cell]
   760   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.128: Neuropeptides were chosen for analysis because they were a prominent class of molecules expressed relatively higher in A10 DA neurons (Tables2 and 3). 

Phrase: "Neuropeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027895:Neuropeptides [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "were"

Phrase: "chosen for analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]
   790   C1707391:Chosen [Activity]

Phrase: "because"

Phrase: "they"

Phrase: "were"

Phrase: "a prominent class of molecules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456387:Class [Intellectual Product]
   760   C1705943:Class [Classification]

Phrase: "expressed"

Phrase: "relatively higher in A10 DA neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "(Tables2"

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.129: Gastrin releasing peptide (GRP), calcitonin/calcitonin gene-related peptide alpha (CGRP) and pituitary adenylate cyclase activating polypeptide (PACAP) were individually applied in the presence of MPP+ in PC12-Syn cells or primary VM cultures. 

Phrase: "Gastrin releasing peptide (GRP),"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0061132:Gastrin releasing peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1333714:gastrin-releasing peptide [Gene or Genome]
   827   C0017151:Gastrin [Amino Acid, Peptide, or Protein,Hormone]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0376180:Gastrin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1283071:Releasing [Functional Concept]
   793 E C0030685:Release [Health Care Activity]
   793 E C0391871:Release [Functional Concept]
   793 E C0439180:% release [Quantitative Concept]
   793 E C0680255:release [Health Care Activity]
   793 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "calcitonin/calcitonin gene-related peptide alpha (CGRP)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0439095:Alpha [Intellectual Product]
   799   C2003941:Alpha [Intellectual Product]
   799   C2350010:Alpha [Qualitative Concept]
   734   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   734   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]

Phrase: "and"

Phrase: "pituitary adenylate cyclase activating polypeptide"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0071163:pituitary adenylate cyclase activating polypeptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412228:PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE [Gene or Genome]
   840   C0001492:Adenylate Cyclase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C1382029:Adenylate Cyclase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0032005:Pituitary, NOS [Body Part, Organ, or Organ Component]
   804   C0597765:adenylate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]
   804   C1879547:activating [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "(PACAP)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0071163:PACAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412228:PACAP [Gene or Genome]
  1000   C1836172:PACAP [Gene or Genome]

Phrase: "were"

Phrase: "individually"

Phrase: "applied in the presence of MPP+"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0000098:MPP+ [Hazardous or Poisonous Substance,Organic Chemical]
   753   C0185125:Applied [Health Care Activity]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1417248:MPP [Gene or Genome]
   719 E C1632850:Apply [Functional Concept]
   719 E C1879355:Apply [Functional Concept]

Phrase: "in PC12-Syn cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0085262:PC12 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "primary VM cultures."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.130: GRP exhibited a dose-dependent neuroprotective effect on both PC12-Syn cells and GIRK2-positive DA neurons of primary VM cultures (Fig.4A and 4B). 

Phrase: "GRP"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0061132:Gastrin releasing peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1333714:gastrin-releasing peptide [Gene or Genome]
   827   C0017151:Gastrin [Amino Acid, Peptide, or Protein,Hormone]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0376180:Gastrin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1283071:Releasing [Functional Concept]
   793 E C0030685:Release [Health Care Activity]
   793 E C0391871:Release [Functional Concept]
   793 E C0439180:% release [Quantitative Concept]
   793 E C0680255:release [Health Care Activity]
   793 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a dose-dependent neuroprotective effect on both PC12-Syn cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0815279:Neuroprotective Effect [Functional Concept]
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "GIRK2-positive DA neurons of primary VM cultures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1512035:dopamine neurons [Cell]
   742   C0027882:Neurons [Cell]

Phrase: "(Fig.4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "and"

Phrase: "4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.131: CGRP was also able to significantly reduce MPP+-induced LDH release in PC12-Syn cells (Fig.4C). 

Phrase: "CGRP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0439095:Alpha [Intellectual Product]
   804   C2003941:Alpha [Intellectual Product]
   804   C2350010:Alpha [Qualitative Concept]
   771   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   771   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]

Phrase: "was"

Phrase: "also able to significantly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0085732:Able [Organism Attribute]
   812   C1299581:Able [Finding]

Phrase: "reduce"

Phrase: "MPP+-induced LDH release in PC12-Syn cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0030685:Release [Health Care Activity]
   742   C0391871:Release [Functional Concept]
   742   C0439180:% release [Quantitative Concept]
   742   C0680255:release [Health Care Activity]
   742   C1283071:Release [Functional Concept]
   742   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(Fig.4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.132: In primary VM culture, it had no effect on GIRK2-positive DA neurons, whereas it exhibited a significant toxic effect on GIRK2-negative DA neurons at higher doses (Fig.4D). 

Phrase: "In primary VM culture,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C2242979:Culture [Laboratory Procedure]

Phrase: "it"

Phrase: "had"

Phrase: "no effect on GIRK2-positive DA neurons,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1301751:No effect [Qualitative Concept]
   774   C3179498:Dopamine Effect [Physiologic Function]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "whereas"

Phrase: "it"

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a significant toxic effect on GIRK2-negative DA neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0600688:Toxic effect [Injury or Poisoning]
           toxic
   762   C3179498:Dopamine Effect [Physiologic Function]
   742   C1280500:Effect [Qualitative Concept]
   742   C1407029:Toxic [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "at higher doses"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   966   C0444956:High dose [Quantitative Concept]
   861   C0178602:Doses [Quantitative Concept]
   827 E C0869039:Dose [Quantitative Concept]
   827 E C1114758:Dose # [Clinical Attribute]
   827 E C1428722:DOS [Gene or Genome]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450377:4d [Intellectual Product]
  1000   C2986754:4D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.133: PACAP was able to reduce MPP+ toxicity in PC12-Syn cells and in GIRK2-positive and GIRK2-negative DA neurons of primary VM cultures in a dose-dependent manner (Fig.4F and 4E). 

Phrase: "PACAP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0071163:PACAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412228:PACAP [Gene or Genome]
  1000   C1836172:PACAP [Gene or Genome]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "reduce"

Phrase: "MPP+ toxicity in PC12-Syn cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040539:toxicity [Qualitative Concept]
   753   C0600688:Toxicity [Injury or Poisoning]

Phrase: "and in GIRK2-positive"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0439178:% Positive [Quantitative Concept]
   770   C1416588:GIRK2 [Gene or Genome]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C1515981:And [Idea or Concept]
   770   C2825490:Positive [Qualitative Concept]

Phrase: "and"

Phrase: "GIRK2-negative DA neurons of primary VM cultures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1512035:dopamine neurons [Cell]
   742   C0027882:Neurons [Cell]

Phrase: "in a dose-dependent manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "(Fig.4F"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450379:4f [Intellectual Product]

Phrase: "and"

Phrase: "4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450378:4e [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.134: These results support the hypothesis that certain molecules with differential expression patterns between A9 and A10 DA neurons may play key roles in protection and vulnerability of DA neurons. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that certain molecules with differential expression patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0567416:molecules [Substance]

Phrase: "between A9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0933647:A9 [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "A10 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "key roles in protection"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "vulnerability of DA neurons."
Processing 00000000.tx.135: View larger version (39K): [in this window] [in a new window]  Figure4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(39K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure4."
Processing 00000000.tx.136: Altered vulnerability of PC12-Syn cells and primary VM cultures by A10-elevated molecules. 

Phrase: "Altered vulnerability of PC12-Syn cells"

Phrase: "and"

Phrase: "primary VM cultures by A10-elevated molecules."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0010453:Cultures [Idea or Concept]
   711 E C0220814:culture [Functional Concept]
   711 E C0430400:Culture [Laboratory Procedure]
   711 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.137: In PC12 cells (A, C and E), cells were pretreated with GRP (A), CGRP (C) and PACAP (E) with concentrations indicated under the bar graph for 2h prior to 1mM MPP+ treatment for 24h. 

Phrase: "In PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(A,"

Phrase: "C"

Phrase: "and"

Phrase: "E"

Phrase: ")"

Phrase: ","

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pretreated with GRP"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   862   C0061132:Gastrin releasing peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   862   C1333714:gastrin-releasing peptide [Gene or Genome]
   760   C0017151:Gastrin [Amino Acid, Peptide, or Protein,Hormone]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C0376180:Gastrin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1283071:Releasing [Functional Concept]
   726 E C0030685:Release [Health Care Activity]
   726 E C0391871:Release [Functional Concept]
   726 E C0439180:% release [Quantitative Concept]
   726 E C0680255:release [Health Care Activity]
   726 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "CGRP (C"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   799   C0007634:Cells [Cell]
   799   C0439095:Alpha [Intellectual Product]
   799   C2003941:Alpha [Intellectual Product]
   799   C2350010:Alpha [Qualitative Concept]
   799   C3282337:Cells [Cell]
   793   C0030280:Alpha cell [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
   734   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   734   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "PACAP (E) with concentrations"

Phrase: "indicated under the bar graph"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0681493:Graph [Intellectual Product]
   760   C1444656:Indicated [Finding]
   760   C2698021:Graph [Conceptual Entity]

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "prior to 1mM MPP+ treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "for 24h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]
Processing 00000000.tx.138: The levels of LDH release were presented as percentage of control group without treatment. 

Phrase: "The levels of LDH release"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   804   C0202113:Lactate dehydrogenase level [Laboratory Procedure]
   783   C0428445:lactate levels [Laboratory Procedure]
   783   C1304767:lactate levels [Laboratory or Test Result]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "presented as percentage of control group"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   790   C0009932:Control Group [Group]
   753   C0243148:control [Qualitative Concept]
   753   C0439165:Percentage [Quantitative Concept]
   753   C0441833:Group [Idea or Concept]
   753   C0449450:Presented [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1549488:Percentage [Idea or Concept]
   753   C1550141:Control [Substance]
   753   C1552516:Group [Health Care Related Organization]
   753   C1561533:Percentage [Idea or Concept]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719 E C0150312:Present [Quantitative Concept]

Phrase: "without treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.139: Significant dose-dependent decreases in LDH release were detected in these experiments indicating neuroprotective effects of these peptides from toxic insult [*P<0.01 in the comparison with the group of MPP+ only treatment (black bar graph); Student's t-test]. 

Phrase: "Significant dose-dependent decreases in LDH release"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C1512045:Dose-dependent [Quantitative Concept]
   744   C0178602:Dose [Quantitative Concept]
   744   C0547047:decreases [Quantitative Concept]
   744   C0851827:Dependent [Qualitative Concept]
   744   C0869039:Dose [Quantitative Concept]
   744   C1114758:Dose # [Clinical Attribute]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]
   711 E C0392756:Decrease [Qualitative Concept]

Phrase: "were"

Phrase: "detected in these experiments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0442726:Detected [Finding]
   770   C0681814:Experiments [Research Activity]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "indicating"

Phrase: "neuroprotective effects of these peptides"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0815279:Neuroprotective Effects [Functional Concept]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "from toxic insult"

Phrase: "["

Phrase: "*P<0.01 in the comparison"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C1707455:Comparison [Activity]
   753   C2603361:P' [Clinical Attribute]

Phrase: "with the group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "of MPP+ only treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "(black bar graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0681493:Graph [Intellectual Product]
   827   C2698021:Graph [Conceptual Entity]

Phrase: ")"

Phrase: "; Student's t-test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.140: In primary VM cultures (B, D and F), GRP (B), CGRP (D) and PACAP (E) were added to the cells at 5 days in vitro 2h prior to treatment with 10M MPP+. 

Phrase: "In primary VM cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "F),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "GRP"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0061132:Gastrin releasing peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1333714:gastrin-releasing peptide [Gene or Genome]
   827   C0017151:Gastrin [Amino Acid, Peptide, or Protein,Hormone]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0376180:Gastrin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1283071:Releasing [Functional Concept]
   793 E C0030685:Release [Health Care Activity]
   793 E C0391871:Release [Functional Concept]
   793 E C0439180:% release [Quantitative Concept]
   793 E C0680255:release [Health Care Activity]
   793 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "CGRP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0439095:Alpha [Intellectual Product]
   804   C2003941:Alpha [Intellectual Product]
   804   C2350010:Alpha [Qualitative Concept]
   771   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   771   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]

Phrase: "("

Phrase: "D)"

Phrase: "and"

Phrase: "PACAP (E)"

Phrase: "were"

Phrase: "added to the cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1524062:Added [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1883712:Add [Functional Concept]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "at 5 days in vitro 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1292425:2H [Temporal Concept]

Phrase: "prior to treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with 10M MPP+."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0000098:MPP+ [Hazardous or Poisonous Substance,Organic Chemical]
   861   C1417248:MPP [Gene or Genome]
Processing 00000000.tx.141: After 48h, TH(+)/GIRK2(+) and TH(+)/GIRK2() neurons were counted and presented as percentage of total TH(+) neurons of control (no MPP+) conditions [*P<0.05 in the comparison with the group of MPP+ only treatment (black bar graph)]. 

Phrase: "After 48h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "TH(+)/GIRK2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416588:GIRK2 [Gene or Genome]

Phrase: "(+"

Phrase: ")"

Phrase: "and"

Phrase: "TH(+)/GIRK2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416588:GIRK2 [Gene or Genome]

Phrase: "("

Phrase: ")"

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "and"

Phrase: "presented as percentage of total TH(+) neurons of control"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   742   C0027882:Neurons [Cell]
   742   C0039725:TH [Geographic Area]
   742   C0039738:Th [Element, Ion, or Isotope]
   742   C0243148:control [Qualitative Concept]
   742   C0439165:Percentage [Quantitative Concept]
   742   C0439175:% total [Quantitative Concept]
   742   C0439810:Total [Qualitative Concept]
   742   C0449450:Presented [Idea or Concept]
   742   C1420718:TH [Gene or Genome]
   742   C1549488:Percentage [Idea or Concept]
   742   C1550141:Control [Substance]
   742   C1561533:Percentage [Idea or Concept]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]
   708 E C0150312:Present [Quantitative Concept]

Phrase: "("

Phrase: "no MPP+) conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "["

Phrase: "*P<0.05 in the comparison"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C1707455:Comparison [Activity]
   753   C2603361:P' [Clinical Attribute]

Phrase: "with the group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "of MPP+ only treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "(black bar graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0681493:Graph [Intellectual Product]
   827   C2698021:Graph [Conceptual Entity]

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.142: Student's t-test was used to obtain statistical significance.   

Phrase: "Student's t-test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "statistical significance."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.143: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES  In this study, we used LCM and genomic profiling to characterize the innate physiological differences between A9 and A10 DA midbrain neurons. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS SUPPLEMENTARY MATERIAL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "REFERENCES  In this study,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C2985663:Study Reference [Intellectual Product]
   770   C0557651:Study [Manufactured Object]
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]
   770   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "LCM"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1113652:Laser Capture Microdissection [Laboratory Procedure]
   827   C0023089:Laser [Manufactured Object]
   827   C0458142:Laser [Phenomenon or Process]
   827   C0598304:Microdissection [Laboratory Procedure]
   827   C1023865:Laser [Plant]
   827   C1706315:Laser [Medical Device]

Phrase: "and"

Phrase: "genomic profiling to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C2986505:Genomic Profile [Laboratory Procedure]
   793   C1979963:Profile [Laboratory Procedure]
   793   C2003903:Profile [Functional Concept]

Phrase: "characterize"

Phrase: "the innate physiological differences between A9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "A10 DA midbrain neurons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   875   C1512035:dopamine neurons [Cell]
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.144: Despite an overall high similarity in the gene expression profiles of these related DA neurons, several genes from different biological categories showed cell type-specific expression patterns. 

Phrase: "Despite an overall high similarity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2348205:Similarity [Qualitative Concept]

Phrase: "in the gene expression profiles"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1956267:Gene Expression Profiles [Quantitative Concept]
   983 E C1449575:gene expression profile [Laboratory Procedure]
   793   C1979963:Profile [Laboratory Procedure]
   793   C2003903:Profile [Functional Concept]
   734   C0017262:Gene Expression [Genetic Function]

Phrase: "of these related DA neurons,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "several genes from different biological categories"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017337:Genes [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "cell type-specific expression patterns."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0449774:Patterns [Spatial Concept]
Processing 00000000.tx.145: We examined some of these differentially expressed molecules using PC12-Syn cells and primary VM cultures exposed to the PD-related neurotoxin, MPP+. 

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "some of these differentially expressed molecules"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205392:Some [Quantitative Concept]
   753   C0567416:molecules [Substance]
   753   C3540770:Some [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PC12-Syn cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0085262:PC12 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "primary VM cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "exposed to the PD-related neurotoxin,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   753   C0027934:Neurotoxin [Hazardous or Poisonous Substance]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]

Phrase: "MPP+."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000098:MPP+ [Hazardous or Poisonous Substance,Organic Chemical]
  1000   C1417248:MPP [Gene or Genome]
Processing 00000000.tx.146: Results from these bioassays showed that neuropeptides (GRP, CGRP and PACAP) expressed predominantly in A10 DA neurons protected against MPP+. 

Phrase: "Results from these bioassays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that neuropeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027895:Neuropeptides [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "(GRP,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0061132:Gastrin releasing peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1333714:gastrin-releasing peptide [Gene or Genome]
   827   C0017151:Gastrin [Amino Acid, Peptide, or Protein,Hormone]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0376180:Gastrin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1283071:Releasing [Functional Concept]
   793 E C0030685:Release [Health Care Activity]
   793 E C0391871:Release [Functional Concept]
   793 E C0439180:% release [Quantitative Concept]
   793 E C0680255:release [Health Care Activity]
   793 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "CGRP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0439095:Alpha [Intellectual Product]
   804   C2003941:Alpha [Intellectual Product]
   804   C2350010:Alpha [Qualitative Concept]
   771   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   771   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]

Phrase: "and"

Phrase: "PACAP)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0071163:PACAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412228:PACAP [Gene or Genome]
  1000   C1836172:PACAP [Gene or Genome]

Phrase: "expressed"

Phrase: "predominantly in A10 DA neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1512035:dopamine neurons [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0027882:Neurons [Cell]
   760   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]

Phrase: "protected against MPP+."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0000098:MPP+ [Hazardous or Poisonous Substance,Organic Chemical]
   790   C1417248:MPP [Gene or Genome]
Processing 00000000.tx.147: Of genes elevated in A9 DA neurons, growth factors such as IGF-1 also decreased the vulnerability, whereas ANT-2 and GIRK2 appeared to increase cell toxicity. 

Phrase: "Of genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "elevated in A9 DA neurons,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1512035:dopamine neurons [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0027882:Neurons [Cell]
   760   C0205250:Elevated [Qualitative Concept]
   760   C0933647:A9 [Body Part, Organ, or Organ Component]
   760   C3163633:Elevated [Qualitative Concept]

Phrase: "growth factors such as IGF-1 also"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0220844:growth [Physiologic Function]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C2911660:Growth [Activity]
   708   C1521761:Factor [Functional Concept]
   708   C2827422:Factor [Conceptual Entity]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the vulnerability,"

Phrase: "whereas"

Phrase: "ANT-2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0600150:Adenine Nucleotide Translocator 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335834:ADENINE NUCLEOTIDE TRANSLOCATOR 2 [Gene or Genome]
  1000   C1442882:Adenine Nucleotide Translocator-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   812   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "GIRK2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416588:GIRK2 [Gene or Genome]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "cell toxicity."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.148: These results suggest that the study of genes with differential expression levels between A9 and A10 midbrain DA neurons can provide insights into specific neuroprotective and/or degenerative responses. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the study of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "with differential expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C3244092:expression level [Idea or Concept]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "between A9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0933647:A9 [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "A10 midbrain DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1512035:dopamine neurons [Cell]
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "can"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "insights into specific neuroprotective"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0233820:insights [Mental Process]

Phrase: "and/or"

Phrase: "degenerative responses."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]
Processing 00000000.tx.149: We propose at least two possible mechanisms whereby differential gene expression in A9 DA neurons could alter the vulnerability to neurotoxins. 

Phrase: "We"

Phrase: "propose at least two possible mechanisms whereby differential gene expression"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   782   C1519516:Differential Gene Expression [Genetic Function]
   760   C0017262:Gene Expression [Genetic Function]
   739   C0017337:Gene [Gene or Genome]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0205448:Two [Quantitative Concept]
   739   C0332149:Possible [Qualitative Concept]
   739   C0441712:Mechanisms [Functional Concept]
   739   C0443199:Differential [Qualitative Concept]
   739   C1705242:Differential [Qualitative Concept]
   739   C1705910:Possible [Qualitative Concept]
   739   C2362652:Possible [Qualitative Concept]
   706 E C1706376:Mechanism [Manufactured Object]

Phrase: "in A9 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "could"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the vulnerability to neurotoxins."
Processing 00000000.tx.150: First, certain molecules may by themselves confer increased susceptibility in these neurons when their expression levels are relatively elevated. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "certain molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "may by themselves"

Phrase: "confer"

Phrase: "increased susceptibility in these neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "when"

Phrase: "their expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C3244092:expression level [Idea or Concept]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "relatively"

Phrase: "elevated."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]
Processing 00000000.tx.151: Elevated expression of such molecules may then decrease the threshold to extrinsic and intrinsic factors leading to cell-type specific degeneration (31,32). 

Phrase: "Elevated expression of such molecules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the threshold to extrinsic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449864:Threshold [Qualitative Concept]

Phrase: "and"

Phrase: "intrinsic factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021918:intrinsic factors [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0205102:Intrinsic [Spatial Concept]
   861   C0439674:Intrinsic [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "leading to cell-type specific degeneration"
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   790   C0007634:Cell Type [Cell]
           Cell
   790   C0449475:cell type [Intellectual Product]
   783   C0333467:Cell degeneration [Pathologic Function]
   753   C0011164:Degeneration [Pathologic Function]
   753   C0205369:Specific [Qualitative Concept]
   753   C0332152:Leading [Temporal Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C1269647:Cell [Cell]
   753   C1522538:Leading [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]
   753   C1552740:specific [Intellectual Product]
   753   C1704653:Cell [Medical Device]
   753   C1880269:Degeneration [Functional Concept]
   753   C1948049:Cell [Spatial Concept]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.152: For example, GIRK2 and ANT-2 may render A9 DA neurons more vulnerable because of their pathophysiological actions on the membrane potential and on the mitochondrial permeability transition, respectively (discussed subsequently). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "GIRK2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416588:GIRK2 [Gene or Genome]

Phrase: "and"

Phrase: "ANT-2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0600150:Adenine Nucleotide Translocator 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1335834:ADENINE NUCLEOTIDE TRANSLOCATOR 2 [Gene or Genome]
  1000   C1442882:Adenine Nucleotide Translocator-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   812   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "may"

Phrase: "render"

Phrase: "A9 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "more vulnerable because of their pathophysiological actions"

Phrase: "on the membrane potential"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0025251:Membrane Potential [Cell Function]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   861   C3245505:Potential [Qualitative Concept]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "and on the mitochondrial permeability transition,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C3158983:mitochondrial permeability transition [Cell Function]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0031164:Permeability [Natural Phenomenon or Process]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C0599156:Transition [Cell or Molecular Dysfunction]
   753   C1515981:And [Idea or Concept]
   753   C2700061:Transition [Activity]

Phrase: "respectively"

Phrase: "("

Phrase: "discussed"

Phrase: "subsequently"

Phrase: ")."
Processing 00000000.tx.153: Or pro-apoptotic molecules, such as caspase 7 and Bim (38) in A9 DA neurons (Table3), may increase susceptibility of these neurons in pathological conditions. 

Phrase: "Or"

Phrase: "pro-apoptotic molecules,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "such as caspase 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0537969:caspase-7 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Bim (38"

Phrase: ")"

Phrase: "in A9 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(Table3"

Phrase: ")"

Phrase: ","

Phrase: "may"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "susceptibility of these neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "in pathological conditions."
Meta Candidates (Total=16; Excluded=11; Pruned=0; Remaining=5)
   861   C0030664:Pathological [Biomedical Occupation or Discipline]
   861   C1521733:Pathological [Functional Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   789 E C0205469:pathology [Functional Concept]
   789 E C0677042:pathology [Pathologic Function]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.154: A second possibility is that A9 DA neurons may be more functionally dependent upon molecules with higher expression and therefore more vulnerable to fluctuation in their levels. 

Phrase: "A second possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that A9 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "may"

Phrase: "be"

Phrase: "more functionally dependent upon molecules"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]

Phrase: "with higher expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "therefore more vulnerable to fluctuation"

Phrase: "in their levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.155: In such cases, any insult, genetic polymorphisms or an age-dependent decrease in expression levels (45) that reduces the physiological functions of these molecules may be neurotoxic. 

Phrase: "In such cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "any insult,"

Phrase: "genetic polymorphisms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0032529:Genetic Polymorphisms [Genetic Function]
           polymorphisms
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "or"

Phrase: "an age-dependent decrease in expression levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "(45"

Phrase: ")"

Phrase: "that"

Phrase: "reduces"

Phrase: "the physiological functions of these molecules"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0542341:Functions [Functional Concept]
   725   C1148560:molecular function [Molecular Function]
   719 E C0031843:function [Physiologic Function]
   719 E C0700205:FUNCTION [Classification]
   719 E C1705273:Function [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "neurotoxic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.156: An example of this class of A9-elevated molecule might be IGF-1, a known neuroprotective factor (46,47). 

Phrase: "An example of this class of A9-elevated molecule"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1707959:Example [Conceptual Entity]

Phrase: "might"

Phrase: "be"

Phrase: "IGF-1,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "a known neuroprotective factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(46,"

Phrase: "47"

Phrase: ")."
Processing 00000000.tx.157: GIRK controls the neuronal membrane excitability by selectively permitting the flux of K+ ions near the resting membrane potential (48). 

Phrase: "GIRK"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   937   C0214230:INWARDLY RECTIFYING K CHANNEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0439799:Channel [Spatial Concept]
   804   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C1706095:Channel [Conceptual Entity]
   804   C1708601:K' [Quantitative Concept]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the neuronal membrane excitability by selectively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0235169:Excitability [Sign or Symptom]

Phrase: "permitting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0023636:Permit [Regulation or Law]
   966   C0329040:Permit [Fish]

Phrase: "the flux of K+ ions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348693:Flux [Natural Phenomenon or Process]

Phrase: "near the resting membrane potential"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0025251:resting membrane potential [Cell Function]
           resting potential
           Membrane Potential
  1000   C1704297:Resting Membrane Potential [Cell Function]
           Resting Potential
   827   C0025255:Membrane [Tissue]
   827   C0035253:Resting [Daily or Recreational Activity]
   827   C0596901:Membrane [Cell Component]
   827   C1512899:resting [Cell]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   793 E C1622890:ResT [Molecular Function]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.158: Among four isoforms of GIRK, only GIRK2 is exclusively expressed in vulnerable DA neurons (26,27). 

Phrase: "Among four isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "of GIRK,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0214230:INWARDLY RECTIFYING K CHANNEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0332285:Of [Spatial Concept]
   799   C0439799:Channel [Spatial Concept]
   799   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   799   C1706095:Channel [Conceptual Entity]
   799   C1708601:K' [Quantitative Concept]

Phrase: "only GIRK2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416588:GIRK2 [Gene or Genome]

Phrase: "is"

Phrase: "exclusively"

Phrase: "expressed in vulnerable DA neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1512035:dopamine neurons [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0027882:Neurons [Cell]

Phrase: "(26,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.159: GIRK2 generates a slow IPSP in DA neurons via activation of D2 or GABAB receptors and controls the membrane excitability of DA neurons. 

Phrase: "GIRK2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416588:GIRK2 [Gene or Genome]

Phrase: "generates"

Phrase: "a slow IPSP in DA neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C1720982:Postsynaptic Potential, Inhibitory [Organ or Tissue Function]
   770   C2350339:Potential, Postsynaptic [Organ or Tissue Function]
   767   C0234122:Inhibitory potential [Organ or Tissue Function]
   767   C0597474:slow potential [Cell Function]
   744   C3245505:Potential [Qualitative Concept]
   744   C3463820:Inhibitory [Activity]

Phrase: "via activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of D2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1414052:D2 [Gene or Genome]
  1000   C1415944:D2 [Gene or Genome]

Phrase: "or"

Phrase: "GABAB receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the membrane excitability of DA neurons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0235169:Excitability [Sign or Symptom]
Processing 00000000.tx.160: A potential role of GIRK2 in A9 DA neuron pathology in PD has been revealed in weaver mice, which have a spontaneous mutation in the GIRK2 gene and display PD-like patterns of DA neuron degeneration (2830). 

Phrase: "A potential role of GIRK2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in A9 DA neuron pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0030664:Pathology [Biomedical Occupation or Discipline]
   812   C0205469:pathology [Functional Concept]
   812   C0677042:pathology [Pathologic Function]
   741 E C1521733:Pathologic [Functional Concept]

Phrase: "in PD"

Phrase: "has"

Phrase: "been"

Phrase: "revealed in weaver mice,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0043086:Weaver Mice [Mammal]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0326812:Weaver [Bird]
   770   C0443289:Revealed [Qualitative Concept]

Phrase: "which"

Phrase: "have"

Phrase: "a spontaneous mutation in the GIRK2 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0678939:spontaneous mutation [Genetic Function]
   774   C0596611:Gene Mutation [Genetic Function]
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "PD-like patterns of DA neuron degeneration"

Phrase: "(2830"

Phrase: ")."
Processing 00000000.tx.161: Mutation in GIRK2 decreases the channel selectivity for K+, leading to the destabilization of the cell membrane (49). 

Phrase: "Mutation in GIRK2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026882:Mutation [Genetic Function]
   790   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the channel selectivity for K+,"

Phrase: "leading to the destabilization of the cell membrane"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   770   C0007603:Cell Membrane [Cell Component]
   770   C3161472:Cell Membrane [Cell Component]
   744   C0007634:Cell [Cell]
   744   C0025255:Membrane [Tissue]
   744   C0332152:Leading [Temporal Concept]
   744   C0596901:Membrane [Cell Component]
   744   C1269647:Cell [Cell]
   744   C1522538:Leading [Functional Concept]
   744   C1704653:Cell [Medical Device]
   744   C1706182:Membrane [Manufactured Object]
   744   C1948049:Cell [Spatial Concept]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.162: Our data suggest that elevated expression levels of GIRK2 may also contribute to the increased vulnerability of A9 DA neurons. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that elevated expression levels of GIRK2"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   756   C3244092:expression level [Idea or Concept]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "also"

Phrase: "contribute to the increased vulnerability of A9 DA neurons."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C1512035:dopamine neurons [Cell]
   742   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   742   C0027882:Neurons [Cell]
   742   C0205217:Increased [Quantitative Concept]
   742   C0442805:Increased [Functional Concept]
   742   C0933647:A9 [Body Part, Organ, or Organ Component]
   742   C1880177:Contribute [Activity]
Processing 00000000.tx.163: ANT is thought to play a role in the transport of ADP and ATP across the mitochondrial inner membrane (43,50). 

Phrase: "ANT"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1141015:Adenine Nucleotide Translocase [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1153238:adenine nucleotide translocase [Molecular Function]
   901   C1135982:Nucleotide Translocase [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0582119:Translocase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the transport of ADP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "ATP across the mitochondrial inner membrane"

Phrase: "(43,"

Phrase: "50"

Phrase: ")."
Processing 00000000.tx.164: In addition, it is involved in the formation of the mitochondrial permeability transition pore (mPTP), a non-specific pore that is an important mediator of apoptosis (43,50). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "it"

Phrase: "is"

Phrase: "involved in the formation of the mitochondrial permeability transition pore (mPTP),"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   806   C0908146:mitochondrial permeability transition pore [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C2000322:permeability transition pore, mitochondrial [Amino Acid, Peptide, or Protein]
   782   C3158983:mitochondrial permeability transition [Cell Function]
   757   C1326292:pore formation [Cell Function]
   739   C0026237:Mitochondrial [Cell Component]
   739   C0031164:Permeability [Natural Phenomenon or Process]
   739   C0220781:formation [Biologic Function]
   739   C0439634:formation [Spatial Concept]
   739   C0521451:Mitochondrial [Functional Concept]
   739   C0599156:Transition [Cell or Molecular Dysfunction]
   739   C1314939:Involved [Functional Concept]
   739   C1325742:Pore [Cell Component]
   739   C1522492:Formation [Functional Concept]
   739   C2700061:Transition [Activity]

Phrase: "a non-specific pore"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1325742:Pore [Cell Component]
   734   C0205370:Non-specific [Qualitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "an important mediator of apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(43,"

Phrase: "50"

Phrase: ")."
Processing 00000000.tx.165: The mPTP opens in response to stimuli including reactive oxygen species and inhibitors of the electron transport chain, including MPP+ (51). 

Phrase: "The mPTP"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
  1000   C0908146:mitochondrial permeability transition pore [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2000322:permeability transition pore, mitochondrial [Amino Acid, Peptide, or Protein]
   923   C3158983:mitochondrial permeability transition [Cell Function]
   812   C0026237:Mitochondrial [Cell Component]
   812   C0031164:Permeability [Natural Phenomenon or Process]
   812   C0521451:Mitochondrial [Functional Concept]
   812   C0599156:Transition [Cell or Molecular Dysfunction]
   812   C1325742:Pore [Cell Component]
   812   C2700061:Transition [Activity]
   741 E C0205326:Permeable [Functional Concept]
   741 E C1182674:Transitional [Spatial Concept]
   741 E C1548597:Transitional [Idea or Concept]

Phrase: "opens in response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0175566:Open [Spatial Concept]
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to stimuli"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234402:Stimuli [Phenomenon or Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "reactive oxygen species"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "and"

Phrase: "inhibitors of the electron transport chain,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0597607:transport inhibitor [Pharmacologic Substance]
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   719 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "MPP+ (51"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0000098:MPP+ [Hazardous or Poisonous Substance,Organic Chemical]
   861   C1417248:MPP [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.166: In our study, blocking the function of ANT-2 by BA decreased the vulnerability of both PC12-Syn cells and primary VM culture neurons to MPP+. 

Phrase: "In our study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the function of ANT-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "by BA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005982:Bongkrekic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the vulnerability of both PC12-Syn cells"

Phrase: "and"

Phrase: "primary VM culture neurons to MPP+."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0027882:Neurons [Cell]
Processing 00000000.tx.167: This demonstrates that inhibition of ANT-2 is neuroprotective and, therefore, elevated ANT-2 expression levels in A9 DA neurons could confer increased susceptibility of these neurons to oxidative stress and toxins such as MPP+. 

Phrase: "This"

Phrase: "demonstrates"

Phrase: "that inhibition of ANT-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "is"

Phrase: "neuroprotective"

Phrase: "and"

Phrase: ","

Phrase: "therefore,"

Phrase: "elevated ANT-2 expression levels in A9 DA neurons"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   738   C0185117:Expression [Therapeutic or Preventive Procedure]
   738   C0441889:Levels [Qualitative Concept]
   737   C0456948:Level 2 [Intellectual Product]
   722   C3244092:expression level [Idea or Concept]
   704 E C0456079:Level [Classification]
   704 E C1547707:Level [Geographic Area]
   704 E C2946261:Level [Pharmacologic Substance]

Phrase: "could"

Phrase: "confer"

Phrase: "increased susceptibility of these neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "to oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "toxins such as MPP+."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040549:Toxins [Biologically Active Substance,Hazardous or Poisonous Substance]
Processing 00000000.tx.168: It is interesting to note the toxic effect of BA at higher doses (Fig.3G). 

Phrase: "It"

Phrase: "is"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the toxic effect of BA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   864   C0161695:Toxic effect of acid [Injury or Poisoning]
   790   C0600688:Toxic effect [Injury or Poisoning]
           toxic
   753   C1280500:Effect [Qualitative Concept]
   753   C1407029:Toxic [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "at higher doses"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   966   C0444956:High dose [Quantitative Concept]
   861   C0178602:Doses [Quantitative Concept]
   827 E C0869039:Dose [Quantitative Concept]
   827 E C1114758:Dose # [Clinical Attribute]
   827 E C1428722:DOS [Gene or Genome]

Phrase: "(Fig.3G"

Phrase: ")."
Processing 00000000.tx.169: It is unlikely that the toxic effect is due to non-specific inhibition of other proteins by BA as the doses used in our experiments are much lower than what is conventionally used in the field (44,52). 

Phrase: "It"

Phrase: "is"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "the toxic effect"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0600688:Toxic effect [Injury or Poisoning]
           toxic
   861   C1280500:Effect [Qualitative Concept]
   861   C1407029:Toxic [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "is due to non-specific inhibition of other proteins"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   764   C0205370:Non-specific [Qualitative Concept]
   764   C0678226:Due to [Functional Concept]
           due
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205369:Specific [Qualitative Concept]
   742   C1518422:Non [Functional Concept]
   742   C1552740:specific [Intellectual Product]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3146286:Due [Idea or Concept]
   742   C3463820:Inhibition [Activity]

Phrase: "by BA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005982:Bongkrekic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "as the doses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0178602:Doses [Quantitative Concept]
   966 E C0869039:Dose [Quantitative Concept]
   966 E C1114758:Dose # [Clinical Attribute]
   966 E C1428722:DOS [Gene or Genome]

Phrase: "used in our experiments"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]
   737 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: "much lower than what"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "is"

Phrase: "conventionally"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "in the field"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C3539073:In the Field [Spatial Concept]
           FIELD
   827   C0150312:In [Quantitative Concept]
   827   C0332285:In [Spatial Concept]
   827   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   827   C1521738:Field [Conceptual Entity]
   827   C2346620:Field [Conceptual Entity]
   827   C2349184:Field [Conceptual Entity]

Phrase: "(44,"

Phrase: "52"

Phrase: ")."
Processing 00000000.tx.170: However, it could be that the unusual doseresponse curve of BA may depend on ANT's dual functions. 

Phrase: "However,"

Phrase: "it"

Phrase: "could"

Phrase: "be"

Phrase: "that"

Phrase: "the unusual doseresponse curve of BA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0683162:dose-response curve [Quantitative Concept]
   748   C0205134:Curve [Spatial Concept]

Phrase: "may"

Phrase: "depend on ANT's dual functions."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0003455:Ant, NOS [Eukaryote]
   760   C0542341:Functions [Functional Concept]
   760   C0725813:depend [Medical Device]
   760   C1554184:Dual [Intellectual Product]
   726 E C0031843:function [Physiologic Function]
   726 E C0700205:FUNCTION [Classification]
   726 E C1705273:Function [Intellectual Product]
Processing 00000000.tx.171: Under pathological conditions, ANT is involved in forming the mPTP, which leads to cell death (44,50). 

Phrase: "Under pathological conditions,"
Meta Candidates (Total=16; Excluded=11; Pruned=0; Remaining=5)
   861   C0030664:Pathological [Biomedical Occupation or Discipline]
   861   C1521733:Pathological [Functional Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   789 E C0205469:pathology [Functional Concept]
   789 E C0677042:pathology [Pathologic Function]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "ANT"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1141015:Adenine Nucleotide Translocase [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1153238:adenine nucleotide translocase [Molecular Function]
   901   C1135982:Nucleotide Translocase [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0582119:Translocase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "is"

Phrase: "involved in forming"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205431:Forming [Functional Concept]
   790   C1314939:Involved [Functional Concept]
   790   C1522492:Forming [Functional Concept]
   756 E C0348078:Form [Qualitative Concept]
   756 E C0376315:Form [Manufactured Object]

Phrase: "the mPTP,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
  1000   C0908146:mitochondrial permeability transition pore [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2000322:permeability transition pore, mitochondrial [Amino Acid, Peptide, or Protein]
   923   C3158983:mitochondrial permeability transition [Cell Function]
   812   C0026237:Mitochondrial [Cell Component]
   812   C0031164:Permeability [Natural Phenomenon or Process]
   812   C0521451:Mitochondrial [Functional Concept]
   812   C0599156:Transition [Cell or Molecular Dysfunction]
   812   C1325742:Pore [Cell Component]
   812   C2700061:Transition [Activity]
   741 E C0205326:Permeable [Functional Concept]
   741 E C1182674:Transitional [Spatial Concept]
   741 E C1548597:Transitional [Idea or Concept]

Phrase: "which"

Phrase: "leads to cell death"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0007587:Cell Death [Cell Function]
   770   C0007634:Cell [Cell]
   770   C0011065:Death [Organism Function]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C1269647:Cell [Cell]
   770   C1306577:Death, NOS [Finding]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(44,"

Phrase: "50"

Phrase: ")."
Processing 00000000.tx.172: Thus, blocking the mPTP-forming function of ANT would be protective to cells. 

Phrase: "Thus,"

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the mPTP-forming function of ANT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0031843:function [Physiologic Function]
   738   C0542341:Function [Functional Concept]
   738   C0700205:FUNCTION [Classification]
   738   C1705273:Function [Intellectual Product]

Phrase: "would"

Phrase: "be"

Phrase: "protective to cells."
Processing 00000000.tx.173: However, under physiological conditions, ANT imports ADP from the cytosol and exports ATP synthesized by mitochondria back to the cytosol to be used as an energy source. 

Phrase: "However,"

Phrase: "under physiological conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "ANT"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1141015:Adenine Nucleotide Translocase [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1153238:adenine nucleotide translocase [Molecular Function]
   901   C1135982:Nucleotide Translocase [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0582119:Translocase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "imports"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0699788:Import [Occupational Activity]

Phrase: "ADP from the cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0523452:ADP [Laboratory Procedure]

Phrase: "and"

Phrase: "exports"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0699789:Export [Phenomenon or Process]

Phrase: "ATP"

Phrase: "synthesized by mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1883254:Synthesized [Activity]

Phrase: "back to the cytosol to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004600:Back [Body Location or Region]
   760   C0205095:Back [Spatial Concept]
   760   C0460009:Back [Body Location or Region]
   760   C1995000:Back [Body Location or Region]

Phrase: "be"

Phrase: "used as an energy source."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0014275:energy source [Functional Concept]
   760   C0424589:Energy [Finding]
   760   C0449416:Source [Finding]
   760   C0542479:Energy [Natural Phenomenon or Process]
   760   C1273517:used [Finding]
   760   C1442080:Energy [Quantitative Concept]
   760   C1705919:Source [Idea or Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.174: Therefore, inhibition of ANT's physiological function could then be toxic (52). 

Phrase: "Therefore,"

Phrase: "inhibition of ANT's physiological function"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0021469:Inhibition, function [Molecular Function]
           Inhibition
   760   C0021467:Inhibition [Mental Process]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "could"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "be"

Phrase: "toxic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600688:toxic [Injury or Poisoning]
  1000   C1407029:Toxic [Qualitative Concept]

Phrase: "(52"

Phrase: ")."
Processing 00000000.tx.175: At the MPP+ concentration used in our experiment, some ANT molecules may be involved in mPTP formation, but the remainder may still function as ADP/ATP carriers. 

Phrase: "At the MPP+ concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "used in our experiment,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0681814:Experiment [Research Activity]
   770   C1273517:used [Finding]
   770   C1706386:Experiment [Conceptual Entity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "some ANT molecules"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0567416:molecules [Substance]
   756   C1141015:Adenine Nucleotide Translocase [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1153238:adenine nucleotide translocase [Molecular Function]
   729 E C1521991:Molecular [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "involved in mPTP formation,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   853   C0908146:mitochondrial permeability transition pore [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C2000322:permeability transition pore, mitochondrial [Amino Acid, Peptide, or Protein]
   814   C3158983:mitochondrial permeability transition [Cell Function]
   778   C1326292:pore formation [Cell Function]
   748   C0026237:Mitochondrial [Cell Component]
   748   C0031164:Permeability [Natural Phenomenon or Process]
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C0521451:Mitochondrial [Functional Concept]
   748   C0599156:Transition [Cell or Molecular Dysfunction]
   748   C1314939:Involved [Functional Concept]
   748   C1325742:Pore [Cell Component]
   748   C1522492:Formation [Functional Concept]
   748   C2700061:Transition [Activity]

Phrase: "but"

Phrase: "the remainder"

Phrase: "may"

Phrase: "still"

Phrase: "function as ADP/ATP carriers."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   851   C1141015:ADP,ATP Carrier [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0007294:carriers [Finding]
   760   C0031843:function [Physiologic Function]
   760   C0523452:ADP [Laboratory Procedure]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
   726 E C0560175:Carrier [Finding]
   726 E C1706209:Carrier [Medical Device]
   726 E C3273162:Carrier [Intellectual Product]
Processing 00000000.tx.176: At higher doses, this normal physiological function of ANT could be inhibited, thus depleting the cellular energy source and deleteriously affecting cell survival. 

Phrase: "At higher doses,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   966   C0444956:High dose [Quantitative Concept]
   861   C0178602:Doses [Quantitative Concept]
   827 E C0869039:Dose [Quantitative Concept]
   827 E C1114758:Dose # [Clinical Attribute]
   827 E C1428722:DOS [Gene or Genome]

Phrase: "this normal physiological function of ANT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1705273:Function [Intellectual Product]

Phrase: "could"

Phrase: "be"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: ","

Phrase: "thus"

Phrase: "depleting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   928   C1550032:Unload [Idea or Concept]
   928   C1880497:Empty [Qualitative Concept]
   928   C1996907:Emptying [Activity]
   907 E C0333668:Depleted [Functional Concept]

Phrase: "the cellular energy source"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0014275:energy source [Functional Concept]
   827   C0449416:Source [Finding]
   827   C1705919:Source [Idea or Concept]

Phrase: "and"

Phrase: "deleteriously"

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "cell survival."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.177: IGF-1 is neuroprotective in brain hypoxiaischemia (53,54), axotomy (55), age-induced hippocampal death (56) and glutamate-induced motor neuron death (57). 

Phrase: "IGF-1"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "neuroprotective in brain hypoxiaischemia"

Phrase: "(53,"

Phrase: "54"

Phrase: ")"

Phrase: ","

Phrase: "axotomy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0524955:Axotomy [Research Activity]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "age-induced hippocampal death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0742983:age death [Finding]
   812   C0011065:Death [Organism Function]
   812   C1306577:Death, NOS [Finding]

Phrase: "(56"

Phrase: ")"

Phrase: "and"

Phrase: "glutamate-induced motor neuron death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C2754100:neuron death [Cell Function]
   804   C0011065:Death [Organism Function]
   804   C1306577:Death, NOS [Finding]

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.178: It protects embryonic DA neurons from apoptosis (58) and dopaminergic cells from toxin-induced cell death in vitro (59). 

Phrase: "It"

Phrase: "protects"

Phrase: "embryonic DA neurons from apoptosis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C1512035:dopamine neurons [Cell]
   781   C1660771:neuron apoptosis [Cell Function]
   762 E C1836846:Apoptotic neurons [Finding]
   760   C0027882:Neurons [Cell]

Phrase: "(58"

Phrase: ")"

Phrase: "and"

Phrase: "dopaminergic cells from toxin-induced cell death"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   778   C1512035:Dopaminergic cells [Cell]
   774   C0007587:cells death [Cell Function]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(59"

Phrase: ")."
Processing 00000000.tx.179: In addition, IGF-1 or the N-terminal tripeptide of IGF-1 protected DA neurons and improved functional deficits in 6-OHDA treated rats (46,47). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "IGF-1"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "the N-terminal tripeptide of IGF-1 protected DA neurons"

Phrase: "and"

Phrase: "improved functional deficits in 6-OHDA treated rats"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C2987487:deficits [Qualitative Concept]
   711 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "(46,"

Phrase: "47"

Phrase: ")."
Processing 00000000.tx.180: Consistent with these findings, application of IGF-1 to the medium also reduced the MPP+ toxicity in PC12-Syn cells and A9-like DA neurons of primary VM cultures in our study. 

Phrase: "Consistent with these findings,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent
   767   C0332529:Consistency finding [Qualitative Concept]

Phrase: "application of IGF-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0185125:Application [Health Care Activity]
   753   C1947919:Application [Intellectual Product]
   753   C2347934:Application [Intellectual Product]
   753   C3539080:APPLICATION [Quantitative Concept]

Phrase: "to the medium also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the MPP+ toxicity in PC12-Syn cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0040539:toxicity [Qualitative Concept]
   748   C0600688:Toxicity [Injury or Poisoning]

Phrase: "and"

Phrase: "A9-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0933647:A9 [Body Part, Organ, or Organ Component]

Phrase: "like DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1512035:dopamine neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "of primary VM cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "in our study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.181: This supports the notion that IGF-1 is an important neuroprotective factor which A9 DA neurons may depend on. 

Phrase: "This"

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the notion"

Phrase: "that IGF-1"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "an important neuroprotective factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "which A9 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "may"

Phrase: "depend on."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0725813:depend [Medical Device]
Processing 00000000.tx.182: Interestingly, plasma IGF-1 levels decrease with age (60) and a causal relationship between age-dependent decrease in IGF-1 and reduced cognitive brain function has been proposed in many studies (61). 

Phrase: "Interestingly,"

Phrase: "plasma IGF-1 levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   887   C1276042:Plasma insulin level [Laboratory Procedure]
   876   C0202098:insulin levels [Laboratory Procedure]
   876   C0428405:insulin levels [Laboratory or Test Result]
   799   C0441889:Levels [Qualitative Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]

Phrase: "decrease with age (60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001779:Age [Organism Attribute]
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "a causal relationship between age-dependent decrease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439849:Relationship [Qualitative Concept]
   748   C1705630:Relationship [Idea or Concept]
   748   C1706279:Relationship [Idea or Concept]
   748   C3540605:Relationship [Intellectual Product]

Phrase: "in IGF-1"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "reduced cognitive brain function"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   875   C0392335:cognitive function [Mental Process]
   861   C0678908:brain function [Organ or Tissue Function]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1705273:Function [Intellectual Product]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "proposed in many studies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0947630:studies [Laboratory Procedure]
   770   C1441414:PROPOSED [Idea or Concept]
   770   C1553874:Proposed [Qualitative Concept]
   770   C1578820:Proposed [Idea or Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "(61"

Phrase: ")."
Processing 00000000.tx.183: Taken together, the reduction of IGF-1 due to aging may contribute to increased vulnerability of A9 DA neurons in PD. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the reduction of IGF-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "due to aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "may"

Phrase: "contribute to increased vulnerability of A9 DA neurons"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C1512035:dopamine neurons [Cell]
   744   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   744   C0027882:Neurons [Cell]
   744   C0205217:Increased [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C0933647:A9 [Body Part, Organ, or Organ Component]
   744   C1880177:Contribute [Activity]

Phrase: "in PD."
Processing 00000000.tx.184: In our study, A10 DA neurons showed elevated transcription levels of several neuropeptides. 

Phrase: "In our study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "A10 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "elevated transcription levels of several neuropeptides."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.185: We selected GRP, CGRP and PACAP to examine their roles in protecting DA cells from MPP+-induced toxicity. 

Phrase: "We"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "GRP,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0061132:Gastrin releasing peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1333714:gastrin-releasing peptide [Gene or Genome]
   827   C0017151:Gastrin [Amino Acid, Peptide, or Protein,Hormone]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0376180:Gastrin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1283071:Releasing [Functional Concept]
   793 E C0030685:Release [Health Care Activity]
   793 E C0391871:Release [Functional Concept]
   793 E C0439180:% release [Quantitative Concept]
   793 E C0680255:release [Health Care Activity]
   793 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "CGRP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0439095:Alpha [Intellectual Product]
   804   C2003941:Alpha [Intellectual Product]
   804   C2350010:Alpha [Qualitative Concept]
   771   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   771   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]

Phrase: "and"

Phrase: "PACAP to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0071163:PACAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1412228:PACAP [Gene or Genome]
   861   C1836172:PACAP [Gene or Genome]

Phrase: "examine"

Phrase: "their roles in protecting DA cells"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0035820:Roles [Social Behavior]
   719 E C1705810:Role [Conceptual Entity]

Phrase: "from MPP+-induced toxicity."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   827   C0040539:toxicity [Qualitative Concept]
   827   C0600688:Toxicity [Injury or Poisoning]
   755 E C1407029:Toxic [Qualitative Concept]
   734 E C0032346:Poison [Hazardous or Poisonous Substance]
   734 E C1548769:Poison [Intellectual Product]
   734 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.186: GRP is a neuroendocrine peptide known to act primarily in the enteric and central nervous systems, where it regulates diverse functions, from satiety and smooth muscle contraction to the release of other gastrointestinal hormones (62). 

Phrase: "GRP"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0061132:Gastrin releasing peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1333714:gastrin-releasing peptide [Gene or Genome]
   827   C0017151:Gastrin [Amino Acid, Peptide, or Protein,Hormone]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0376180:Gastrin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1283071:Releasing [Functional Concept]
   793 E C0030685:Release [Health Care Activity]
   793 E C0391871:Release [Functional Concept]
   793 E C0439180:% release [Quantitative Concept]
   793 E C0680255:release [Health Care Activity]
   793 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "a neuroendocrine peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "primarily in the enteric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1304890:Enteric [Spatial Concept]

Phrase: "and"

Phrase: "central nervous systems,"
Meta Candidates (Total=19; Excluded=10; Pruned=0; Remaining=9)
  1000   C0927232:Systems, Central Nervous [Body System]
   966 E C1269563:Central nervous system [Body System]
   901   C0027763:Systems, Nervous [Body System]
   867 E C0422837:NERVOUS SYSTEM [Finding]
   867 E C1269560:Nervous system [Body System]
   829 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1879652:Central - [Laboratory Procedure]
   801 E C0027855:Neurology [Biomedical Occupation or Discipline]
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   785 E C2707261:Neurological [Clinical Attribute]
   743 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "where"

Phrase: "it"

Phrase: "regulates"

Phrase: "diverse functions,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: "from satiety"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036239:Satiety [Mental Process]

Phrase: "and"

Phrase: "smooth muscle contraction to the release of other gastrointestinal hormones"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   782   C1155937:smooth muscle contraction [Organ or Tissue Function]
   760   C0026820:Muscle Contraction [Physiologic Function]
   739   C1140999:Contraction [Pathologic Function]

Phrase: "(62"

Phrase: ")."
Processing 00000000.tx.187: It has also been studied extensively in the context of cancer cells where it plays a role as an autocrine growth factor (63,64). 

Phrase: "It"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "extensively in the context of cancer cells where"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0334227:cancer cells [Cell]
   744   C0006826:Cancer [Neoplastic Process]
   744   C0007634:Cells [Cell]
   744   C0449255:Context [Finding]
   744   C0542559:Context [Functional Concept]
   744   C0998265:Cancer [Eukaryote]
   744   C1306459:Cancer [Finding]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "it"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role as an autocrine growth factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "(63,"

Phrase: "64"

Phrase: ")."
Processing 00000000.tx.188: Although the presence of GRP in SN was reported many years ago (65), its function in DA neurons has not been described. 

Phrase: "Although"

Phrase: "the presence of GRP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in SN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "many years ago"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "its function in DA neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "described."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]
Processing 00000000.tx.189: In this study, our microarray data raised the possibility that GRP might be protective to DA neurons and we show here for the first time that GRP could reduce the toxic responses of both PC12-Syn cells and primary mesencephalic DA neurons against MPP+. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "our microarray data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "raised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442818:Raised [Quantitative Concept]

Phrase: "the possibility"

Phrase: "that GRP"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0061132:Gastrin releasing peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1333714:gastrin-releasing peptide [Gene or Genome]
   827   C0017151:Gastrin [Amino Acid, Peptide, or Protein,Hormone]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0376180:Gastrin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1283071:Releasing [Functional Concept]
   793 E C0030685:Release [Health Care Activity]
   793 E C0391871:Release [Functional Concept]
   793 E C0439180:% release [Quantitative Concept]
   793 E C0680255:release [Health Care Activity]
   793 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "might"

Phrase: "be"

Phrase: "protective to DA neurons"

Phrase: "and"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "here for the first time"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:Time [Temporal Concept]
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "that GRP"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0061132:Gastrin releasing peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1333714:gastrin-releasing peptide [Gene or Genome]
   827   C0017151:Gastrin [Amino Acid, Peptide, or Protein,Hormone]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0376180:Gastrin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1283071:Releasing [Functional Concept]
   793 E C0030685:Release [Health Care Activity]
   793 E C0391871:Release [Functional Concept]
   793 E C0439180:% release [Quantitative Concept]
   793 E C0680255:release [Health Care Activity]
   793 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "could"

Phrase: "reduce"

Phrase: "the toxic responses of both PC12-Syn cells"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0871261:responses [Organism Attribute]
   711 E C1704632:Response [Finding]
   711 E C1706817:Response [Intellectual Product]
   711 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "primary mesencephalic DA neurons against MPP+."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1512035:dopamine neurons [Cell]
   753   C0027882:Neurons [Cell]
Processing 00000000.tx.190: We thus suggest that GRP may contribute to the reduced susceptibility of A10 DA neurons in PD. 

Phrase: "We thus"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that GRP"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0061132:Gastrin releasing peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1333714:gastrin-releasing peptide [Gene or Genome]
   827   C0017151:Gastrin [Amino Acid, Peptide, or Protein,Hormone]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0376180:Gastrin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1283071:Releasing [Functional Concept]
   793 E C0030685:Release [Health Care Activity]
   793 E C0391871:Release [Functional Concept]
   793 E C0439180:% release [Quantitative Concept]
   793 E C0680255:release [Health Care Activity]
   793 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "contribute to the reduced susceptibility of A10 DA neurons"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C1512035:dopamine neurons [Cell]
   742   C0012655:Susceptibility [Clinical Attribute]
   742   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   742   C0027882:Neurons [Cell]
   742   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]
   742   C0220898:Susceptibility [Organism Attribute]
   742   C0392756:Reduced [Qualitative Concept]
   742   C1264642:Susceptibility [Functional Concept]
   742   C1547045:*Susceptibility [Quantitative Concept]
   742   C1880177:Contribute [Activity]

Phrase: "in PD."
Processing 00000000.tx.191: CGRP exerts multiple biological actions in the central nervous, gastrointestinal and cardiovascular systems (66,67). 

Phrase: "CGRP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0439095:Alpha [Intellectual Product]
   804   C2003941:Alpha [Intellectual Product]
   804   C2350010:Alpha [Qualitative Concept]
   771   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   771   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "multiple biological actions in the central nervous, gastrointestinal"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0005532:Biological [Biomedical Occupation or Discipline]
   744   C0205460:biological [Qualitative Concept]
   744   C0441472:actions [Functional Concept]
   711 E C3266814:Action [Activity]

Phrase: "and"

Phrase: "cardiovascular systems"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0007226:Systems, Cardiovascular [Body System]
           Cardiovascular
   966 E C0425560:CARDIOVASCULAR SYSTEM [Finding]
   966 E C1269562:Cardiovascular system [Body System]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "(66,"

Phrase: "67"

Phrase: ")."
Processing 00000000.tx.192: CGRP also influences the differentiation of immature DA neurons in primary VM cultures by inducing neurite outgrowth and increasing DA uptake per neuron, but not their normal rate of survival (68). 

Phrase: "CGRP also"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0439095:Alpha [Intellectual Product]
   799   C2003941:Alpha [Intellectual Product]
   799   C2350010:Alpha [Qualitative Concept]
   734   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   734   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]

Phrase: "influences"

Phrase: "the differentiation of immature DA neurons"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   767   C1159970:neuron differentiation [Cell Function]
   753   C0007589:Differentiation [Cell Function]
   753   C1511938:Differentiation [Clinical Attribute]
   753   C2945687:Differentiation [Functional Concept]
   742 E C1518294:Neuronal Differentiation [Finding]

Phrase: "in primary VM cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "by inducing neurite outgrowth"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C3158384:neurite outgrowth [Cell Function]
   827   C0085103:Neurite [Cell Component]

Phrase: "and"

Phrase: "increasing DA uptake per neuron,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1657587:dopamine uptake [Cell Function]
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "their normal rate of survival"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0038954:Survival Rate [Quantitative Concept]
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "(68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.193: In our study, CGRP reduced mitochondrial toxicity of PC12-Syn cells. 

Phrase: "In our study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "CGRP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0439095:Alpha [Intellectual Product]
   804   C2003941:Alpha [Intellectual Product]
   804   C2350010:Alpha [Qualitative Concept]
   771   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   771   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "mitochondrial toxicity of PC12-Syn cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1096176:Mitochondrial Toxicity [Pathologic Function]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0040539:toxicity [Qualitative Concept]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C0600688:Toxicity [Injury or Poisoning]
Processing 00000000.tx.194: In primary VM cultures, it increased the susceptibility of A10-like DA neurons to the toxin in a dose-dependent manner, whereas it had no effect on the survival of A9-like DA neurons. 

Phrase: "In primary VM cultures,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "it"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the susceptibility of A10-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "like DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1512035:dopamine neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "to the toxin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "in a dose-dependent manner,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "whereas"

Phrase: "it"

Phrase: "had"

Phrase: "no effect on the survival of A9-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "like DA neurons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1512035:dopamine neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.195: These data raise the possibility that CGRP may not be a neuroprotective factor for DA neurons. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "raise"

Phrase: "the possibility"

Phrase: "that CGRP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0439095:Alpha [Intellectual Product]
   804   C2003941:Alpha [Intellectual Product]
   804   C2350010:Alpha [Qualitative Concept]
   771   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   771   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "a neuroprotective factor for DA neurons."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   783   C0960756:factor A [Organic Chemical]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.196: However, it should be noted that primary VM cultures represent not adult but immature neurons. 

Phrase: "However,"

Phrase: "it"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that primary VM cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "not adult"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001675:Adult [Age Group]
   861   C1706450:Adult [Human]

Phrase: "but"

Phrase: "immature neurons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0814005:immature neuron [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.197: Given that there was a positive effect observed in PC12-Syn cells, one cannot exclude a potential protective effect of CGRP in adult DA neurons in vivo. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that there"

Phrase: "was"

Phrase: "a positive effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "observed in PC12-Syn cells,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   797   C0085262:PC12 Cells [Cell]
           PC-12
   760   C0007634:Cells [Cell]
   760   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   760   C1441672:Observed [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "cannot"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "a potential protective effect of CGRP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "in adult DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.198: PACAP belongs to the family of peptides containing secretin, glucagons and vasoactive intestinal peptide (VIP) (69,70). 

Phrase: "PACAP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0071163:PACAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412228:PACAP [Gene or Genome]
  1000   C1836172:PACAP [Gene or Genome]

Phrase: "belongs to the family of peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0015576:Family [Family Group]
   753   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   753   C1704727:Family [Conceptual Entity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "secretin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036534:Secretin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C2752584:secretin [Molecular Function]

Phrase: "glucagons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017687:glucagons [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   966 E C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "vasoactive intestinal peptide (VIP)"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0042395:Vasoactive Intestinal Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1366646:VASOACTIVE INTESTINAL PEPTIDE [Gene or Genome]
   827   C0021853:Intestinal [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C1980011:Vasoactive [Qualitative Concept]
   755 E C1708548:INTESTINE [Tissue]

Phrase: "(69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "70"

Phrase: ")."
Processing 00000000.tx.199: It is thought to act as a neurotrophic factor during development and as a neuroprotective factor against various insults (71,72). 

Phrase: "It"

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act as a neurotrophic factor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   806   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   797   C0960756:factor A [Organic Chemical]
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C1521761:Factor [Functional Concept]
   760   C2827422:Factor [Conceptual Entity]

Phrase: "during development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "and as a neuroprotective factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0960756:factor A [Organic Chemical]
   760   C1515981:And [Idea or Concept]
   760   C1521761:Factor [Functional Concept]
   760   C2827422:Factor [Conceptual Entity]

Phrase: "against various insults"

Phrase: "(71,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: "72"

Phrase: ")."
Processing 00000000.tx.200: PACAP is also neurotrophic for TH-positive neurons in primary VM culture (73,74). 

Phrase: "PACAP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0071163:PACAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412228:PACAP [Gene or Genome]
  1000   C1836172:PACAP [Gene or Genome]

Phrase: "is"

Phrase: "also neurotrophic for TH-positive neurons"

Phrase: "in primary VM culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C2242979:Culture [Laboratory Procedure]

Phrase: "(73,"

Phrase: "74"

Phrase: ")."
Processing 00000000.tx.201: In our in vitro assays, PACAP reduced the toxic responses of both the PC12-Syn cells and the DA neurons of primary VM cultures to MPP+. 

Phrase: "In our in vitro assays,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1515653:In Vitro Assay [Research Activity]
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "PACAP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0071163:PACAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412228:PACAP [Gene or Genome]
  1000   C1836172:PACAP [Gene or Genome]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the toxic responses of both"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "the PC12-Syn cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0085262:PC12 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the DA neurons of primary VM cultures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1512035:dopamine neurons [Cell]
   744   C0027882:Neurons [Cell]

Phrase: "to MPP+."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000098:MPP+ [Hazardous or Poisonous Substance,Organic Chemical]
  1000   C1417248:MPP [Gene or Genome]
Processing 00000000.tx.202: In addition, the results from the primary VM cultures demonstrated that A9-like DA neurons were more responsive to the effects of PACAP than A10-like DA neurons. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the results from the primary VM cultures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "demonstrated"

Phrase: "that A9-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0933647:A9 [Body Part, Organ, or Organ Component]

Phrase: "like DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1512035:dopamine neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "more responsive to the effects of PACAP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205342:Responsive [Functional Concept]

Phrase: "than A10-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]

Phrase: "like DA neurons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1512035:dopamine neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.203: This result is further substantiated by a recent study in which injection of PACAP into the SN protected DA neurons and improved behavioral deficits in a rat model of PD (73). 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "substantiated by a recent study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332185:Recent [Temporal Concept]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]

Phrase: "in which injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "of PACAP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0071163:PACAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412228:PACAP [Gene or Genome]
  1000   C1836172:PACAP [Gene or Genome]

Phrase: "into the SN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "protected"

Phrase: "DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1512035:dopamine neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "improved behavioral deficits in a rat model of PD (73"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C2987487:deficits [Qualitative Concept]
   706 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.204: Another neuropeptide from the same class, VIP is also expressed higher in A10 DA neurons (Table2) and its neurotrophic and neuroprotective effects in DA neurons against MPP+ have also been reported in a mouse model of PD (75). 

Phrase: "Another neuropeptide from the same class,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "VIP"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0042395:Vasoactive Intestinal Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1366646:VASOACTIVE INTESTINAL PEPTIDE [Gene or Genome]
   827   C0021853:Intestinal [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C1980011:Vasoactive [Qualitative Concept]
   755 E C1708548:INTESTINE [Tissue]

Phrase: "is"

Phrase: "also"

Phrase: "expressed"

Phrase: "higher in A10 DA neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "(Table2"

Phrase: ")"

Phrase: "and"

Phrase: "its neurotrophic"

Phrase: "and"

Phrase: "neuroprotective effects in DA neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0815279:Neuroprotective Effects [Functional Concept]
   797   C3179498:Dopamine Effects [Physiologic Function]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "against MPP+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000098:MPP+ [Hazardous or Poisonous Substance,Organic Chemical]
  1000   C1417248:MPP [Gene or Genome]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "reported in a mouse model of PD (75"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C2986594:Mouse Model [Experimental Model of Disease]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0684224:Reported [Intellectual Product]
   744   C0700287:Reported [Health Care Activity]
   744   C3161035:Model [Intellectual Product]
   744   C3496591:Reported [Clinical Attribute]
   711 E C3273238:Report [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.205: These data indicate that some A10-elevated molecules may contribute to the reduced vulnerability of A10 DA neurons, suggesting that these factors may be applied to protect A9 DA neurons. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that"

Phrase: "some A10-elevated molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "may"

Phrase: "contribute to the reduced vulnerability of A10 DA neurons,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C1512035:dopamine neurons [Cell]
   742   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   742   C0027882:Neurons [Cell]
   742   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]
   742   C0392756:Reduced [Qualitative Concept]
   742   C1880177:Contribute [Activity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "may"

Phrase: "be"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "protect"

Phrase: "A9 DA neurons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.206: Interestingly, several neuropeptides, including PACAP and VIP, are known to be transported through the blood brain barrier via transmembrane diffusion (76), thus increasing their potential to be utilized in therapies for PD. 

Phrase: "Interestingly,"

Phrase: "several neuropeptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027895:Neuropeptides [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "PACAP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0071163:PACAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412228:PACAP [Gene or Genome]
  1000   C1836172:PACAP [Gene or Genome]

Phrase: "and"

Phrase: "VIP,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0042395:Vasoactive Intestinal Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1366646:VASOACTIVE INTESTINAL PEPTIDE [Gene or Genome]
   827   C0021853:Intestinal [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C1980011:Vasoactive [Qualitative Concept]
   755 E C1708548:INTESTINE [Tissue]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "transported through the blood brain barrier"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
   833   C1305865:Blood-brain barrier [Organ or Tissue Function]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0229664:Blood [Body Substance]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1706912:BARRIER [Medical Device]
   719   C0005528:Transport, NOS [Cell Function]
   719   C1317949:Transport [Manufactured Object]
   719   C3495449:transport [Medical Device]
   717   C1623014:vascular transport [Cell Function]

Phrase: "via transmembrane diffusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012222:Diffusion [Natural Phenomenon or Process]
   861   C1696141:Diffusion [Functional Concept]

Phrase: "(76"

Phrase: ")"

Phrase: ","

Phrase: "thus"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "their potential to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "be"

Phrase: "utilized in therapies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0087111:therapies [Therapeutic or Preventive Procedure]
   756 E C0039798:therapy [Functional Concept]
   756 E C1363945:Therapy [Finding]

Phrase: "for PD."
Processing 00000000.tx.207: The microarray analyses also revealed that genes encoding energy-related metabolism and mitochondrial proteins are highly expressed in A9 DA neurons (Supplementary Material, TableS1). 

Phrase: "The microarray analyses also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C1449575:Microarray Analysis [Laboratory Procedure]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "energy-related metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0014272:Energy Metabolism [Physiologic Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "mitochondrial proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0949610:Mitochondrial Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "expressed in A9 DA neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1512035:dopamine neurons [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0027882:Neurons [Cell]
   760   C0933647:A9 [Body Part, Organ, or Organ Component]

Phrase: "(Supplementary Material,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936424:Supplementary Material [Intellectual Product]
   861   C0520510:Material [Substance]

Phrase: "TableS1"

Phrase: ")."
Processing 00000000.tx.208: This is particularly interesting as mitochondrial dysfunction is thought to contribute to the etiology of PD (77). 

Phrase: "This"

Phrase: "is"

Phrase: "particularly"

Phrase: "interesting as mitochondrial dysfunction"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0026237:Mitochondrial [Cell Component]
   770   C0031847:dysfunction [Functional Concept]
   770   C0277785:Dysfunction, NOS [Qualitative Concept]
   770   C0521451:Mitochondrial [Functional Concept]
   770   C0543488:interesting [Mental Process]
   715 E C0231174:Malfunction [Functional Concept]
   715 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contribute to the etiology of PD (77"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0015127:aetiology [Functional Concept]
   748   C1314792:Aetiology [Functional Concept]
   748   C1524003:Etiology [Conceptual Entity]
   748   C1880177:Contribute [Activity]

Phrase: ")."
Processing 00000000.tx.209: Elevated expression levels of these genes in A9 DA neurons are consistent with the notion that this neuronal population is highly energy (ATP)-dependent. 

Phrase: "Elevated expression levels of these genes"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   767   C0017262:Gene Expression [Genetic Function]
   756   C3244092:expression level [Idea or Concept]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in A9 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "are"

Phrase: "consistent with the notion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that"

Phrase: "this neuronal population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "is"

Phrase: "highly energy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0424589:Energy [Finding]
   861   C0542479:Energy [Natural Phenomenon or Process]
   861   C1442080:Energy [Quantitative Concept]

Phrase: "(ATP"

Phrase: ")-"

Phrase: "dependent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]
Processing 00000000.tx.210: Given the role of mitochondria in cellular energy metabolism, A9 DA neurons may be particularly susceptible to toxins such as MPP+ and rotenone (78) and to mutant -synuclein or parkin which have been reported to cause mitochondrial dysfunction (7981). 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the role of mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in cellular energy metabolism,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C1524026:cellular metabolism [Cell Function]
   901   C0014272:Energy Metabolism [Physiologic Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   827   C0424589:Energy [Finding]
   827   C0542479:Energy [Natural Phenomenon or Process]
   827   C1442080:Energy [Quantitative Concept]

Phrase: "A9 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "may"

Phrase: "be"

Phrase: "particularly susceptible to toxins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0231204:Susceptible [Functional Concept]
   770   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "such as MPP+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000098:MPP+ [Hazardous or Poisonous Substance,Organic Chemical]
  1000   C1417248:MPP [Gene or Genome]

Phrase: "and"

Phrase: "rotenone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035871:Rotenone [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "(78"

Phrase: ")"

Phrase: "and to mutant -synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0596988:Mutant [Cell or Molecular Dysfunction]
   770   C1515981:And [Idea or Concept]

Phrase: "or"

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "which"

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "mitochondrial dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "(7981"

Phrase: ")."
Processing 00000000.tx.211: Another group of genes that are elevated in A9 DA neurons are genes related to vesicle-mediated transport, including RAB1, RAB3C, RAB6, RAB11A, RAB14, vacuolar protein sorting 35 and very low density lipoprotein receptor (Supplementary Material, TableS1). 

Phrase: "Another group of genes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "that"

Phrase: "are"

Phrase: "elevated in A9 DA neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1512035:dopamine neurons [Cell]
   760   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0027882:Neurons [Cell]
   760   C0205250:Elevated [Qualitative Concept]
   760   C0933647:A9 [Body Part, Organ, or Organ Component]
   760   C3163633:Elevated [Qualitative Concept]

Phrase: "are"

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "related to vesicle-mediated transport,"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   862   C1325417:vesicle-mediated transport [Cell Function]
           vesicle transport
   797   C0887882:Transport vesicle [Cell Component]
   797   C1550030:Transport To [Idea or Concept]
   760   C0005528:Transport, NOS [Cell Function]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0333262:Vesicle [Acquired Abnormality]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C1317949:Transport [Manufactured Object]
   760   C1622418:vesicle [Cell Component]
   760   C3495449:transport [Medical Device]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "RAB1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419187:RAB1 [Gene or Genome]

Phrase: "RAB3C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428952:RAB3C [Gene or Genome]

Phrase: "RAB6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419215:RAB6 [Gene or Genome]

Phrase: "RAB11A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419189:RAB11A [Gene or Genome]

Phrase: "RAB14,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1424352:RAB14 [Gene or Genome]

Phrase: "vacuolar protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "sorting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237886:Sorting [Mental Process]
  1000   C0700314:sorting [Cell Function]
  1000   C1947906:Sorting [Activity]

Phrase: "35"

Phrase: "and"

Phrase: "very low density lipoprotein receptor"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
  1000   C1421455:VERY LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   937   C0023825:Very low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   937   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   937   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   884   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   840   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C0442811:Very low [Finding]
   804   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0178587:density [Quantitative Concept]
   804   C0205251:low [Qualitative Concept]
   804   C0442824:Very [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1299352:Low [Qualitative Concept]
   804   C1550472:low [Idea or Concept]
   733 E C0439794:Dense [Qualitative Concept]

Phrase: "(Supplementary Material,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936424:Supplementary Material [Intellectual Product]
   861   C0520510:Material [Substance]

Phrase: "TableS1"

Phrase: ")."
Processing 00000000.tx.212: Efficient DA sequestration into vesicles protects DA neurons from the deleterious effects of DA oxidation (82). 

Phrase: "Efficient DA sequestration into vesicles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443301:Sequestration [Functional Concept]

Phrase: "protects"

Phrase: "DA neurons from the deleterious effects of DA oxidation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1512035:dopamine neurons [Cell]
   742   C0027882:Neurons [Cell]

Phrase: "(82"

Phrase: ")."
Processing 00000000.tx.213: As A9 DA neurons have higher levels of the DA transporter than A10 or hypothalamic (A11, A13A15) DA neurons (8386), vesicle-mediated transport may be a more active and critical physiological process in this neuronal population. 

Phrase: "As A9 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "have"

Phrase: "higher levels of the DA transporter"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "than A10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "hypothalamic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020663:Hypothalamic [Body Part, Organ, or Organ Component]

Phrase: "(A11,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1848335:A11 [Gene or Genome]

Phrase: "A13A15"

Phrase: ")"

Phrase: "DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1512035:dopamine neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(8386"

Phrase: ")"

Phrase: ","

Phrase: "vesicle-mediated transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1325417:vesicle-mediated transport [Cell Function]
           vesicle transport
   827   C0005528:Transport, NOS [Cell Function]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]

Phrase: "may"

Phrase: "be"

Phrase: "a more active"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205177:Active [Functional Concept]

Phrase: "and"

Phrase: "critical physiological process in this neuronal population."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0031845:Physiological Process [Physiologic Function]
   774   C1514233:Population Process [Phenomenon or Process]
   748   C1184743:Process [Body Part, Organ, or Organ Component]
   748   C1522240:Process [Phenomenon or Process]
   738   C0085103:neuron process [Cell Component]
Processing 00000000.tx.214: Interestingly, vesicle-mediated transport genes have recently been recognized as susceptibility factors in PD (45,87,88). 

Phrase: "Interestingly,"

Phrase: "vesicle-mediated transport genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0017337:Genes [Gene or Genome]
   756   C1325417:vesicle-mediated transport [Cell Function]
           vesicle transport

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "recognized as susceptibility factors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "in PD (45,"

Phrase: "87,"

Phrase: "88"

Phrase: ")."
Processing 00000000.tx.215: In a genome-wide yeast screen for modifiers of -synuclein-induced toxicity, modifiers were most prominently clustered in the vesicle-mediated transport and lipid metabolism categories (87). 

Phrase: "In a genome-wide yeast screen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0220908:screen [Health Care Activity]
   812   C1305399:screen [Functional Concept]
   812   C1705053:Screen [Medical Device]

Phrase: "for modifiers of -synuclein-induced toxicity,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   804   C0040539:toxicity [Qualitative Concept]
   804   C0600688:Toxicity [Injury or Poisoning]
   733 E C1407029:Toxic [Qualitative Concept]
   711 E C0032346:Poison [Hazardous or Poisonous Substance]
   711 E C1548769:Poison [Intellectual Product]
   711 E C1550590:poison [Idea or Concept]

Phrase: "modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0205349:Modifier [Qualitative Concept]
   966   C1514623:Modifier [Conceptual Entity]
   966   C1516451:Modifier [Chemical Viewed Functionally]
   966   C3542952:Modifier [Intellectual Product]

Phrase: "were"

Phrase: "most prominently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "clustered in the vesicle-mediated transport"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C1325417:vesicle-mediated transport [Cell Function]
           vesicle transport
   783   C0887882:Transport vesicle [Cell Component]
   753   C0005528:Transport, NOS [Cell Function]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0333262:Vesicle [Acquired Abnormality]
   753   C1317949:Transport [Manufactured Object]
   753   C1622418:vesicle [Cell Component]
   753   C3495449:transport [Medical Device]
   719   C1555715:Cluster [Idea or Concept]
   719   C1704332:Cluster [Quantitative Concept]

Phrase: "and"

Phrase: "lipid metabolism categories"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0683312:Categories [Intellectual Product]
   793 E C1555713:category [Idea or Concept]
   734   C0598783:Lipid Metabolism [Molecular Function]
   734   C1517898:Lipid Metabolism [Molecular Function]

Phrase: "(87"

Phrase: ")."
Processing 00000000.tx.216: Furthermore, several vesicle-mediated transport genes, including several RAB genes, were found within genomic linkage regions for PD (88), and many vesicular transport genes were downregulated after age 40 in a recent study describing aging-dependent changes in human frontal cortex transcriptional profiles (45). 

Phrase: "Furthermore,"

Phrase: "several vesicle-mediated transport genes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0017337:Genes [Gene or Genome]
   717   C1325417:vesicle-mediated transport [Cell Function]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "several RAB genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "were"

Phrase: "found within genomic linkage regions"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0017428:Genomic [Gene or Genome]
   760   C0023745:linkage [Molecular Function]
   760   C0150312:Found [Quantitative Concept]
   760   C0887950:genomic [Biomedical Occupation or Discipline]
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]
   726 E C0243095:Find [Finding]

Phrase: "for PD (88"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "many vesicular transport genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017337:Genes [Gene or Genome]
   734   C1325417:vesicular transport [Cell Function]

Phrase: "were"

Phrase: "downregulated after age 40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001779:Age [Organism Attribute]
   770   C0439509:/40 [Temporal Concept]

Phrase: "in a recent study describing aging-dependent changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0392747:changes [Functional Concept]
   799   C0443172:changes [Quantitative Concept]
   766 E C1705241:Change [Quantitative Concept]

Phrase: "in human frontal cortex transcriptional profiles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1979963:Profile [Laboratory Procedure]
   771   C2003903:Profile [Functional Concept]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.217: This suggests that defective vesicular transport may contribute to the increased susceptibility of the aged patient population to neurodegenerative diseases. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that defective vesicular transport"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1325417:vesicular transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]

Phrase: "may"

Phrase: "contribute to the increased susceptibility of the aged patient population"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   739   C0001779:Aged [Organism Attribute]
   739   C0001792:Aged [Population Group]
   739   C0012655:Susceptibility [Clinical Attribute]
   739   C0030705:*^patient [Patient or Disabled Group]
   739   C0032659:Population [Quantitative Concept]
   739   C0205217:Increased [Quantitative Concept]
   739   C0220898:Susceptibility [Organism Attribute]
   739   C0442805:Increased [Functional Concept]
   739   C1257890:Population [Population Group]
   739   C1264642:Susceptibility [Functional Concept]
   739   C1547045:*Susceptibility [Quantitative Concept]
   739   C1880177:Contribute [Activity]
   739   C1999167:aged [Population Group]

Phrase: "to neurodegenerative diseases."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.218: Taken together, A9 DA neurons may be particularly vulnerable to genetic or environmental factors that diminish the function of the vesicle-recycling machinery. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "A9 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "may"

Phrase: "be"

Phrase: "particularly vulnerable to genetic"

Phrase: "or"

Phrase: "environmental factors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1516998:Environmental Factors [Functional Concept]
   983 E C0686732:Environmental Factor [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "diminish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:diminish [Quantitative Concept]

Phrase: "the function of the vesicle-recycling machinery."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]
Processing 00000000.tx.219: A recent paper published after the completion of our study described gene expression differences between catecholaminergic neurons in the rat (89). 

Phrase: "A recent paper"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030351:Paper [Manufactured Object]
   861   C1547566:Paper [Idea or Concept]

Phrase: "published after the completion of our study described gene expression differences"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   756   C0017262:Gene Expression [Genetic Function]
   738   C0017337:Gene [Gene or Genome]
   738   C0034037:Published [Occupational Activity]
   738   C0185117:Expression [Therapeutic or Preventive Procedure]
   738   C0205197:Completion [Qualitative Concept]
   738   C0557651:Study [Manufactured Object]
   738   C1552738:described [Idea or Concept]
   738   C1554962:completion [Qualitative Concept]
   738   C1704324:Published [Intellectual Product]
   738   C2603343:Study [Research Activity]
   730   C1519516:Differential Gene Expression [Genetic Function]
   718   C2348557:Completed Study [Functional Concept]
   704   C1705241:*Difference [Quantitative Concept]
   704   C1705242:Difference [Qualitative Concept]

Phrase: "between catecholaminergic neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in the rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "(89"

Phrase: ")."
Processing 00000000.tx.220: Although the study was done in rat tissue using a different microarray platform (14800 element cDNA array), many of the genes the authors reported are consistent with the expression patterns seen in the mouse midbrain DA neuron microarray analysis reported here (Affymetrix oligonucleotide array with 22000 probes). 

Phrase: "Although"

Phrase: "the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "done in rat tissue"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0040300:Tissue [Tissue]
   770   C1272695:Done [Qualitative Concept]
   770   C1547928:Tissue [Intellectual Product]
   770   C2746065:Done [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a different microarray platform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2964215:Microarray platform [Intellectual Product]
   827   C1710360:Platform [Research Device]

Phrase: "(14800 element cDNA array"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0887808:cDNA Array [Medical Device,Research Device]
   812   C1510941:Array [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "many of the genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017337:Genes [Gene or Genome]
   770   C0439064:Many [Quantitative Concept]
   770   C0747726:many [Conceptual Entity]

Phrase: "the authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "are"

Phrase: "consistent with the expression patterns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "seen in the mouse midbrain DA neuron microarray analysis"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   764   C1449575:Microarray Analysis [Laboratory Procedure]
   764   C1512035:dopamine neuron [Cell]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   742   C0025462:Mid-brain [Body Part, Organ, or Organ Component]
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0027882:Neuron [Cell]
   742   C0205397:Seen [Qualitative Concept]
   742   C0936012:Analysis [Research Activity]
   742   C1280997:Midbrain [Body Part, Organ, or Organ Component]
   742   C1524024:analysis [Functional Concept]
   742   C1709016:Microarray [Manufactured Object]
   708 E C0042789:see [Organism Function]
   708 E C1947903:See [Activity]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "here"

Phrase: "(Affymetrix oligonucleotide array with 22000 probes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0600597:Oligonucleotide Array [Medical Device,Research Device]
   753   C1510941:Array [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.221: In addition to the microarray results, our study also includes the quantitative validation by real-time PCR and functional analyses, which illustrate that these differences in phenotypic gene expression may be relevant to neurotoxic responses. 

Phrase: "In addition to the microarray results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "our study also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the quantitative validation by real-time PCR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1519941:Validation [Research Activity]

Phrase: "and"

Phrase: "functional analyses,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0558024:Functional analysis [Health Care Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "which"

Phrase: "illustrate"

Phrase: "that"

Phrase: "these differences in phenotypic gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1519516:Differential Gene Expression [Genetic Function]
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "relevant to neurotoxic responses."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2347946:Relevant [Qualitative Concept]
Processing 00000000.tx.222: In summary, we used LCM, microarray analysis and real-time PCR to determine gene expression profiles of A9 and A10 midbrain DA neurons and have begun to screen some of the molecules using in vitro bioassays. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "LCM,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1113652:Laser Capture Microdissection [Laboratory Procedure]
   827   C0023089:Laser [Manufactured Object]
   827   C0458142:Laser [Phenomenon or Process]
   827   C0598304:Microdissection [Laboratory Procedure]
   827   C1023865:Laser [Plant]
   827   C1706315:Laser [Medical Device]

Phrase: "microarray analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1449575:Microarray Analysis [Laboratory Procedure]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "real-time PCR to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0677874:pCR [Finding]

Phrase: "determine"

Phrase: "gene expression profiles of A9"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   862   C1956267:Gene Expression Profiles [Quantitative Concept]
   845 E C1449575:gene expression profile [Laboratory Procedure]
   726   C1979963:Profile [Laboratory Procedure]
   726   C2003903:Profile [Functional Concept]

Phrase: "and"

Phrase: "A10 midbrain DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1512035:dopamine neurons [Cell]
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "have"

Phrase: "begun"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "screen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220908:screen [Health Care Activity]
  1000   C1305399:screen [Functional Concept]
  1000   C1705053:Screen [Medical Device]

Phrase: "some of the molecules"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205392:Some [Quantitative Concept]
   770   C0567416:molecules [Substance]
   770   C3540770:Some [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "in vitro bioassays."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0005507:Bioassays [Laboratory Procedure]
   793 E C1704780:Bioassay [Conceptual Entity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.223: These data may offer opportunities for further in vivo modeling of neuroprotective and neurotoxic responses in midbrain DA neurons. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "may"

Phrase: "offer"

Phrase: "opportunities for further in vivo modeling of neuroprotective"

Phrase: "and"

Phrase: "neurotoxic responses in midbrain DA neurons."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]
Processing 00000000.tx.224: Such scientific work may ultimately provide clues to pathogenetic mechanisms involved in PD and delineate neuroprotective and therapeutic interventions against this disease.  

Phrase: "Such scientific work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "may"

Phrase: "ultimately"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "clues to pathogenetic mechanisms"

Phrase: "involved in PD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1314939:Involved [Functional Concept]

Phrase: "and"

Phrase: "delineate"

Phrase: "neuroprotective"

Phrase: "and"

Phrase: "therapeutic interventions against this disease."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0087111:Therapeutic Interventions [Therapeutic or Preventive Procedure]
   806   C0808232:therapeutic interventions [Therapeutic or Preventive Procedure]
   760   C0886296:interventions [Health Care Activity]
   760   C1273869:Interventions [Health Care Activity]
   760   C2979881:Interventions [Clinical Attribute]
   760   C3542921:Interventions [Classification]
   726 E C1948041:Intervention [Therapeutic or Preventive Procedure]
Processing 00000000.tx.225: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES  Laser capture microdissection Tissue preparation Adult C57/B6 mice (Jackson Laboratory, West Grove, PA, USA) were anesthetized with intraperitoneal (i.p.) sodium pentobarbital (300mg/kg) and decapitated. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS SUPPLEMENTARY MATERIAL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Laser capture microdissection Tissue preparation Adult C57/B6 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C0025914:Mice [Mammal]
   791   C0025929:mice [Mammal]
   791   C0026809:Mice [Mammal]

Phrase: "(Jackson Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022877:Laboratory [Manufactured Object,Organization]
   861   C3244292:laboratory [Functional Concept]

Phrase: "West Grove,"

Phrase: "PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "were"

Phrase: "anesthetized with intraperitoneal (i.p.) sodium pentobarbital"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0700349:sodium pentobarbital [Organic Chemical,Pharmacologic Substance]
   760   C0030883:Pentobarbital [Organic Chemical,Pharmacologic Substance]
   760   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   760   C0442120:Intraperitoneal [Spatial Concept]
   760   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1720436:Anesthetized [Finding]

Phrase: "(300mg/kg)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022718:KG [Geographic Area]
   861   C0439209:kg [Quantitative Concept]

Phrase: "and"

Phrase: "decapitated."
Processing 00000000.tx.226: The brain was removed, snap-frozen in dry ice-cooled 2-methylbutane (60C). 

Phrase: "The brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "snap-"

Phrase: "frozen in dry ice-"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0013239:Dry Ice [Inorganic Chemical]
   770   C0011682:Dry [Natural Phenomenon or Process]
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0020746:Ice [Inorganic Chemical]
   770   C0205222:Dry [Qualitative Concept]
   770   C0677542:Frozen [Functional Concept]
   770   C1512080:Dry [Qualitative Concept]

Phrase: "cooled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1548792:Cool [Qualitative Concept]

Phrase: "2-methylbutane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0083072:2-methylbutane [Organic Chemical]
           Methylbutane

Phrase: "(60C"

Phrase: ")."
Processing 00000000.tx.227: Ten micron-thick coronal sections of the midbrain were cut using a cryostat, mounted on LCM slides (Arcturus Engineering, Inc., Mountain View, CA, USA) and immediately stored at 70C. 

Phrase: "Ten micron-thick coronal sections of the midbrain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0205123:Coronal [Spatial Concept]
   711   C0205155:Section [Spatial Concept]
   711   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   711   C1522472:Section [Substance]
   711   C1552923:Section [Quantitative Concept]
   711   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "cut"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000925:Cut [Injury or Poisoning]
  1000   C1883724:CUT [Phenomenon or Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a cryostat,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0180202:Cryostat [Medical Device]

Phrase: "mounted on LCM slides"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C1113652:Laser Capture Microdissection [Laboratory Procedure]
   753   C0023089:Laser [Manufactured Object]
   753   C0444330:slides [Research Device]
   753   C0449878:mounted [Finding]
   753   C0458142:Laser [Phenomenon or Process]
   753   C0598304:Microdissection [Laboratory Procedure]
   753   C1023865:Laser [Plant]
   753   C1706315:Laser [Medical Device]
   719 E C0181909:Mount [Medical Device]
   719 E C1705201:Slide [Manufactured Object]

Phrase: "(Arcturus Engineering,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014279:Engineering [Occupation or Discipline]

Phrase: "Inc.,"

Phrase: "Mountain View,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449911:View [Spatial Concept]

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "stored at 70C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]
Processing 00000000.tx.228: Quick immunostaining and dehydration of sections A quick immunostaining protocol for TH was used to identify the DA neurons to be captured. 

Phrase: "Quick immunostaining"

Phrase: "and"

Phrase: "dehydration of sections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0011175:Dehydration [Disease or Syndrome]

Phrase: "A quick immunostaining protocol for TH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0442711:Protocol [Intellectual Product]
   753   C1507394:Protocol [Intellectual Product]
   753   C1522729:Protocol [Intellectual Product]
   753   C2348563:Protocol [Intellectual Product]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the DA neurons to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "be"

Phrase: "captured."
Processing 00000000.tx.229: First, the tissue sections were fixed in cold acetone for 5min. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the tissue sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   983   C2316368:Tissue section [Tissue]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "fixed in cold acetone"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0001002:Acetone [Organic Chemical,Pharmacologic Substance]
   770   C0009264:Cold [Natural Phenomenon or Process]
   770   C0009443:Cold [Disease or Syndrome]
   770   C0231441:Fixed [Finding]
   770   C0234192:Cold [Physiologic Function]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "for 5min."
Processing 00000000.tx.230: The slides were then washed in phosphate-buffered saline (PBS), incubated with rabbit anti-TH (Pel-Freez Biologicals, Rogers, AR, USA; 

Phrase: "The slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed in phosphate-buffered saline (PBS),"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1548982:Washed [Idea or Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726 E C0441648:Wash [Activity]

Phrase: "incubated with rabbit anti-TH"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0034493:Rabbit [Mammal]
   760   C0039725:TH [Geographic Area]
   760   C0039738:Th [Element, Ion, or Isotope]
   760   C1420718:TH [Gene or Genome]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "(Pel-Freez Biologicals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2979985:Biologicals [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Rogers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3463939:Roger [Eukaryote]

Phrase: "AR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986463:AR+ [Finding]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ";"
Processing 00000000.tx.231: 1:25) for 4min, washed in PBS and exposed to biotinylated anti-rabbit antibody (Vector Laboratories, Burlingame, CA, USA; 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "25"

Phrase: ")"

Phrase: "for 4min,"

Phrase: "washed in PBS"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1548982:Washed [Idea or Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "exposed to biotinylated anti-rabbit antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0034493:Rabbit [Mammal]

Phrase: "(Vector Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "Burlingame,"

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ";"
Processing 00000000.tx.232: 1:25) for 4min. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "25"

Phrase: ")"

Phrase: "for 4min."
Processing 00000000.tx.233: The slides were washed in PBS, incubated in ABC-horseradish peroxidase enzyme complex (Vectastain, Vector Laboratories) for 4min and the staining was detected with the substrate, diaminobenzidine (DAB). 

Phrase: "The slides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0444330:slides [Research Device]
   966 E C1705201:Slide [Manufactured Object]

Phrase: "were"

Phrase: "washed in PBS,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1548982:Washed [Idea or Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726 E C0441648:Wash [Activity]

Phrase: "incubated in ABC-horseradish peroxidase enzyme complex"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   778   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0330510:Horseradish [Food]
   748   C0439855:Complex [Qualitative Concept]
   748   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   748   C1110641:Horseradish [Plant]
   748   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(Vectastain,"

Phrase: "Vector Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: "for 4min"

Phrase: "and"

Phrase: "the staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "detected with the substrate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1710236:Substrate [Manufactured Object]

Phrase: "diaminobenzidine (DAB)."
Processing 00000000.tx.234: Sections were subsequently dehydrated in graded ethanol solution (30s each in water, 70% ethanol, 95% ethanol, 100% ethanol, and twice for 5min in xylene). 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "subsequently"

Phrase: "dehydrated in graded ethanol solution"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0001962:Ethanol [Organic Chemical]
   760   C0011175:Dehydrated [Disease or Syndrome]
   760   C0037633:Solution [Substance]
   760   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(30s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0227073:30S [Body Part, Organ, or Organ Component]

Phrase: "each in water,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   790   C0599638:WATER [Substance]
   790   C1457900:Each [Quantitative Concept]
   790   C1550678:Water [Inorganic Chemical]
   718 E C0443350:Watery [Qualitative Concept]

Phrase: "70% ethanol,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1381542:70% Ethanol [Clinical Drug]
   861   C0001962:Ethanol [Organic Chemical]

Phrase: "95% ethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001962:Ethanol [Organic Chemical]

Phrase: "100% ethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001962:Ethanol [Organic Chemical]

Phrase: "and"

Phrase: "twice for 5min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720725:Twice [Intellectual Product]
   790   C1948050:Twice [Quantitative Concept]

Phrase: "in xylene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043367:Xylene [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")."
Processing 00000000.tx.235: On the basis of our qualitative assessment, the sensitivity of the quick TH staining protocol did not differ from regular staining protocols, providing similar intensities of TH staining between A9 and A10 regions. 

Phrase: "On the basis of our qualitative assessment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1261322:Assessment [Health Care Activity]
   861   C1516048:Assessment [Activity]

Phrase: "the sensitivity of the quick TH staining protocol"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0036667:Sensitivity [Quantitative Concept]
   744   C0312418:Sensitivity [Mental Process]
   744   C0427965:Sensitivity [Finding]
   744   C1511883:Sensitivity [Quantitative Concept]
   744   C1522640:Sensitivity [Qualitative Concept]
   744   C2346484:SENSITIVITY [Phenomenon or Process]
   744   C2349185:Sensitivity [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ from regular staining protocols,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0205272:Regular [Qualitative Concept]
   760   C0442711:Protocols [Intellectual Product]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   726 E C1507394:Protocol [Intellectual Product]
   726 E C1522729:Protocol [Intellectual Product]
   726 E C2348563:Protocol [Intellectual Product]

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "similar intensities of TH staining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522510:intensities [Qualitative Concept]

Phrase: "between A9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0933647:A9 [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "A10 regions."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.236: LCM of mouse midbrain tissue The PixCell II System (Arcturus Engineering, Inc.) was used for LCM. 

Phrase: "LCM of mouse midbrain tissue"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C1113652:Laser Capture Microdissection [Laboratory Procedure]
   748   C0023089:Laser [Manufactured Object]
   748   C0458142:Laser [Phenomenon or Process]
   748   C0598304:Microdissection [Laboratory Procedure]
   748   C1023865:Laser [Plant]
   748   C1706315:Laser [Medical Device]

Phrase: "The PixCell II System"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(Arcturus Engineering,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014279:Engineering [Occupation or Discipline]

Phrase: "Inc.)"

Phrase: "was"

Phrase: "used for LCM."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   862   C1113652:Laser Capture Microdissection [Laboratory Procedure]
   760   C0023089:Laser [Manufactured Object]
   760   C0458142:Laser [Phenomenon or Process]
   760   C0598304:Microdissection [Laboratory Procedure]
   760   C1023865:Laser [Plant]
   760   C1273517:used [Finding]
   760   C1706315:Laser [Medical Device]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.237: Five-hundred to seven-hundred neurons were captured in each region of A9 and A10 in each animal. 

Phrase: "Five-hundred to seven-hundred neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0027882:Neurons [Cell]
   716 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "captured in each region of A9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]
   753   C0933647:A9 [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "A10 in each animal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.238: Five replicates of A9 samples were from five different mice and six replicates of A10 samples were from six different mice. 

Phrase: "Five"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205451:Five [Quantitative Concept]

Phrase: "replicates of A9 samples"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205173:Replicate [Functional Concept]
   770   C0205341:Replicate [Functional Concept]
   770   C0933647:A9 [Body Part, Organ, or Organ Component]
   770   C1883725:Replicate [Qualitative Concept]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "were from five different mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0205451:Five [Quantitative Concept]
   760   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "six"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205452:Six [Quantitative Concept]

Phrase: "replicates of A10 samples"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0052080:A-10 [Organic Chemical,Pharmacologic Substance]
   770   C0205173:Replicate [Functional Concept]
   770   C0205341:Replicate [Functional Concept]
   770   C1883725:Replicate [Qualitative Concept]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "were from six different mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0205452:Six [Quantitative Concept]
   760   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.239: As ventrolateral A9 DA neurons are the most vulnerable and medial A10 DA neurons the most resistant to degeneration, only ventrolateral A9 [ventrolateral SNc and SN pars reticulata (SNr)] and medial A10 DA neurons [central linear nucleus (CLi), interfascicular nucleus (IF), medial VTA, medial nucleus paranigralis (PN), medial nucleus parabrachialis pigmentosus (PBN)] were microdissected (Fig.1A1D). 

Phrase: "As ventrolateral A9 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1512035:dopamine neurons [Cell]
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "are"

Phrase: "the most vulnerable"

Phrase: "and"

Phrase: "medial A10 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1512035:dopamine neurons [Cell]
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "the most resistant to degeneration,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332325:Resistant to [Functional Concept]
           Resistant
   760   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "only ventrolateral A9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0933647:A9 [Body Part, Organ, or Organ Component]

Phrase: "[ventrolateral SNc"

Phrase: "and"

Phrase: "SN pars reticulata"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0175413:Substantia nigra pars reticulata [Body Part, Organ, or Organ Component]
           Pars reticulata
   861   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   861   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
   812   C0032405:PARS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1414437:PARS [Gene or Genome]
   779 E C1417826:PAR [Gene or Genome]
   779 E C1514229:PAR [Quantitative Concept]
   779 E C1705885:PAR [Gene or Genome]

Phrase: "(SNr)]"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986823:SNR [Quantitative Concept]

Phrase: "and"

Phrase: "medial A10 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1512035:dopamine neurons [Cell]
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "[central linear nucleus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0175404:Linear nucleus [Body Part, Organ, or Organ Component]
   827   C0007610:Nucleus [Cell Component]

Phrase: "(CLi"

Phrase: ")"

Phrase: ","

Phrase: "interfascicular nucleus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2331355:Interfascicular nucleus [Body Part, Organ, or Organ Component]
   861   C0007610:Nucleus [Cell Component]

Phrase: "("

Phrase: "IF"

Phrase: ")"

Phrase: ","

Phrase: "medial VTA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0175405:Ventral Tegmental Area [Body Part, Organ, or Organ Component]
   812   C0017446:Area [Geographic Area]
   812   C0205146:Area [Spatial Concept]
   812   C1704448:Ventral [Spatial Concept]
   741   C0039441:tegmentum [Body Part, Organ, or Organ Component]

Phrase: "medial nucleus paranigralis (PN),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C2330526:Nucleus paranigralis [Body Part, Organ, or Organ Component]

Phrase: "medial nucleus parabrachialis pigmentosus"

Phrase: "(PBN)]"

Phrase: "were"

Phrase: "microdissected"

Phrase: "(Fig.1A1D"

Phrase: ")."
Processing 00000000.tx.240: Affymetrix GeneChip microarrays Sample and array processing Total RNA was separately extracted from the individual replicate samples using the PicoPure RNA isolation kit (Arcturus Engineering, Inc.). 

Phrase: "Affymetrix GeneChip microarrays"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1709016:Microarray [Manufactured Object]

Phrase: "Sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "array"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510941:Array [Spatial Concept]

Phrase: "processing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]
   966 E C1522240:Process [Phenomenon or Process]

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "separately"

Phrase: "extracted from the individual replicate samples"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   753   C0027361:Individual [Population Group]
   753   C0185115:Extracted [Therapeutic or Preventive Procedure]
   753   C0205173:Replicate [Functional Concept]
   753   C0205341:Replicate [Functional Concept]
   753   C0237401:Individual [Human]
   753   C1883725:Replicate [Qualitative Concept]
   753   C3541890:EXTRACTED [Finding]
   719   C0370003:Sample [Substance]
   719   C2347026:Sample [Conceptual Entity]
   719 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the PicoPure RNA isolation kit (Arcturus Engineering,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0014279:Engineering [Occupation or Discipline]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.241: Nanogram quantities of total RNA from each sample were used to generate a high fidelity cDNA, which is modified at the 3' end to contain an initiation site for T7 RNA polymerase. 

Phrase: "Nanogram quantities of total RNA"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C1265611:QUANTITIES [Quantitative Concept]
   726 E C1554108:Quantity [Intellectual Product]
   726 E C1561573:Quantity [Intellectual Product]

Phrase: "from each sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "a high fidelity cDNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "which"

Phrase: "is"

Phrase: "modified at the 3'"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392747:Modified [Functional Concept]

Phrase: "end"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an initiation site for T7 RNA polymerase."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205145:Site [Spatial Concept]
   748   C0589507:Initiation [Mental Process]
   748   C1158830:Initiation [Genetic Function]
   748   C1515974:Site [Body Location or Region]
   748   C1704686:Initiation [Functional Concept]
   748   C2825164:Site [Spatial Concept]
Processing 00000000.tx.242: Upon completion of cDNA synthesis, all of the product was used in an in vitro transcription (IVT) reaction to generate aRNA. 

Phrase: "Upon completion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205197:Completion [Qualitative Concept]
  1000   C1554962:completion [Qualitative Concept]

Phrase: "of cDNA synthesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "all of the product"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0444868:All [Quantitative Concept]
   770   C1514468:product [Entity]
   770   C1704444:Product [Quantitative Concept]
   770   C3539085:All [Idea or Concept]

Phrase: "was"

Phrase: "used in an in vitro transcription"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   783   C0021135:In Vitro [Intellectual Product]
   783   C1533691:in vitro [Qualitative Concept]
           vitro
   783   C2827718:In Vitro [Functional Concept]
   753   C0040649:Transcription [Genetic Function]
   753   C1273517:used [Finding]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "(IVT) reaction to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "generate"

Phrase: "aRNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3131480:Arna [Eukaryote]
Processing 00000000.tx.243: Up to 2g of aRNA was used for a second round of amplification which was initiated by random hexamer priming for first strand cDNA synthesis. 

Phrase: "Up to 2g"

Phrase: "of aRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3131480:Arna [Eukaryote]

Phrase: "was"

Phrase: "used for a second round of amplification"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   757   C1524063:Use of [Functional Concept]
   748   C0205436:Second [Quantitative Concept]
   748   C0332490:Round [Spatial Concept]
   748   C0457385:Second [Temporal Concept]
   748   C0565930:/second [Quantitative Concept]
   748   C1273517:used [Finding]
   748   C1517480:Amplification [Molecular Biology Research Technique]
   748   C1521871:Amplification [Phenomenon or Process]
   748   C1561503:second [Idea or Concept]
   748   C1705190:Second [Qualitative Concept]
   748   C1705759:Amplification [Cell or Molecular Dysfunction]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "which"

Phrase: "was"

Phrase: "initiated by random hexamer priming"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0034656:RANDOM [Research Activity]
   760   C0439605:Random [Qualitative Concept]
   760   C0871133:Priming [Functional Concept]
   726   C1548602:Initiate [Idea or Concept]
   726   C1704686:Initiate [Functional Concept]

Phrase: "for first strand cDNA synthesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0220781:synthesis [Biologic Function]
   812   C1883254:Synthesis [Activity]
Processing 00000000.tx.244: The second round IVT contained biotinylated UTP and CTP which are utilized for detection following hybridization to the oligonucleotide microarray. 

Phrase: "The second round IVT"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "biotinylated UTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042010:UTP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "CTP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010734:CTP [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1420150:CTP [Gene or Genome]

Phrase: "which"

Phrase: "are"

Phrase: "utilized for detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "hybridization to the oligonucleotide microarray."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020202:Hybridisation [Genetic Function]
   760   C1300517:Hybridization [Laboratory Procedure]
Processing 00000000.tx.245: Twenty micrograms of full-length cRNA, from both controls and enriched samples, were fragmented and hybridized to GeneChip arrays following the manufacturer's protocol. 

Phrase: "Twenty micrograms of full-length cRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439211:microgram [Quantitative Concept]

Phrase: "from both controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "enriched samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "fragmented"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392767:Fragmented [Functional Concept]
  1000   C1708096:Fragmented [Qualitative Concept]
   966 E C0332255:fragment [Functional Concept]

Phrase: "and"

Phrase: "hybridized to GeneChip arrays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0872345:Gene Chip [Medical Device,Research Device]
   770   C1955272:Genechip [Manufactured Object]
   737   C1510941:Array [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the manufacturer's protocol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.246: All samples were subjected to gene expression analysis via the Affymetrix Murine 430A high-density oligonucleotide array, which queries 22000 mouse probe sets. 

Phrase: "All samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "subjected to gene expression analysis"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C1880945:Gene Expression Analysis [Molecular Biology Research Technique]
   806   C0017262:Gene Expression [Genetic Function]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0017337:Gene [Gene or Genome]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "via the Affymetrix Murine 430A high-density oligonucleotide array,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C0600597:Oligonucleotide Array [Medical Device,Research Device]
   795   C1510941:Array [Spatial Concept]

Phrase: "which queries 22000 mouse probe sets."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0036849:Set [Mental Process]
   804   C0182400:Probe [Medical Device]
   804   C1442518:Set [Functional Concept]
   804   C1704681:Probe [Gene or Genome]
   804   C1705195:Set [Conceptual Entity]
   804   C2347609:Probe [Chemical Viewed Functionally]
   804   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.247: Protocols for target hybridization, washing and staining were performed according to the manufacturer's protocol (http://www.affymetrix.com). 

Phrase: "Protocols for target hybridization,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0442711:Protocols [Intellectual Product]
   737 E C1507394:Protocol [Intellectual Product]
   737 E C1522729:Protocol [Intellectual Product]
   737 E C2348563:Protocol [Intellectual Product]

Phrase: "washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "and"

Phrase: "staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "were"

Phrase: "performed according to the manufacturer's protocol"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0442711:Protocol [Intellectual Product]
   753   C0680240:according [Social Behavior]
   753   C0884358:Performed [Functional Concept]
   753   C0947322:Manufacturer [Intellectual Product]
   753   C1507394:Protocol [Intellectual Product]
   753   C1522729:Protocol [Intellectual Product]
   753   C1705426:Manufacturer [Population Group]
   753   C2348563:Protocol [Intellectual Product]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www.affymetrix.com"

Phrase: ")."
Processing 00000000.tx.248: Data normalization and statistical analysis Several complementary data analysis approaches were used to identify differentially expressed genes. 

Phrase: "Data normalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1882115:Normalization [Research Activity]

Phrase: "and"

Phrase: "statistical analysis Several complementary data analysis approaches"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0449445:Approaches [Spatial Concept]
   795   C1292724:Approaches [Functional Concept]
   717   C0010998:Data Analysis, Statistical [Quantitative Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "differentially expressed genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.249: The Gene Chip Operating System 1.0 (GCOS, Affymetrix) was employed to generate one approach to comparative analysis presented in this study. 

Phrase: "The Gene Chip Operating System 1.0"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   827   C0872345:Gene Chip [Medical Device,Research Device]
   827   C1709324:Operating System [Intellectual Product]
   827   C1955272:Genechip [Manufactured Object]
   799   C0017337:Gene [Gene or Genome]
   799   C0449913:System [Functional Concept]
   799   C0600596:Chip [Research Device]
   799   C1553451:System [Manufactured Object]
   799   C1704459:System [Medical Device]
   766   C3242339:operate [Functional Concept]
   727 E C0205373:Systemic [Functional Concept]

Phrase: "(GCOS,"

Phrase: "Affymetrix"

Phrase: ")"

Phrase: "was"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "one approach to comparative analysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449445:Approach [Spatial Concept]

Phrase: "presented in this study."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0449450:Presented [Idea or Concept]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   737 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.250: Distinct algorithms were used to determine the absolute call, which distinguishes the presence or absence of a transcript, the differential change in gene expression and the magnitude of change, which is represented as signal log ratio (on a log base 2 scale). 

Phrase: "Distinct algorithms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0002045:Algorithms [Intellectual Product]
   827 E C1553907:algorithm [Laboratory Procedure]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the absolute call,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0679006:Call [Mental Process]
   861   C1292769:c-ALL [Neoplastic Process]
   861   C1947967:Call [Functional Concept]

Phrase: "which"

Phrase: "distinguishes"

Phrase: "the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of a transcript,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "the differential change in gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0025320:The change [Physiologic Function]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "the magnitude of change,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449286:magnitude [Quantitative Concept]
   770   C1704240:Magnitude [Quantitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "represented as signal log ratio"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]
   760   C1708728:Log [Intellectual Product]
   760   C1710082:Signal [Phenomenon or Process]
   760   C2986775:log [Occupational Activity]
   726   C1882932:Represent [Activity]

Phrase: "("

Phrase: "on a log base 2 scale"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0175659:Scale [Medical Device]
   812   C0349674:Scale [Intellectual Product]
   812   C1947916:Scale [Activity]
   812   C3536777:Scale [Manufactured Object]
   741 E C1710017:Scalar [Qualitative Concept]
   729 E C0222045:Scales [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.251: The mathematical definitions for each of these algorithms can be found in the GCOS data analysis guide. 

Phrase: "The mathematical definitions for each of these algorithms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1550452:definition [Idea or Concept]
   711   C1704788:Definition [Conceptual Entity]
   711   C3539107:Definition [Intellectual Product]

Phrase: "can"

Phrase: "be"

Phrase: "found in the GCOS data analysis guide."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0010992:Data Analysis [Occupational Activity]
   774   C1553409:Data found [Idea or Concept]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0150312:Found [Quantitative Concept]
   748   C0181090:Guide [Professional or Occupational Group]
   748   C0302614:Guide [Medical Device]
   748   C0936012:Analysis [Research Activity]
   748   C1511726:Data [Idea or Concept]
   748   C1524024:analysis [Functional Concept]
   748   C1706050:Guide [Manufactured Object]
   748   C3245479:data [Medical Device]
   714 E C0243095:Find [Finding]
Processing 00000000.tx.252: Two additional low level analysis methods were applied to all data sets outside of the Affymetrix normalization schema. 

Phrase: "Two additional low level analysis methods"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   810   C2707190:Analysis method [Laboratory Procedure]
   799   C0025663:Methods [Intellectual Product]
   799   C0025664:methods [Intellectual Product]
   799   C0449851:Methods [Functional Concept]
   766 E C0871511:METHOD [Intellectual Product]

Phrase: "were"

Phrase: "applied to all data sets"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0150098:data sets [Intellectual Product]
   760   C0036849:Set [Mental Process]
   760   C0185125:Applied [Health Care Activity]
   760   C1442518:Set [Functional Concept]
   760   C1511726:Data [Idea or Concept]
   760   C1705195:Set [Conceptual Entity]
   760   C3245479:data [Medical Device]
   726 E C1632850:Apply [Functional Concept]
   726 E C1879355:Apply [Functional Concept]

Phrase: "outside of the Affymetrix normalization schema."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0871287:schema [Intellectual Product]
Processing 00000000.tx.253: Iobion's GeneTraffic MULTI was used to perform Robust Multi-Chip Analysis (RMA), which is a median polishing algorithm used in conjunction with both background subtraction and quantile normalization approaches. 

Phrase: "Iobion's GeneTraffic MULTI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439064:Multi [Quantitative Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "Robust Multi-Chip Analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "(RMA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "a median polishing algorithm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002045:algorithm [Intellectual Product]
   827   C1553907:algorithm [Laboratory Procedure]
   717   C1879661:Median Polish [Research Activity]

Phrase: "used in conjunction with both background subtraction"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C1273517:used [Finding]
   748   C1706907:Background [Conceptual Entity]
   748   C2348589:Subtraction [Phenomenon or Process]
   748   C2699427:Conjunction [Idea or Concept]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "quantile normalization approaches."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449445:Approaches [Spatial Concept]
   827   C1292724:Approaches [Functional Concept]
Processing 00000000.tx.254: For each normalization approach, statistical analysis using the Significance Analysis Tool set in GeneTraffic was utilized. 

Phrase: "For each normalization approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Significance Analysis Tool set in GeneTraffic"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0036849:Set [Mental Process]
   748   C0336791:Tool [Manufactured Object]
   748   C1442518:Set [Functional Concept]
   748   C1705195:Set [Conceptual Entity]
   748   C2827396:Tool [Manufactured Object]

Phrase: "was"

Phrase: "utilized."
Processing 00000000.tx.255: A two class unpaired analytical approach employing BenjaminiHochberg correction for false discovery rate (FDR) was used for all probe level normalized data. 

Phrase: "A two class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: "unpaired"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700112:Unpaired [Qualitative Concept]

Phrase: "analytical approach employing BenjaminiHochberg correction for false discovery rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1705565:CORRECTION [Intellectual Product]
   742   C1947976:Correction [Functional Concept]

Phrase: "(FDR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1880720:False Discovery Rate [Quantitative Concept]
   901   C0205557:False Discovery [Laboratory or Test Result]
   827   C0205237:False [Qualitative Concept]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
   827   C1880355:Discovery [Activity]

Phrase: ")"

Phrase: "was"

Phrase: "used for all probe level normalized data."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   748   C0182400:Probe [Medical Device]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1273517:used [Finding]
   748   C1511726:Data [Idea or Concept]
   748   C1547707:Level [Geographic Area]
   748   C1704681:Probe [Gene or Genome]
   748   C1882115:Normalized [Research Activity]
   748   C2347609:Probe [Chemical Viewed Functionally]
   748   C2946261:Level [Pharmacologic Substance]
   748   C3245479:data [Medical Device]
   748   C3536729:Probe [Manufactured Object]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.256: Gene lists of differentially expressed genes were generated from this output for functional analysis. 

Phrase: "Gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "lists of differentially expressed genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0017337:Genes [Gene or Genome]
   760   C0745732:List [Conceptual Entity]
   760   C3272378:LIST [Intellectual Product]

Phrase: "were"

Phrase: "generated from this output"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1709366:Output [Conceptual Entity]
   770   C3146294:Generated [Activity]

Phrase: "for functional analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0558024:Functional analysis [Health Care Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.257: All data were organized in a central database in the University of Rochester Functional Genomics Center and are accessible through the following URL (www.fgc.urmc.rochester). 

Phrase: "All data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "organized in a central database"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205099:Central [Spatial Concept]
   760   C0242356:Database [Intellectual Product]
   760   C0993637:Data Base [Intellectual Product]
   760   C1300196:Organized [Functional Concept]
   760   C1879652:Central - [Laboratory Procedure]

Phrase: "in the University of Rochester Functional Genomics"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0872316:functional genomics [Biomedical Occupation or Discipline]
   804   C0205245:Functional [Functional Concept]
   804   C0542341:Functional [Functional Concept]
   804   C0887950:Genomics [Biomedical Occupation or Discipline]
   804   C2700217:Functional [Conceptual Entity]

Phrase: "Center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "are"

Phrase: "accessible through the following URL"

Phrase: "(www.fgc.urmc.rochester"

Phrase: ")."
Processing 00000000.tx.258: Following each of these normalization approaches, all genes differentially expressed were clustered based on biological relevance utilizing both hierarchical and K-means clustering techniques. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "each of these normalization approaches,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0449445:Approaches [Spatial Concept]
   760   C1292724:Approaches [Functional Concept]
   760   C1457900:Each [Quantitative Concept]
   760   C1882115:Normalization [Research Activity]

Phrase: "all genes differentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "expressed"

Phrase: "were"

Phrase: "clustered"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1555715:Cluster [Idea or Concept]
   966   C1704332:Cluster [Quantitative Concept]

Phrase: "based on biological relevance utilizing"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0005532:Biological [Biomedical Occupation or Discipline]
   760   C0205460:biological [Qualitative Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C2347946:Relevance [Qualitative Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "both hierarchical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0699032:Hierarchy [Functional Concept]

Phrase: "and"

Phrase: "K-means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1704970:Means [Conceptual Entity]
   827 E C0444504:Mean [Quantitative Concept]
   827 E C2347634:Mean [Quantitative Concept]
   827 E C2348143:Mean [Quantitative Concept]

Phrase: "clustering"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009085:Clustering [Research Activity]
   966 E C1555715:Cluster [Idea or Concept]
   966 E C1704332:Cluster [Quantitative Concept]

Phrase: "techniques."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025664:techniques [Intellectual Product]
  1000   C0449851:Techniques [Functional Concept]
Processing 00000000.tx.259: Real-time PCR for candidate gene validation RNA samples from A9 and A10 DA neurons were reverse-transcribed into cDNA using Sensiscript reverse transcriptase (Qiagen, Valencia, CA, USA) and oligo dT as the primer. 

Phrase: "Real-time PCR for candidate gene validation RNA samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   742   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   742   C0677874:pCR [Finding]

Phrase: "from A9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0933647:A9 [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "A10 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "reverse-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "transcribed into cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Sensiscript reverse transcriptase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1555029:Reverse [Idea or Concept]
   827   C2257077:transcriptase [Genetic Function]

Phrase: "(Qiagen,"

Phrase: "Valencia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1217267:Valencia [Fish]
   928 E C1553365:Valencian [Population Group]

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "oligo dT as the primer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0069417:oligo (dT) [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C3539739:DT [Gene or Genome]
   760   C3542920:DT [Idea or Concept]
Processing 00000000.tx.260: PCR reactions were set up in 25l reaction volume using SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA). 

Phrase: "PCR reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "set up in 25l reaction volume"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0036849:Set [Mental Process]
   753   C1442518:Set [Functional Concept]
   753   C1705195:Set [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SYBR Green PCR Master Mix"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0205430:Mix [Functional Concept]
   804   C1421951:MIX [Gene or Genome]
   804   C1720722:Mix [Qualitative Concept]

Phrase: "(Applied Biosystems,"

Phrase: "Foster City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.261: Primers for each candidate gene were designed using MacVacter 7.0 and used with a final concentration of 250nM. 

Phrase: "Primers for each candidate gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "MacVacter 7.0"

Phrase: "and"

Phrase: "used with a final concentration of 250nM."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   757   C1524063:Use of [Functional Concept]
   748   C0086045:Concentration [Mental Process]
   748   C0205088:Final [Temporal Concept]
   748   C1273517:used [Finding]
   748   C1446561:Concentration [Quantitative Concept]
   748   C1546485:Final [Idea or Concept]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.262: For each primer pairs, duplicates of three to five independently collected A9 and A10 samples were compared to quantify relative gene expression differences between these cells using the 2CT method (90). 

Phrase: "For each primer pairs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709450:Pair [Qualitative Concept]

Phrase: "duplicates of three to five independently collected A9"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0205173:Duplicate [Functional Concept]
   744   C0205449:Three [Quantitative Concept]
   744   C0205451:Five [Quantitative Concept]
   744   C0933647:A9 [Body Part, Organ, or Organ Component]
   744   C1516695:Collected [Idea or Concept]
   744   C1516698:Collected [Functional Concept]
   744   C3539942:Duplicate [Intellectual Product]

Phrase: "and"

Phrase: "A10 samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "quantify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantify [Quantitative Concept]

Phrase: "relative gene expression differences between these cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   763   C1519516:Differential Gene Expression [Genetic Function]
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 2CT method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "(90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.263: Beta-actin was used as an internal control gene. 

Phrase: "Beta-actin"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0005186:beta-Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1384510:ACTIN, BETA [Gene or Genome]
  1000   C3542398:Beta-Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]
   789 E C0439681:Actinic [Qualitative Concept]

Phrase: "was"

Phrase: "used as an internal control gene."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   790   C0597937:internal control [Mental Process]
   753   C0017337:Gene [Gene or Genome]
   753   C0205102:Internal [Spatial Concept]
   753   C0243148:control [Qualitative Concept]
   753   C1273517:used [Finding]
   753   C1550141:Control [Substance]
   753   C1553872:Internal [Intellectual Product]
   753   C1619620:Internal [Intellectual Product]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.264: -actin was selected not only because it is widely used as a housekeeping gene, but also because it did not show differential expression between A9 and A10 DA neurons based on our microarray analysis. 

Phrase: "-actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "was"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "because"

Phrase: "it"

Phrase: "is"

Phrase: "widely"

Phrase: "used as a housekeeping gene,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C1334046:House-keeping Gene [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]
   760   C0020053:Housekeeping [Occupational Activity]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "but"

Phrase: "also"

Phrase: "because"

Phrase: "it"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "differential expression between A9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "A10 DA neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "based on our microarray analysis."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   835   C1449575:Microarray-Based Analysis [Laboratory Procedure]
           Microarray Analysis
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C1709016:Microarray [Manufactured Object]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.265: We also compared -actin with other genes that do not show differential expression based on our microarray analysis, such as capping protein (NM_009798) and alex3 (NM_027870). 

Phrase: "We also"

Phrase: "compared -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "actin with other genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "differential expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "based on our microarray analysis,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   835   C1449575:Microarray-Based Analysis [Laboratory Procedure]
           Microarray Analysis
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C1709016:Microarray [Manufactured Object]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "such as capping protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(NM_009798"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: ")"

Phrase: "and"

Phrase: "alex3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538941:ALEX3 [Gene or Genome]

Phrase: "(NM_027870"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: ")."
Processing 00000000.tx.266: A9/A10 ratios of these genes, when normalized with -actin, were approximately 1, which means that all three genes are not differentially expressed between A9 and A10 DA neurons. 

Phrase: "A9/A10 ratios of these genes,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0456603:Ratios [Quantitative Concept]
   753   C1610540:*Ratios [Quantitative Concept]
   719 E C1547037:Ratio [Intellectual Product]

Phrase: "when"

Phrase: "normalized with -actin,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1882115:Normalized [Research Activity]
   718 E C0439681:Actinic [Qualitative Concept]

Phrase: "were"

Phrase: "approximately 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332232:Approximately [Qualitative Concept]

Phrase: "which means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "that"

Phrase: "all three genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "not differentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "expressed between A9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0933647:A9 [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "A10 DA neurons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:dopamine neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.267: On the basis of this, we decided to use -actin as an internal control gene. 

Phrase: "On the basis of this,"

Phrase: "we"

Phrase: "decided"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "use -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "actin as an internal control gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.268: Primers for candidate genes with approximately equal (within 5% difference) amplification efficiency to that of the internal control were chosen. 

Phrase: "Primers for candidate genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "with approximately equal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205163:Equal [Qualitative Concept]
   861   C1549782:Equal [Idea or Concept]

Phrase: "("

Phrase: "within 5% difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: ")"

Phrase: "amplification efficiency to that of the internal control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0013682:Efficiency [Quantitative Concept]

Phrase: "were"

Phrase: "chosen."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]
Processing 00000000.tx.269: The P-value for real-time PCR results was calculated by one-sample t-test. 

Phrase: "The P-value for real-time PCR results"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1709380:P-Value [Quantitative Concept]
   744   C1522609:Value [Quantitative Concept]

Phrase: "was"

Phrase: "calculated by one-sample t-test."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   882   C1709321:One Sample t-Test [Intellectual Product]
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0205447:One [Quantitative Concept]
   753   C0370003:Sample [Substance]
   753   C0392366:test [Intellectual Product]
   753   C0444686:Calculated [Functional Concept]
   753   C1441506:Calculated [Activity]
   753   C1443182:Calculated [Laboratory Procedure]
   753   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.270: Generation of GIRK2-expressing lentivirus Construction of lentiviral vectors The mouse GIRK2 cDNA (a gift from Dr David Clapham, Children's Hospital, Boston, MA, USA) was cloned into the lentiviral vector, pRRL.cPPT.PGK.GFP.W.Sin-18 vector (kindly provided by Drs R. Zufferey and D. Trono, University of Geneva, Switzerland) by exchanging the GFP gene with the GIRK2 cDNA and confirmed by sequence analyses. 

Phrase: "Generation of GIRK2-expressing lentivirus Construction of lentiviral vectors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0079411:Generation [Temporal Concept]
   742   C3146294:Generation [Activity]

Phrase: "The mouse GIRK2 cDNA ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "a gift from Dr David Clapham,"

Phrase: "Children's Hospital,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0020017:Children's hospital [Health Care Related Organization]
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "was"

Phrase: "cloned into the lentiviral vector,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0009013:cloned [Cell]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   726 E C1522642:Clone [Tissue]

Phrase: "pRRL.cPPT.PGK.GFP.W.Sin-18 vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0442335:Vector [Spatial Concept]
   793   C1705099:Vector [Idea or Concept]

Phrase: "(kindly"

Phrase: "provided by Drs R. Zufferey"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205090:R- [Spatial Concept]
   760   C0684010:R. [Professional or Occupational Group]
   760   C1999230:Provided [Activity]
   760   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "D. Trono,"

Phrase: "University of Geneva,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "by exchanging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678640:exchanging [Social Behavior]

Phrase: "the GFP gene with the GIRK2 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "confirmed by sequence analyses."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0162801:Sequence Analyses [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1519249:Sequence [Functional Concept]
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737 E C1456348:Confirm [Qualitative Concept]
   737   C1524024:analysis [Functional Concept]
Processing 00000000.tx.271: Production of lentiviral vectors and cell transduction The lentiviral vector system used in our studies was kindly provided by Drs R. 

Phrase: "Production of lentiviral vectors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "cell transduction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1160185:transduction [Organism Function]

Phrase: "The lentiviral vector system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "used in our studies"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   802   C0869040:Use studies [Research Activity]
   770   C0947630:studies [Laboratory Procedure]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C1947944:Use [Intellectual Product]
   737 E C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "kindly"

Phrase: "provided by Drs R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205090:R- [Spatial Concept]
   770   C0684010:R. [Professional or Occupational Group]
   770   C1999230:Provided [Activity]
   770   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.272: Zufferey and D. 

Phrase: "Zufferey"

Phrase: "and"

Phrase: "D."
Processing 00000000.tx.273: Trono, University of Geneva, Switzerland. 

Phrase: "Trono,"

Phrase: "University of Geneva,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Switzerland."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]
Processing 00000000.tx.274: High titer of infectious lentiviral particles were produced in 293 T-cells using a four-plasmid transfection protocol (Current Protocols in Neuroscience, 2000, 4.21.14.21.12). 

Phrase: "High titer of infectious lentiviral particles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0475208:Titer [Quantitative Concept]

Phrase: "were"

Phrase: "produced in 293 T-cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0039194:T-Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a four-plasmid transfection protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0442711:Protocol [Intellectual Product]
   812   C1507394:Protocol [Intellectual Product]
   812   C1522729:Protocol [Intellectual Product]
   812   C2348563:Protocol [Intellectual Product]

Phrase: "(Current Protocols in Neuroscience,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0442711:Protocols [Intellectual Product]
   737 E C1507394:Protocol [Intellectual Product]
   737 E C1522729:Protocol [Intellectual Product]
   737 E C2348563:Protocol [Intellectual Product]

Phrase: "2000,"

Phrase: "4.21.14.21.12"

Phrase: ")."
Processing 00000000.tx.275: For this, the following packaging plasmids pMDLg/pRRE (for gag and pol expression), pMD.G (for expression of the VSV-G env protein) and pRSV.Rev (for rev expression) were co-transfected with the recombinant pRRL.cPPT.GIRK2.W.Sin-18 vector to produce viral transduction units (TU). 

Phrase: "For this,"

Phrase: "the following packaging plasmids pMDLg/pRRE"

Phrase: "("

Phrase: "for gag"

Phrase: "and"

Phrase: "pol expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: ","

Phrase: "pMD.G (for expression of the VSV-G env protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   757   C1319635:g/g [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "pRSV.Rev (for rev expression"

Phrase: ")"

Phrase: "were"

Phrase: "co-transfected"

Phrase: "with the recombinant pRRL.cPPT.GIRK2.W.Sin-18 vector to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   791   C0442335:Vector [Spatial Concept]
   791   C1705099:Vector [Idea or Concept]

Phrase: "produce"

Phrase: "viral transduction units (TU)."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0439148:Units [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.276: Virus supernatants were collected and filtered through a 0.2M filter and either used freshly, stored at 80C or ultracentrifuged to obtain high concentrations of viral stocks. 

Phrase: "Virus supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "filtered through a 0.2M filter"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C3171718:2M [Quantitative Concept]
   719   C0180860:Filter [Manufactured Object]
   719   C0581406:Filter [Medical Device]
   719   C1522664:Filter [Intellectual Product]
   719   C1704449:Filter [Conceptual Entity]
   719   C1704684:Filter [Medical Device]
   719   C1875155:FILTER [Medical Device]

Phrase: "and"

Phrase: "either"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "freshly,"

Phrase: "stored at 80C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]

Phrase: "or"

Phrase: "ultracentrifuged"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "high concentrations of viral stocks."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.277: Virus titers were determined according to published protocols (91) measuring the viral capsid protein p24 by ELISA in collaboration with Dr C. 

Phrase: "Virus titers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C2713348:Virus Titer [Quantitative Concept]
   827   C0475208:Titer [Quantitative Concept]

Phrase: "were"

Phrase: "determined according to published protocols"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0034037:Published [Occupational Activity]
   760   C0442711:Protocols [Intellectual Product]
   760   C0680240:according [Social Behavior]
   760   C1704324:Published [Intellectual Product]
   726 E C1507394:Protocol [Intellectual Product]
   726 E C1522729:Protocol [Intellectual Product]
   726 E C2348563:Protocol [Intellectual Product]

Phrase: "(91"

Phrase: ")"

Phrase: "measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the viral capsid protein p24 by ELISA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0054970:p24 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C1846989:p24 [Gene or Genome]
   748   C3539699:P24 [Gene or Genome]

Phrase: "in collaboration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282116:Collaboration [Social Behavior]

Phrase: "with Dr C."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.278: Brander, AIDS Research Center, Massachusetts General Hospital. 

Phrase: "Brander,"

Phrase: "AIDS Research Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0683939:research center [Manufactured Object,Organization]
   827   C0205099:Center [Spatial Concept]

Phrase: "Massachusetts General Hospital."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0020008:general hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0205246:General [Spatial Concept]
   827   C1510665:Hospital [Qualitative Concept]
   827   C1553889:General [Idea or Concept]
   743 E C1609061:Hospitals [Intellectual Product]
Processing 00000000.tx.279: For in vitro transduction, PC12-Syn were cultured directly in virus-containing media supplemented with 8g/ml polybrene. 

Phrase: "For in vitro transduction,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1160185:transduction [Organism Function]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "PC12-Syn"

Phrase: "were"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "directly in virus-containing media"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   760   C0009458:Media [Intellectual Product]
   760   C0042776:Virus [Virus]
   760   C0162867:Media [Tissue]
   760   C0319157:virus [Virus]
   760   C0332256:Containing [Functional Concept]
   760   C1254021:Media [Tissue]
   760   C1947931:Directly [Qualitative Concept]
   760   C2700400:Containing [Activity]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "supplemented with 8g/ml polybrene."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0282194:Polybrene [Organic Chemical,Pharmacologic Substance]
   760   C0439526:/mL [Quantitative Concept]
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.280: In vitro functional analysis of candidate molecules -Synuclein overexpressing PC-12 cell culture A PC12 cell line expressing wild-type human -synuclein was used (kindly provided by Dr Peter Lansbury). 

Phrase: "In vitro functional analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0558024:Functional analysis [Health Care Activity]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "of candidate molecules -Synuclein overexpressing PC-12 cell culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   812   C0007585:Cell Culture [Laboratory Procedure]
   793   C0007634:Cell [Cell]
   793   C0010453:Culture [Idea or Concept]
   793   C0220814:culture [Functional Concept]
   793   C0430400:Culture [Laboratory Procedure]
   793   C1269647:Cell [Cell]
   793   C1704653:Cell [Medical Device]
   793   C1948049:Cell [Spatial Concept]
   793   C2242979:Culture [Laboratory Procedure]

Phrase: "A PC12 cell line"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0007600:Cell Line [Cell]
   901   C0085262:PC12 Cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "wild-type human -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "(kindly"

Phrase: "provided by Dr Peter Lansbury"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031831:DR [Professional or Occupational Group]
   760   C1707664:DR [Biomedical or Dental Material]
   760   C1999230:Provided [Activity]
   760   C2348314:Dr. [Conceptual Entity]
   760   C3540849:DR [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.281: -Synuclein expressing PC12 cells were grown in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen, Carlsbad, CA, USA) supplemented with 10% heat-inactivated horse serum, 5% heat-inactivated fetal calf serum (Hyclone, Logan, UT, USA), 4mM L-glutamine, streptomycin and penicillin G (Fisher, Pittsburgh, PA, USA). 

Phrase: "-Synuclein expressing PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0085262:PC12 Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in Dulbecco's modified Eagle's medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0009458:Medium [Intellectual Product]
   753   C0325564:Eagle [Bird]
   753   C0392747:Modified [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1551720:Eagle [Population Group]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]

Phrase: "(DMEM"

Phrase: ")"

Phrase: "(Invitrogen,"

Phrase: "Carlsbad,"

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "supplemented with 10% heat-inactivated horse serum,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C1518416:Serum, Horse [Immunologic Factor]
   748   C0018837:Heat [Natural Phenomenon or Process]
   748   C0019944:Horse [Mammal]
   748   C0229671:Serum [Body Substance]
   748   C0242616:Horse [Mammal]
   748   C1265527:Horse [Mammal]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]
   714   C0242295:Supplement [Food]
   714   C1947943:Supplement [Intellectual Product]
   714   C2348609:Supplement [Functional Concept]

Phrase: "5% heat-inactivated fetal calf serum"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   799   C0015965:Fetal [Embryonic Structure]
   799   C0229671:Serum [Body Substance]
   799   C0230445:Calf [Body Location or Region]
   799   C0521457:Fetal [Functional Concept]
   799   C1305418:Calf [Body Part, Organ, or Organ Component]
   799   C1546774:Serum [Intellectual Product]
   799   C1550100:Serum [Body Substance]
   743 E C0626053:sural [Pharmacologic Substance]

Phrase: "(Hyclone,"

Phrase: "Logan,"

Phrase: "UT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042124:UT [Geographic Area]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "4mM L-glutamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "streptomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "penicillin G"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0030827:Penicillin G [Antibiotic,Organic Chemical]
   861   C0030842:Penicillin [Antibiotic,Organic Chemical]
   861   C0220892:Penicillin [Antibiotic,Organic Chemical]
   861   C0439267:g% [Quantitative Concept]

Phrase: "(Fisher,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325045:Fisher [Mammal]

Phrase: "Pittsburgh,"

Phrase: "PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.282: Cells were maintained at 37C, in 5% CO2 humid atmosphere. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained at 37C,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1314677:Maintained [Functional Concept]
   756 E C0024501:Maintain [Activity]

Phrase: "in 5% CO2 humid atmosphere."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0004178:Atmosphere [Natural Phenomenon or Process]
   812   C0678214:atmosphere [Quantitative Concept]
Processing 00000000.tx.283: For the bioassay, -synuclein overexpressing PC-12 cells were treated with 1mM MPP+ to determine the neuroprotective effects of BA, insulin growth factor-1 (IGF-1), CGRP alpha, GRP and PACAP molecules. 

Phrase: "For the bioassay, -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005507:Bioassay [Laboratory Procedure]
  1000   C1704780:Bioassay [Conceptual Entity]

Phrase: "synuclein overexpressing PC-12 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 1mM MPP+ to"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0000098:MPP+ [Hazardous or Poisonous Substance,Organic Chemical]
   760   C1417248:MPP [Gene or Genome]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "determine"

Phrase: "the neuroprotective effects of BA,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0815279:Neuroprotective Effects [Functional Concept]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "insulin growth factor-1 (IGF-1),"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "CGRP alpha,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   734   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]

Phrase: "GRP"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0061132:Gastrin releasing peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1333714:gastrin-releasing peptide [Gene or Genome]
   827   C0017151:Gastrin [Amino Acid, Peptide, or Protein,Hormone]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0376180:Gastrin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1283071:Releasing [Functional Concept]
   793 E C0030685:Release [Health Care Activity]
   793 E C0391871:Release [Functional Concept]
   793 E C0439180:% release [Quantitative Concept]
   793 E C0680255:release [Health Care Activity]
   793 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "PACAP molecules."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.284: Various doses of the molecules were applied to the cells 2h prior to MPP+ treatment and after 24h, supernatants were collected for measuring a cell-death related release of lactate dehydrogenase (LDH) using an LDH release assay kit (Roche, Indianapolis, IN, USA). 

Phrase: "Various doses of the molecules"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0178602:Doses [Quantitative Concept]
   726 E C0869039:Dose [Quantitative Concept]
   726 E C1114758:Dose # [Clinical Attribute]
   726 E C1428722:DOS [Gene or Genome]

Phrase: "were"

Phrase: "applied to the cells 2h"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0185125:Applied [Health Care Activity]
   760   C1292425:2H [Temporal Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1632850:Apply [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1879355:Apply [Functional Concept]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "prior to MPP+ treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "and after 24h,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0456696:/24h [Temporal Concept]
   790   C1442770:24H [Temporal Concept]
   790   C1515981:And [Idea or Concept]

Phrase: "supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "collected for measuring a cell-death"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   790   C0007587:Cell Death [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C0444706:measuring [Qualitative Concept]
   753   C0449770:measuring [Quantitative Concept]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1516695:Collected [Idea or Concept]
   753   C1516698:Collected [Functional Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "release of lactate dehydrogenase (LDH)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an LDH release assay kit (Roche,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0331965:Roche [Health Care Related Organization]

Phrase: "Indianapolis,"

Phrase: "IN,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.285: BA was purchased from Sigma; 

Phrase: "BA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005982:Bongkrekic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "purchased from Sigma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.286: IGF-1 from R&D and CGRP, GRP and PACAP from Calbiochem. 

Phrase: "IGF-1 from R&D"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0033457:Factor D [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   774   C0034471:R factor [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   774   C0602449:R-factor [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0205090:R- [Spatial Concept]
   748   C0220844:growth [Physiologic Function]
   748   C0684010:R. [Professional or Occupational Group]
   748   C1521761:Factor [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2603358:R' [Clinical Attribute]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "CGRP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0439095:Alpha [Intellectual Product]
   804   C2003941:Alpha [Intellectual Product]
   804   C2350010:Alpha [Qualitative Concept]
   771   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   771   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]

Phrase: "GRP"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0061132:Gastrin releasing peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1333714:gastrin-releasing peptide [Gene or Genome]
   827   C0017151:Gastrin [Amino Acid, Peptide, or Protein,Hormone]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0376180:Gastrin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1283071:Releasing [Functional Concept]
   793 E C0030685:Release [Health Care Activity]
   793 E C0391871:Release [Functional Concept]
   793 E C0439180:% release [Quantitative Concept]
   793 E C0680255:release [Health Care Activity]
   793 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "PACAP from Calbiochem."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0071163:PACAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1412228:PACAP [Gene or Genome]
   790   C1836172:PACAP [Gene or Genome]
Processing 00000000.tx.287: Primary VM cell culture Primary cultures of DA neurons were obtained from E15 Sprague-Dawley rat (Charles River, MA, USA) ventral mesencephalon (VM). 

Phrase: "Primary VM cell culture Primary cultures of DA neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   775   C1449562:Primary Cell Cultures [Laboratory Procedure]
   757   C0007585:Cell Cultures [Laboratory Procedure]
   739   C0010453:Cultures [Idea or Concept]

Phrase: "were"

Phrase: "obtained from E15 Sprague-Dawley rat"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0034715:Sprague-Dawley rat [Mammal]
   790   C2699239:Sprague-Dawley [Mammal]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C1301820:Obtained [Functional Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "(Charles River,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337050:River [Natural Phenomenon or Process]

Phrase: "MA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "ventral mesencephalon"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0025462:Mesencephalon [Body Part, Organ, or Organ Component]
   861   C1704448:Ventral [Spatial Concept]
   805 E C1280997:Midbrain [Body Part, Organ, or Organ Component]

Phrase: "(VM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025462:Mesencephalic [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.288: The dissected VM tissue was mechanically dissociated with a fine-polished pasteur pipette. 

Phrase: "The dissected VM tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0040300:Tissue [Tissue]
   812   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "mechanically"

Phrase: "dissociated with a fine-polished pasteur pipette."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0491340:PIPETTE, PASTEUR [Medical Device]
   748   C0182301:Pipette [Medical Device]
   748   C0205232:Fine [Qualitative Concept]
   748   C0220896:polished [Population Group]
   748   C0687757:fine [Regulation or Law]
   748   C1706407:Pipette [Medical Device]
Processing 00000000.tx.289: The cells were resuspended in DMEM containing heat-inhibited horse serum (10%), glucose (6.0mg/ml), penicillin, streptomycin and 2mM glutamine (Gibco). 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "resuspended in DMEM containing heat-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0018837:Heat [Natural Phenomenon or Process]
   760   C0332256:Containing [Functional Concept]
   760   C2700400:Containing [Activity]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "horse serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1518416:Serum, Horse [Immunologic Factor]
   861   C0019944:Horse [Mammal]
   861   C0229671:Serum [Body Substance]
   861   C0242616:Horse [Mammal]
   861   C1265527:Horse [Mammal]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "(10%"

Phrase: ")"

Phrase: ","

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(6.0mg/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "penicillin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030842:Penicillin [Antibiotic,Organic Chemical]
  1000   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "streptomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "2mM glutamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(Gibco"

Phrase: ")."
Processing 00000000.tx.290: Cell suspensions containing 4x105 cells were plated on coverslips in 24-well plates and precoated with a 1:500 diluted solution of polyornithine and fibronectin in 50mM sodium borate (pH 7.4). 

Phrase: "Cell suspensions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0038960:Suspensions [Biomedical or Dental Material]
   827 E C1382107:Suspension [Substance]
   827 E C1705537:Suspension [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "4x105 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated on coverslips"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0005971:Plate [Medical Device]
   756   C1139930:plate [Medical Device]
   756   C3537155:Plate [Manufactured Object]

Phrase: "in 24-well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "precoated with a 1"

Phrase: ":"

Phrase: "500 diluted solution of polyornithine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037633:Solution [Substance]
   760   C0525069:Solution [Biomedical or Dental Material]

Phrase: "and"

Phrase: "fibronectin in 50mM sodium borate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.291: For the MPP+ doseresponse curves, cultures were treated at day 5 for 48h with MPP+ at concentrations ranging from 0.1 to 10M. 

Phrase: "For the MPP+ doseresponse curves,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0683162:dose-response curve [Quantitative Concept]
   793   C0205134:Curve [Spatial Concept]

Phrase: "cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "treated at day 5"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0332173:/day [Temporal Concept]
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "for 48h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "with MPP+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000098:MPP+ [Hazardous or Poisonous Substance,Organic Chemical]
  1000   C1417248:MPP [Gene or Genome]

Phrase: "at concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "ranging from 0.1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1514721:Range [Quantitative Concept]
   737   C2348147:Range [Quantitative Concept]
   737   C3542016:Range [Intellectual Product]

Phrase: "to 10M."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]
Processing 00000000.tx.292: Neuropeptides, IGF-1 and BA were applied at various doses 2h prior to 10M MPP+ treatment. 

Phrase: "Neuropeptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027895:Neuropeptides [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "IGF-1"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "BA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005982:Bongkrekic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "applied at various doses 2h"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   760   C0178602:Doses [Quantitative Concept]
   760   C0185125:Applied [Health Care Activity]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C1292425:2H [Temporal Concept]
   726 E C0869039:Dose [Quantitative Concept]
   726 E C1114758:Dose # [Clinical Attribute]
   726 E C1428722:DOS [Gene or Genome]
   726 E C1632850:Apply [Functional Concept]
   726 E C1879355:Apply [Functional Concept]

Phrase: "prior to 10M MPP+ treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.293: After 48h, cells were fixed in paraformaldehyde for immunostaining of TH and GIRK2. 

Phrase: "After 48h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "fixed in paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C2827483:Fixed [Body Substance]

Phrase: "for immunostaining"

Phrase: "of TH"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039725:TH [Geographic Area]
  1000   C0039738:Th [Element, Ion, or Isotope]
  1000   C1420718:TH [Gene or Genome]

Phrase: "and"

Phrase: "GIRK2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416588:GIRK2 [Gene or Genome]
Processing 00000000.tx.294: Immunocytochemistry and stereology Immunocytochemistry Indirect immunofluorescence was performed on 4% paraformaldehyde fixed VM cultures. 

Phrase: "Immunocytochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242349:Immunocytochemistry [Laboratory Procedure]

Phrase: "and"

Phrase: "stereology Immunocytochemistry Indirect immunofluorescence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0282646:Indirect Immunofluorescence [Laboratory Procedure]
   812   C0016318:Immunofluorescence [Laboratory Procedure]
   812   C0079603:Immunofluorescence [Laboratory Procedure]
   812   C0439852:Indirect [Qualitative Concept]
   756 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   741 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "performed on 4% paraformaldehyde"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: "VM cultures."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0010453:Cultures [Idea or Concept]
   793 E C0220814:culture [Functional Concept]
   793 E C0430400:Culture [Laboratory Procedure]
   793 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.295: Fixed cells were incubated in a blocking solution consisting of 10% normal donkey serum (Jackson ImmunoResearch Laboratories Inc., West Grove, PA, USA) and 0.1% Triton X-100 (Sigma, St Louis, MO, USA) in 0.1M PBS for 1h at room temperature. 

Phrase: "Fixed cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1253961:Fixed cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated in a blocking solution"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0037633:Solution [Substance]
   760   C0233660:Blocking [Mental or Behavioral Dysfunction]
   760   C0332206:Blocking [Functional Concept]
   760   C0525069:Solution [Biomedical or Dental Material]
   760   C1439852:Incubated [Laboratory Procedure]
   726 E C0028778:Block [Pathologic Function]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "consisting of 10% normal donkey serum"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0205307:Normal [Qualitative Concept]
   753   C0229671:Serum [Body Substance]
   753   C0324145:Donkey [Mammal]
   753   C0439166:% normal [Quantitative Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C2347086:% Normal [Quantitative Concept]
   719   C0332529:CONSIST [Qualitative Concept]

Phrase: "(Jackson ImmunoResearch Laboratories Inc.,"

Phrase: "West Grove,"

Phrase: "PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "0.1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "(Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "MO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "in 0.1M PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   823   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C0036082:Saline [Substance]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.296: Primary antibodies were diluted in blocking solution and added to the cells. 

Phrase: "Primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "diluted in blocking solution"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   770   C0037633:Solution [Substance]
   770   C0233660:Blocking [Mental or Behavioral Dysfunction]
   770   C0332206:Blocking [Functional Concept]
   770   C0525069:Solution [Biomedical or Dental Material]
   737 E C0028778:Block [Pathologic Function]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "added to the cells."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1524062:Added [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1883712:Add [Functional Concept]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.297: The primary antibodies used were tyrosine hydroxylase (sheep anti-TH, 1:300, Pel-Freez Biologicals, Rogers, AK, USA) and GIRK2 (rabbit; 

Phrase: "The primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "tyrosine hydroxylase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0041491:Tyrosine Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1420718:TYROSINE HYDROXYLASE [Gene or Genome]
   861   C0020364:Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(sheep anti-TH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0039725:TH [Geographic Area]
   827   C0039738:Th [Element, Ion, or Isotope]
   827   C1420718:TH [Gene or Genome]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "300,"

Phrase: "Pel-Freez Biologicals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2979985:Biologicals [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Rogers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3463939:Roger [Eukaryote]

Phrase: "AK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001905:AK [Geographic Area]
  1000   C1412243:AK [Gene or Genome]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "GIRK2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416588:GIRK2 [Gene or Genome]

Phrase: "(rabbit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]

Phrase: ";"
Processing 00000000.tx.298: 1:80, Alomone Laboratories, Jerusalem, Israel). 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "80,"

Phrase: "Alomone Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "Jerusalem,"

Phrase: "Israel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022271:Israel [Geographic Area]

Phrase: ")."
Processing 00000000.tx.299: After incubation at 4C overnight, cells were rinsed three times in 0.1M PBS for 5min each before application of the secondary antibody solution for 1h at room temperature. 

Phrase: "After incubation"

Phrase: "at 4C overnight,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "rinsed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1701810:Rinse [Functional Concept]
   966   C1882955:Rinse [Activity]

Phrase: "three times in 0.1M PBS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0040223:times [Temporal Concept]
   744   C1632851:Times [Quantitative Concept]
   711 E C3541383:Time [Temporal Concept]

Phrase: "for 5min"

Phrase: "each before application of the secondary antibody solution"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0027627:secondary [Neoplastic Process]
   744   C0037633:Solution [Substance]
   744   C0175668:Secondary [Temporal Concept]
   744   C0185125:Application [Health Care Activity]
   744   C0205436:Secondary [Quantitative Concept]
   744   C0525069:Solution [Biomedical or Dental Material]
   744   C1457900:Each [Quantitative Concept]
   744   C1947919:Application [Intellectual Product]
   744   C2347934:Application [Intellectual Product]
   744   C3539080:APPLICATION [Quantitative Concept]

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.300: The secondary antibodies were diluted in 10% normal donkey serum in 0.1M PBS. 

Phrase: "The secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "diluted in 10% normal donkey serum"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0205307:Normal [Qualitative Concept]
   753   C0229671:Serum [Body Substance]
   753   C0324145:Donkey [Mammal]
   753   C0439166:% normal [Quantitative Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C2347086:% Normal [Quantitative Concept]
   719   C1720119:Dilute [Functional Concept]
   719   C1948037:Dilute [Functional Concept]

Phrase: "in 0.1M PBS."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   823   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C0036082:Saline [Substance]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.301: Secondary antibodies were Alexa Fluor 488 conjugated donkey anti-sheep and Alexa Fluor 594 conjugated donkey anti-rabbit (Molecular Probes, Eugene, OR, USA). 

Phrase: "Secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "Alexa Fluor 488 conjugated donkey"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0324145:Donkey [Mammal]

Phrase: "anti-sheep"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036945:Sheep [Mammal]
   861   C1123019:Sheep [Mammal]

Phrase: "and"

Phrase: "Alexa Fluor 594 conjugated donkey"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0324145:Donkey [Mammal]

Phrase: "anti-rabbit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034493:Rabbit [Mammal]

Phrase: "(Molecular Probes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "Eugene,"

Phrase: "OR"

Phrase: ","

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.302: After rinsing in triplicate for 10min each in 0.1M PBS, the cells were counterstained with 0.0005% Hoechst 33342 (Molecular Probes) in 0.1M Tris buffered saline. 

Phrase: "After"

Phrase: "rinsing in triplicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1882955:Rinsing [Activity]

Phrase: "for 10min"

Phrase: "each in 0.1M PBS,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0036082:Saline [Substance]
   748   C0470296:1M [Quantitative Concept]
   748   C1457900:Each [Quantitative Concept]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "counterstained with 0.0005% Hoechst 33342"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0062907:Hoechst 33342 [Pharmacologic Substance]

Phrase: "(Molecular Probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: ")"

Phrase: "in 0.1M Tris buffered saline."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   823   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   804   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0036082:Saline [Substance]
   804   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   804   C0814229:TRI [Intellectual Product]
Processing 00000000.tx.303: The coverslips containing the fixed cells were then rinsed in 0.1M PBS followed by distilled water and mounted onto slides using an aqueous mountant (Gel/Mount, Biomeda Corp., CA, USA). 

Phrase: "The coverslips"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the fixed cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1253961:Fixed cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "rinsed in 0.1M PBS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0036082:Saline [Substance]
   748   C0470296:1M [Quantitative Concept]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   714   C1701810:Rinse [Functional Concept]
   714   C1882955:Rinse [Activity]

Phrase: "followed by distilled water"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0332283:Followed by [Temporal Concept]
           followed
   833   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0599638:WATER [Substance]
   770   C0681549:distilled [Occupational Activity]
   770   C1550678:Water [Inorganic Chemical]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "mounted onto slides"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444330:slides [Research Device]
   790   C0449878:mounted [Finding]
   756 E C0181909:Mount [Medical Device]
   756 E C1705201:Slide [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an aqueous mountant"

Phrase: "(Gel/Mount,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0181909:Mount [Medical Device]
   861   C0449878:mount [Finding]

Phrase: "Biomeda Corp.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.304: Control coverslips immunostained with secondary antibody only were used to assess specificity of the technique. 

Phrase: "Control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "coverslips"

Phrase: "immunostained with secondary antibody only"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0027627:secondary [Neoplastic Process]
   760   C0175668:Secondary [Temporal Concept]
   760   C0205171:Only [Quantitative Concept]
   760   C0205436:Secondary [Quantitative Concept]
   760   C1720467:Only [Intellectual Product]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "specificity of the technique."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037791:Specificity [Quantitative Concept]
   770   C1511884:Specificity [Quantitative Concept]
Processing 00000000.tx.305: Stereology Design-based stereology was performed by counters blinded to experimental groups on the stained coverslips using an integrated Axioskop 2 microscope (Carl Zeiss, Thornwood, NY, USA) and Stereoinvestigator image capture equipment and software (MicroBrightField, Williston, VT, USA). 

Phrase: "Stereology Design-based stereology"

Phrase: "was"

Phrase: "performed by counters"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C1550369:Performed By [Qualitative Concept]
   790   C0884358:Performed [Functional Concept]
   756   C0677601:Counter [Manufactured Object]
   756   C1705206:Counter [Medical Device]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "blinded to experimental groups"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0150108:Blinded [Research Activity]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   737 E C0456909:Blind [Disease or Syndrome]
   737 E C0525065:blind [Patient or Disabled Group]

Phrase: "on the stained coverslips"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an integrated Axioskop 2 microscope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0181839:Microscope [Medical Device]
   812   C1706379:Microscope [Medical Device]

Phrase: "(Carl Zeiss,"

Phrase: "Thornwood,"

Phrase: "NY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "Stereoinvestigator image capture equipment"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0014672:Equipment [Manufactured Object]
   812   C0220824:equipment [Manufactured Object]
   812   C1523994:Equipment [Manufactured Object]
   812   C2827396:Equipment [Manufactured Object]
   756 E C1706469:Gear [Qualitative Concept]
   756 E C1706470:GEARS [Manufactured Object]

Phrase: "and"

Phrase: "software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(MicroBrightField,"

Phrase: "Williston,"

Phrase: "VT,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.306: A contour was drawn around each coverslip to identify the area of interest. 

Phrase: "A contour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302821:contour [Inorganic Chemical]
  1000   C0876954:Contour [Spatial Concept]

Phrase: "was"

Phrase: "drawn around each coverslip to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0013113:Draw [Intellectual Product]

Phrase: "identify"

Phrase: "the area of interest."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017446:Area [Geographic Area]
   770   C0205146:Area [Spatial Concept]
Processing 00000000.tx.307: A physical dissector probe was utilized and counting frames were placed in a systematically random manner at 200sites/coverslip. 

Phrase: "A physical dissector probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0182400:Probe [Medical Device]
   827   C1704681:Probe [Gene or Genome]
   827   C2347609:Probe [Chemical Viewed Functionally]
   827   C3536729:Probe [Manufactured Object]

Phrase: "was"

Phrase: "utilized"

Phrase: "and"

Phrase: "counting frames"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0180979:frames [Medical Device]
   827 E C0080089:Frame [Nucleotide Sequence]
   827 E C1705858:Frame [Manufactured Object]

Phrase: "were"

Phrase: "placed in a systematically random manner"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0034656:RANDOM [Research Activity]
   753   C0439605:Random [Qualitative Concept]
   719   C0442504:Place [Spatial Concept]
   719   C1704765:Place [Functional Concept]
   719   C1882509:Place [Activity]
   719   C3496241:place [Disease or Syndrome]

Phrase: "at 200sites/coverslip."
Processing 00000000.tx.308: The resultant coefficient of error for the stereological counts was used to assess precision (P<0.05).  

Phrase: "The resultant coefficient of error"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707429:*Coefficient [Quantitative Concept]

Phrase: "for the stereological counts"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439157:counts [Quantitative Concept]
   827 E C0750480:Count [Activity]
   827 E C1705566:Count [Quantitative Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "precision"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1547902:Precision [Temporal Concept]
  1000   C1706245:Precision [Qualitative Concept]
   928 E C2939802:Precise [Pharmacologic Substance]

Phrase: "(P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.309: SUPPLEMENTARY MATERIAL TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES  Supplementary Material is available at HMG Online.  

Phrase: "SUPPLEMENTARY MATERIAL TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS SUPPLEMENTARY MATERIAL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Supplementary Material"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936424:Supplementary Material [Intellectual Product]
   861   C0520510:Material [Substance]

Phrase: "is"

Phrase: "available at HMG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: "Online."
Processing 00000000.tx.310: ACKNOWLEDGEMENTS  We thank Dr Vikram Khurana for discussions and reading of the manuscript; 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr Vikram Khurana for discussions"

Phrase: "and"

Phrase: "reading of the manuscript"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0034754:Reading [Daily or Recreational Activity]
   770   C1705179:Reading [Finding]

Phrase: ";"
Processing 00000000.tx.311: Chin-Yi Chu and Oliver Cooper for excellent technical assistance. 

Phrase: "Chin-Yi Chu"

Phrase: "and"

Phrase: "Oliver Cooper for excellent technical assistance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0335912:Cooper [Professional or Occupational Group]
Processing 00000000.tx.312: We also thank Dr Peter Lansbury for providing synuclein overexpressing PC12 cells. 

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr Peter Lansbury for providing synuclein overexpressing PC12 cells."
Processing 00000000.tx.313: This study was conducted in part in the facilities and collaborative network provided by the Harvard Center for Neurodegeneration and Repair and was supported by funds from the NIH/NINDS P50 Parkinson's Disease Udall Research Centers of Excellence to McLean/Harvard Medical School (PI:OI), USAMRMC grant DAMD 17-01-1-0762 (PI:OI), the Michael Stern Foundation for Parkinson's Disease Research, the Consolidated Anti-Aging Foundation and the Orchard Foundation. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "conducted in part"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]
   756   C0004927:Conduct [Individual Behavior]

Phrase: "in the facilities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547538:Facility [Idea or Concept]

Phrase: "and"

Phrase: "collaborative network"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1513822:Network [Professional or Occupational Group]
   861   C1705739:Network [Manufactured Object]
   861   C1882071:Network [Conceptual Entity]

Phrase: "provided by the Harvard Center"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205099:Center [Spatial Concept]
   760   C1999230:Provided [Activity]

Phrase: "for Neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "Repair"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043240:Repair, NOS [Organism Function]
  1000   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "was"

Phrase: "supported by funds"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0016820:Funds [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]

Phrase: "from the NIH/NINDS P50 Parkinson's Disease Udall Research Centers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0683939:research center [Manufactured Object,Organization]
   793   C0205099:centers [Spatial Concept]

Phrase: "of Excellence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C1548784:Excellent [Qualitative Concept]
   928   C1961136:Excellent [Qualitative Concept]

Phrase: "to McLean/Harvard Medical School"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   812   C0036375:School [Manufactured Object,Organization]

Phrase: "(PI:OI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029434:OI [Congenital Abnormality,Disease or Syndrome]

Phrase: ")"

Phrase: ","

Phrase: "USAMRMC grant DAMD 17-01-1-0762"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0018173:Grant [Quantitative Concept]
   795   C1519744:USAMRMC [Health Care Related Organization]
   795   C1548284:Grant [Idea or Concept]

Phrase: "(PI:OI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029434:OI [Congenital Abnormality,Disease or Syndrome]

Phrase: ")"

Phrase: ","

Phrase: "the Michael Stern Foundation for Parkinson's Disease Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0016617:Foundation [Organization]
   725   C2986512:Research Base [Organization]

Phrase: "the Consolidated Anti-Aging Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "the Orchard Foundation."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]
Processing 00000000.tx.314: Conflict of Interest statement. 

Phrase: "Conflict of Interest statement."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1710187:Statement [Idea or Concept]
   756   C0079152:Conflict of Interest [Idea or Concept]
Processing 00000000.tx.315: None declared.  

Phrase: "None"

Phrase: "declared."
Processing 00000000.tx.316: FOOTNOTES  Present address: Department of Molecular and Life Science, Hanyang University, Korea  REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES  McRitchie, D.A., Hardman, C.D. and Halliday, G.M. 

Phrase: "FOOTNOTES  Present address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0376649:Address [Intellectual Product]
   827   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Department of Molecular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Life Science,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0005526:Science, Life [Occupation or Discipline]
   861   C0036397:Science [Occupation or Discipline]
   861   C0376558:Life [Idea or Concept]
   777 E C0595998:lives [Finding]

Phrase: "Hanyang University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Korea"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0022771:Korea [Geographic Area]
   928 E C1556095:Korean [Population Group]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS SUPPLEMENTARY MATERIAL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "McRitchie,"

Phrase: "D.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Hardman,"

Phrase: "C.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   983   C0524984:cell d [Cell]

Phrase: "and"

Phrase: "Halliday,"

Phrase: "G.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456715:g m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.317: (1996) Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Cytoarchitectural distribution of calcium binding proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0872250:protein distribution [Cell Function]
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "in midbrain dopaminergic regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "of rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "and"

Phrase: "humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.318: J. 

Phrase: "J."
Processing 00000000.tx.319: Comp. 

Phrase: "Comp."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0056167:COMP [Therapeutic or Preventive Procedure]
  1000   C1456376:COMP [Gene or Genome]
Processing 00000000.tx.320: Neurol., 364, 121150.[CrossRef][ISI][Medline] Neuhoff, H., Neu, A., Liss, B. and Roeper, J. 

Phrase: "Neurol.,"

Phrase: "364,"

Phrase: "121150."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Neuhoff,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Neu,"

Phrase: "A.,"

Phrase: "Liss,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1508741:LISS [Laboratory Procedure]
  1000   C2247545:LIS [Molecular Function]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Roeper,"

Phrase: "J."
Processing 00000000.tx.321: (2002) I(h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain. 

Phrase: "(2002"

Phrase: ")"

Phrase: "I(h) channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1956068:I(h) Channels [Amino Acid, Peptide, or Protein]
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]

Phrase: "contribute to the different functional properties of identified dopaminergic subpopulations"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   739   C0205245:Functional [Functional Concept]
   739   C0205396:Identified [Qualitative Concept]
   739   C0282151:Dopaminergic [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   739   C0542341:Functional [Functional Concept]
   739   C0871161:properties [Qualitative Concept]
   739   C1292721:properties [Functional Concept]
   739   C1550043:Identified [Finding]
   739   C1551388:Identified [Functional Concept]
   739   C1705242:Different [Qualitative Concept]
   739   C1880177:Contribute [Activity]
   739   C2700217:Functional [Conceptual Entity]
   706   C1257890:Subpopulation [Population Group]
   706 E C1882134:Property [Conceptual Entity]
   706 E C2347695:Property [Entity]

Phrase: "in the midbrain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025462:Mid-brain [Body Part, Organ, or Organ Component]
  1000   C1280997:Midbrain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.322: J. 

Phrase: "J."
Processing 00000000.tx.323: Neurosci., 22, 12901302.[Abstract/Free FullText] Wolfart, J., Neuhoff, H., Franz, O. and Roeper, J. 

Phrase: "Neurosci.,"

Phrase: "22,"

Phrase: "12901302."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wolfart,"

Phrase: "J.,"

Phrase: "Neuhoff,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Franz,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Roeper,"

Phrase: "J."
Processing 00000000.tx.324: (2001) Differential expression of the small-conductance, calcium-activated potassium channel SK3 is critical for pacemaker control in dopaminergic midbrain neurons. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Differential expression of the small-conductance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "calcium-activated potassium channel SK3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1416610:SK3 [Gene or Genome]
   771   C0949653:Calcium-Activated Potassium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "critical for pacemaker control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511545:Critical [Qualitative Concept]

Phrase: "in dopaminergic midbrain neurons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C1512035:Dopaminergic Neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.325: J. 

Phrase: "J."
Processing 00000000.tx.326: Neurosci., 21, 34433456.[Abstract/Free FullText] Gorell, J.M., Peterson, E.L., Rybicki, B.A. and Johnson, C.C. 

Phrase: "Neurosci.,"

Phrase: "21,"

Phrase: "34433456."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gorell,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Peterson,"

Phrase: "E.L., Rybicki,"

Phrase: "B.A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Johnson,"

Phrase: "C.C."
Processing 00000000.tx.327: (2004) Multiple risk factors for Parkinson's disease. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Multiple risk factors for Parkinson's disease."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0850664:disease factors risk [Finding]
   790   C0035648:risk factors [Quantitative Concept]
   790   C1553898:risk factors [Idea or Concept]
   783   C0679238:disease factors [Functional Concept]
   783   C1281905:disease risk [Finding]
   753   C0035647:Risk [Qualitative Concept]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.328: J. 

Phrase: "J."
Processing 00000000.tx.329: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.330: Sci., 217, 169174.[CrossRef][ISI][Medline] Tanner, C.M., Ottman, R., Goldman, S.M., Ellenberg, J., Chan, P., Mayeux, R. and Langston, J.W. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "217,"

Phrase: "169174."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tanner,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335730:Tanner [Professional or Occupational Group]

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Ottman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Goldman,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Ellenberg,"

Phrase: "J.,"

Phrase: "Chan,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Mayeux,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Langston,"

Phrase: "J.W."
Processing 00000000.tx.331: (1999) Parkinson disease in twins: an etiologic study. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Parkinson disease in twins"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   881   C0012675:Diseases in Twins [Disease or Syndrome]
           twins diseases
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "an etiologic study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.332: JAMA, 281, 341346.[Abstract/Free FullText] Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. etal. 

Phrase: "JAMA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422839:JAMA [Gene or Genome]

Phrase: "281,"

Phrase: "341346."

Phrase: "[Abstract/Free FullText"

Phrase: "] Polymeropoulos,"

Phrase: "M."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lavedan,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Leroy,"

Phrase: "E.,"

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "S."

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A.,"

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Root,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040452:Root [Body Part, Organ, or Organ Component]
  1000   C0242726:Root [Plant]
  1000   C1318154:Root [Body Part, Organ, or Organ Component]
  1000   C1705917:Root [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rubenstein,"

Phrase: "J.,"

Phrase: "Boyer,"

Phrase: "R. etal."
Processing 00000000.tx.333: (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mutation in the alpha-synuclein gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0596611:Gene Mutation [Genetic Function]
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified in families"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0015576:Families [Family Group]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   790   C1704727:Family [Conceptual Entity]
   706 E C0241888:Familial [Functional Concept]

Phrase: "with Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.334: Science, 276, 20452047.[Abstract/Free FullText] Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M.J., Jonnalagada, S., Chernova, T. etal. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "276,"

Phrase: "20452047."

Phrase: "[Abstract/Free FullText"

Phrase: "] Leroy,"

Phrase: "E.,"

Phrase: "Boyer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Auburger,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Leube,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Ulm,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Mezey,"

Phrase: "E.,"

Phrase: "Harta,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Brownstein,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Jonnalagada,"

Phrase: "S."

Phrase: ","

Phrase: "Chernova,"

Phrase: "T. etal."
Processing 00000000.tx.335: (1998) The ubiquitin pathway in Parkinson's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "The ubiquitin pathway in Parkinson's disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C1521736:Parkinson's Disease Pathway [Functional Concept]
   783   C1511986:Disease Pathway [Conceptual Entity]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.336: Nature, 395, 451452.[CrossRef][ISI][Medline] Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "395,"

Phrase: "451452."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kitada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Asakawa,"

Phrase: "S."

Phrase: ","

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Matsumine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yamamura,"

Phrase: "Y.,"

Phrase: "Minoshima,"

Phrase: "S."

Phrase: ","

Phrase: "Yokochi,"

Phrase: "M."

Phrase: ","

Phrase: "Mizuno,"

Phrase: "Y."

Phrase: "and"

Phrase: "Shimizu,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.337: (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mutations in the parkin gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "autosomal recessive juvenile parkinsonism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   923   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   812   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.338: Nature, 392, 605608.[CrossRef][ISI][Medline] Bonifati, V., Rizzu, P., van Baren, M.J., Schaap, O., Breedveld, G.J., Krieger, E., Dekker, M.C., Squitieri, F., Ibanez, P., Joosse, M. etal. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "392,"

Phrase: "605608."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bonifati,"

Phrase: "V.,"

Phrase: "Rizzu,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "van Baren,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Schaap,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Breedveld,"

Phrase: "G.J.,"

Phrase: "Krieger,"

Phrase: "E.,"

Phrase: "Dekker,"

Phrase: "M.C.,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C0599757:M-cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "Squitieri,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Ibanez,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Joosse,"

Phrase: "M. etal."
Processing 00000000.tx.339: (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Mutations in the DJ-1 gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with autosomal recessive early-onset parkinsonism."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   814   C1838631:Parkinsonism, early-onset [Finding]
   804   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C0441748:Autosomal recessive [Intellectual Product]
   778   C1833334:Early-onset [Finding]
   748   C0242422:Parkinsonism [Disease or Syndrome]
   748   C0332162:Onset [Qualitative Concept]
   748   C0596142:autosomal [Cell Component]
   748   C1279919:Early [Temporal Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.340: Science, 299, 256259.[Abstract/Free FullText] Valente, E.M., Abou-Sleiman, P.M., Caputo, V., Muqit, M.M., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A.R., Healy, D.G. etal. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "299,"

Phrase: "256259."

Phrase: "[Abstract/Free FullText"

Phrase: "] Valente,"

Phrase: "E.M.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Abou-Sleiman,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Caputo,"

Phrase: "V.,"

Phrase: "Muqit,"

Phrase: "M."

Phrase: "M."

Phrase: ","

Phrase: "Harvey,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gispert,"

Phrase: "S."

Phrase: ","

Phrase: "Ali,"

Phrase: "Z.,"

Phrase: "Del Turco,"

Phrase: "D."

Phrase: ","

Phrase: "Bentivoglio,"

Phrase: "A.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Healy,"

Phrase: "D."

Phrase: "G. etal."
Processing 00000000.tx.341: (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Hereditary early-onset Parkinson's disease"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   897   C0019247:Hereditary Disease [Disease or Syndrome]
   875   C0679245:early disease [Temporal Concept]
   840   C0030567:Parkinson Disease [Disease or Syndrome]
   840   C1521736:Parkinson's Disease [Functional Concept]
   840   C2681933:PARKINSON DISEASE [Gene or Genome]
   804   C0012634:Disease [Disease or Syndrome]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
   704   C1021144:Parkinsonia [Plant]

Phrase: "caused by mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0026882:Mutations [Genetic Function]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in PINK1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422771:PINK1 [Gene or Genome]
Processing 00000000.tx.342: Science, 304, 11581160.[Abstract/Free FullText] Singleton, A.B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R. etal. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "304,"

Phrase: "11581160."

Phrase: "[Abstract/Free FullText"

Phrase: "] Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Johnson,"

Phrase: "J.,"

Phrase: "Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.,"

Phrase: "Hague,"

Phrase: "S."

Phrase: ","

Phrase: "Kachergus,"

Phrase: "J.,"

Phrase: "Hulihan,"

Phrase: "M."

Phrase: ","

Phrase: "Peuralinna,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Nussbaum,"

Phrase: "R. etal."
Processing 00000000.tx.343: (2003) alpha-Synuclein locus triplication causes Parkinson's disease. 

Phrase: "(2003"

Phrase: ")"

Phrase: "alpha-Synuclein locus triplication"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.344: Science, 302, 841.[Free FullText] Hirsch, E., Graybiel, A.M. and Agid, Y.A. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "302,"

Phrase: "841."

Phrase: "[Free FullText"

Phrase: "] Hirsch,"

Phrase: "E.,"

Phrase: "Graybiel,"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Agid,"

Phrase: "Y."

Phrase: "A."
Processing 00000000.tx.345: (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Melanized dopaminergic neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:Dopaminergic Neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "are"

Phrase: "differentially susceptible to degeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0231204:Susceptible [Functional Concept]
   770   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "in Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.346: Nature, 334, 345348.[CrossRef][ISI][Medline] German, D.C., Manaye, K.F., Sonsalla, P.K. and Brooks, B.A. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "334,"

Phrase: "345348."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] German,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556085:German [Population Group]

Phrase: "D.C.,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0524984:D Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "Manaye,"

Phrase: "K.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Sonsalla,"

Phrase: "P.K."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Brooks,"

Phrase: "B.A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.347: (1992) Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Midbrain dopaminergic cell loss in Parkinson's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "MPTP-induced parkinsonism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0270730:MPTP-Induced Parkinsonism [Injury or Poisoning]
   827   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: ":"

Phrase: "sparing of calbindin-D28k-containing cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0007634:Cells [Cell]
   753   C0054444:Calbindin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332256:Containing [Functional Concept]
   753   C2700400:Containing [Activity]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.348: Ann. 

Phrase: "Ann."
Processing 00000000.tx.349: N Y Acad. 

Phrase: "N Y Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0268596:ACAD [Disease or Syndrome]
   827   C2700624:ACAD [Cell Function]
Processing 00000000.tx.350: Sci., 648, 42-62.[Abstract] Damier, P., Hirsch, E.C., Agid, Y. and Graybiel, A.M. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "648,"

Phrase: "42-62."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Damier,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hirsch,"

Phrase: "E.C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "Agid,"

Phrase: "Y."

Phrase: "and"

Phrase: "Graybiel,"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.351: (1999) The substantia nigra of the human brain. 

Phrase: "(1999"

Phrase: ")"

Phrase: "The substantia nigra of the human brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0038590:BRAIN, SUBSTANTIA NIGRA [Body Part, Organ, or Organ Component]
           Substantia Nigra
   778   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
Processing 00000000.tx.352: II. 

Phrase: "II."
Processing 00000000.tx.353: Patterns of loss of dopamine-containing neurons in Parkinson's disease. 

Phrase: "Patterns of loss of dopamine-containing neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449774:Patterns [Spatial Concept]

Phrase: "in Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.354: Brain, 122, 14371448.[Abstract/Free FullText] German, D.C., Manaye, K., Smith, W.K., Woodward, D.J. and Saper, C.B. 

Phrase: "Brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "122,"

Phrase: "14371448."

Phrase: "[Abstract/Free FullText"

Phrase: "] German,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556085:German [Population Group]

Phrase: "D.C.,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0524984:D Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "Manaye,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "W.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Woodward,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Saper,"

Phrase: "C.B."
Processing 00000000.tx.355: (1989) Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Midbrain dopaminergic cell loss in Parkinson's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1517945:Loss [Quantitative Concept]

Phrase: ":"

Phrase: "computer visualization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0175631:Visualization [Mental Process]
   861   C2827662:Visualization [Occupation or Discipline]
Processing 00000000.tx.356: Ann. 

Phrase: "Ann."
Processing 00000000.tx.357: Neurol., 26, 507514.[CrossRef][ISI][Medline] German, D.C., Dubach, M., Askari, S., Speciale, S.G. and Bowden, D.M. 

Phrase: "Neurol.,"

Phrase: "26,"

Phrase: "507514."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] German,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556085:German [Population Group]

Phrase: "D.C.,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0524984:D Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "Dubach,"

Phrase: "M."

Phrase: ","

Phrase: "Askari,"

Phrase: "S."

Phrase: ","

Phrase: "Speciale,"

Phrase: "S.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Bowden,"

Phrase: "D."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.358: (1988) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost? 

Phrase: "(1988"

Phrase: ")"

Phrase: "1-Methyl-4-phenyl-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0242422:Parkinsonian Syndrome [Disease or Syndrome]
   744   C0039082:Syndrome [Disease or Syndrome]

Phrase: ":"

Phrase: "which midbrain dopaminergic neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1512035:Dopaminergic Neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "are"

Phrase: "lost?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0745777:Lost [Functional Concept]
Processing 00000000.tx.359: Neuroscience, 24, 161174.[CrossRef][ISI][Medline] Rodriguez, M., Barroso-Chinea, P., Abdala, P., Obeso, J. and Gonzalez-Hernandez, T. 

Phrase: "Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "24,"

Phrase: "161174."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rodriguez,"

Phrase: "M."

Phrase: ","

Phrase: "Barroso-Chinea,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Abdala,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Obeso,"

Phrase: "J."

Phrase: "and"

Phrase: "Gonzalez-Hernandez,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.360: (2001) Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in parkinson's disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Dopamine cell degeneration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0333467:Cell degeneration [Pathologic Function]
   827   C0011164:Degeneration [Pathologic Function]
   827   C1880269:Degeneration [Functional Concept]

Phrase: "induced by intraventricular administration of 6-hydroxydopamine"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0001554:Administration [Occupational Activity]
   748   C0205263:Induced [Functional Concept]
   748   C0205795:Hydroxydopamine [Organic Chemical]
   748   C1517569:Intraventricular [Body Location or Region]
   748   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "in the rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: ":"

Phrase: "similarities with cell loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2348205:Similarity [Qualitative Concept]

Phrase: "in parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.361: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.362: Neurol., 169, 163181.[CrossRef][ISI][Medline] Pakkenberg, B., Moller, A., Gundersen, H.J., Mouritzen Dam, A. and Pakkenberg, H. 

Phrase: "Neurol.,"

Phrase: "169,"

Phrase: "163181."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pakkenberg,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Moller,"

Phrase: "A.,"

Phrase: "Gundersen,"

Phrase: "H.J.,"

Phrase: "Mouritzen Dam,"

Phrase: "A."

Phrase: "and"

Phrase: "Pakkenberg,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.363: (1991) The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. 

Phrase: "(1991"

Phrase: ")"

Phrase: "The absolute number of nerve cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "in substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "in normal subjects"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C2347086:% Normal [Quantitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "and in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1515981:And [Idea or Concept]

Phrase: "with Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "estimated with an unbiased stereological method."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0025663:Method [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0750572:Estimated [Quantitative Concept]
   753   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.364: J. 

Phrase: "J."
Processing 00000000.tx.365: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.366: Neurosurg. 

Phrase: "Neurosurg."
Processing 00000000.tx.367: Psychiatry, 54, 3033.[Abstract] McGeer, P.L., Itagaki, S., Akiyama, H. and McGeer, E.G. 

Phrase: "Psychiatry,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033872:Psychiatry [Professional or Occupational Group]
  1000   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   928 E C0205487:Psychiatric [Functional Concept]

Phrase: "54,"

Phrase: "3033."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] McGeer,"

Phrase: "P.L., Itagaki,"

Phrase: "S."

Phrase: ","

Phrase: "Akiyama,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "McGeer,"

Phrase: "E.G."
Processing 00000000.tx.368: (1988) Rate of cell death in parkinsonism indicates active neuropathological process. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Rate of cell death"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0026565:Death rate [Quantitative Concept]
   819   C0205848:Death Rate [Quantitative Concept]
   819   C1108678:death rate [Quantitative Concept]
   770   C0871208:Rate [Activity]
   770   C1521828:Rate [Quantitative Concept]

Phrase: "in parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "indicates"

Phrase: "active neuropathological process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.369: Ann. 

Phrase: "Ann."
Processing 00000000.tx.370: Neurol., 24, 574576.[CrossRef][ISI][Medline] Fearnley, J.M. and Lees, A.J. 

Phrase: "Neurol.,"

Phrase: "24,"

Phrase: "574576."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fearnley,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Lees,"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]
Processing 00000000.tx.371: (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Ageing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "and"

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: ":"

Phrase: "substantia nigra regional selectivity."
Processing 00000000.tx.372: Brain, 114, 22832301.[Abstract] Javoy-Agid, F. and Agid, Y. 

Phrase: "Brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "114,"

Phrase: "22832301."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Javoy-Agid,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Agid,"

Phrase: "Y."
Processing 00000000.tx.373: (1980) Is the mesocortical dopaminergic system involved in Parkinson disease? 

Phrase: "(1980"

Phrase: ")"

Phrase: "Is"

Phrase: "the mesocortical dopaminergic system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "involved in Parkinson disease?"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1314939:Involved [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.374: Neurology, 30, 13261330.[Abstract] McRitchie, D.A., Cartwright, H.R. and Halliday, G.M. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "30,"

Phrase: "13261330."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] McRitchie,"

Phrase: "D.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Cartwright,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335911:Cartwright [Professional or Occupational Group]

Phrase: "H.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Halliday,"

Phrase: "G.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456715:g m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.375: (1997) Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Specific A10 dopaminergic nuclei in the midbrain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0458367:midbrain nuclei [Body Part, Organ, or Organ Component]
   714   C0007610:Nucleus [Cell Component]

Phrase: "degenerate in Parkinson's disease."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   770   C0011164:degenerate [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1880269:Degenerate [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.376: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.377: Neurol., 144, 202213.[CrossRef][ISI][Medline] Yamada, T., McGeer, P.L., Baimbridge, K.G. and McGeer, E.G. 

Phrase: "Neurol.,"

Phrase: "144,"

Phrase: "202213."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yamada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "McGeer,"

Phrase: "P.L., Baimbridge,"

Phrase: "K.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "McGeer,"

Phrase: "E.G."
Processing 00000000.tx.378: (1990) Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Relative sparing in Parkinson's disease of substantia nigra dopamine neurons"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "calbindin-D28K."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.379: Brain Res., 526, 303307.[CrossRef][ISI][Medline] Parent, A., Fortin, M., Cote, P.Y. and Cicchetti, F. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "526,"

Phrase: "303307."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Parent,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030551:parent [Family Group]
  1000   C2699423:Parent [Conceptual Entity]

Phrase: "A.,"

Phrase: "Fortin,"

Phrase: "M."

Phrase: ","

Phrase: "Cote,"

Phrase: "P.Y."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Cicchetti,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.380: (1996) Calcium-binding proteins in primate basal ganglia. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Calcium-binding proteins in primate basal ganglia."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   814   C0006732:Calcium-Binding Proteins [Amino Acid, Peptide, or Protein,Receptor]
   780 E C1822659:calcium binding protein [Gene or Genome]
   778   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1516144:Calcium Binding [Molecular Function]
   757 E C0033618:Protein Binding [Molecular Function]
   757   C0805431:Calcium/Protein [Quantitative Concept]
   748   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0006726:Calcium [Inorganic Chemical]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C2936886:Calcium [Pharmacologic Substance]
Processing 00000000.tx.381: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.382: Res., 25, 309334.[CrossRef][ISI][Medline] Liang, C.L., Sinton, C.M., Sonsalla, P.K. and German, D.C. 

Phrase: "Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]

Phrase: "25,"

Phrase: "309334."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Liang,"

Phrase: "C.L., Sinton,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   734   C0347983:cells/L [Quantitative Concept]
   717 E C0022827:cell l [Cell]

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Sonsalla,"

Phrase: "P.K."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "German,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556085:German [Population Group]

Phrase: "D.C."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0524984:D Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.383: (1996) Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Midbrain dopaminergic neurons in the mouse"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1512035:Dopaminergic Neurons [Cell]
   753   C0027882:Neurons [Cell]

Phrase: "that"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration."
Processing 00000000.tx.384: Neurodegeneration, 5, 313318.[CrossRef][ISI][Medline] Schein, J.C., Hunter, D.D. and Roffler-Tarlov, S. 

Phrase: "Neurodegeneration,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "313318."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schein,"

Phrase: "J.C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "Hunter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239971:HUNTER [Professional or Occupational Group]

Phrase: "D.D."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0112081:D-D [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Roffler-Tarlov,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.385: (1998) Girk2 expression in the ventral midbrain, cerebellum, and olfactory bulb and its relationship to the murine mutation weaver. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Girk2 expression in the ventral midbrain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "cerebellum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "and"

Phrase: "olfactory bulb"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0028936:Olfactory Bulb [Body Part, Organ, or Organ Component]
  1000   C1281094:Olfactory bulb [Body Part, Organ, or Organ Component]
   861   C0025148:Bulb [Body Part, Organ, or Organ Component]
   861   C0037361:olfactory [Organism Function]
   861   C0439826:Olfactory [Organism Function]
   861   C1449865:Bulb [Plant]
   861   C1947952:Bulb [Anatomical Structure]

Phrase: "and"

Phrase: "its relationship to the murine mutation weaver."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439849:Relationship [Qualitative Concept]
   748   C1705630:Relationship [Idea or Concept]
   748   C1706279:Relationship [Idea or Concept]
   748   C3540605:Relationship [Intellectual Product]
Processing 00000000.tx.386: Dev. 

Phrase: "Dev."
Processing 00000000.tx.387: Biol., 204, 432450.[CrossRef][ISI][Medline] Karschin, C., Dissmann, E., Stuhmer, W. and Karschin, A. 

Phrase: "Biol.,"

Phrase: "204,"

Phrase: "432450."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Karschin,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Dissmann,"

Phrase: "E.,"

Phrase: "Stuhmer,"

Phrase: "W."

Phrase: "and"

Phrase: "Karschin,"

Phrase: "A."
Processing 00000000.tx.388: (1996) IRK(13) and GIRK(14) inwardly rectifying K+ channel mRNAs are differentially expressed in the adult rat brain. 

Phrase: "(1996"

Phrase: ")"

Phrase: "IRK"

Phrase: "(13"

Phrase: ")"

Phrase: "and"

Phrase: "GIRK"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   937   C0214230:INWARDLY RECTIFYING K CHANNEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0439799:Channel [Spatial Concept]
   804   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C1706095:Channel [Conceptual Entity]
   804   C1708601:K' [Quantitative Concept]

Phrase: "(14"

Phrase: ")"

Phrase: "inwardly"

Phrase: "rectifying"

Phrase: "K+ channel mRNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "differentially"

Phrase: "expressed in the adult rat brain."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   753   C0001675:Adult [Age Group]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1706450:Adult [Human]
Processing 00000000.tx.389: J. 

Phrase: "J."
Processing 00000000.tx.390: Neurosci., 16, 35593570.[Abstract/Free FullText] Roffler-Tarlov, S., Martin, B., Graybiel, A.M. and Kauer, J.S. 

Phrase: "Neurosci.,"

Phrase: "16,"

Phrase: "35593570."

Phrase: "[Abstract/Free FullText"

Phrase: "] Roffler-Tarlov,"

Phrase: "S."

Phrase: ","

Phrase: "Martin,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Graybiel,"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Kauer,"

Phrase: "J.S."
Processing 00000000.tx.391: (1996) Cell death in the midbrain of the murine mutation weaver. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Cell death in the midbrain of the murine mutation weaver."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0007587:Cell Death [Cell Function]
   739   C0007634:Cell [Cell]
   739   C0011065:Death [Organism Function]
   739   C1269647:Cell [Cell]
   739   C1306577:Death, NOS [Finding]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.392: J. 

Phrase: "J."
Processing 00000000.tx.393: Neurosci., 16, 18191826.[Abstract] Liss, B., Neu, A. and Roeper, J. 

Phrase: "Neurosci.,"

Phrase: "16,"

Phrase: "18191826."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Liss,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1508741:LISS [Laboratory Procedure]
  1000   C2247545:LIS [Molecular Function]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Neu,"

Phrase: "A."

Phrase: "and"

Phrase: "Roeper,"

Phrase: "J."
Processing 00000000.tx.394: (1999) The weaver mouse gain-of-function phenotype of dopaminergic midbrain neurons is determined by coactivation of wvGirk2 and K-ATP channels. 

Phrase: "(1999"

Phrase: ")"

Phrase: "The weaver mouse gain-of-function phenotype of dopaminergic midbrain neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0031437:Phenotype [Organism Attribute]
   738   C1285572:Phenotype [Laboratory Procedure]

Phrase: "is"

Phrase: "determined by coactivation of wvGirk2"

Phrase: "and"

Phrase: "K-ATP channels."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.395: J. 

Phrase: "J."
Processing 00000000.tx.396: Neurosci., 19, 88398848.[Abstract/Free FullText] Inanobe, A., Yoshimoto, Y., Horio, Y., Morishige, K.I., Hibino, H., Matsumoto, S., Tokunaga, Y., Maeda, T., Hata, Y., Takai, Y. etal. 

Phrase: "Neurosci.,"

Phrase: "19,"

Phrase: "88398848."

Phrase: "[Abstract/Free FullText"

Phrase: "] Inanobe,"

Phrase: "A.,"

Phrase: "Yoshimoto,"

Phrase: "Y.,"

Phrase: "Horio,"

Phrase: "Y.,"

Phrase: "Morishige,"

Phrase: "K.I.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hibino,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Matsumoto,"

Phrase: "S."

Phrase: ","

Phrase: "Tokunaga,"

Phrase: "Y.,"

Phrase: "Maeda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hata,"

Phrase: "Y.,"

Phrase: "Takai,"

Phrase: "Y. etal."
Processing 00000000.tx.397: (1999) Characterization of G-protein-gated K+ channels composed of Kir3.2 subunits in dopaminergic neurons of the substantia nigra. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Characterization of G-protein-gated K+ channels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880022:Characterization [Activity]

Phrase: "composed of Kir3.2 subunits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1416588:Kir3.2 [Gene or Genome]
   726   C1711351:Subunit [Quantitative Concept]

Phrase: "in dopaminergic neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1512035:Dopaminergic Neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "of the substantia nigra."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
Processing 00000000.tx.398: J. 

Phrase: "J."
Processing 00000000.tx.399: Neurosci., 19, 10061017.[Abstract/Free FullText] Isacson, O. 

Phrase: "Neurosci.,"

Phrase: "19,"

Phrase: "10061017."

Phrase: "[Abstract/Free FullText"

Phrase: "] Isacson,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.400: (1993) On neuronal health. 

Phrase: "(1993"

Phrase: ")"

Phrase: "On neuronal health."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0018684:Health [Idea or Concept]
   761 E C0031206:healthiness [Finding]
Processing 00000000.tx.401: Trends Neurosci., 16, 306308.[CrossRef][ISI][Medline] Seo, H., Sonntag, K.C. and Isacson, O. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci.,"

Phrase: "16,"

Phrase: "306308."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Seo,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sonntag,"

Phrase: "K.C."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0022686:k cells [Cell]
   966 E C0022688:K cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "Isacson,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.402: (2004) Generalized brain and skin proteasome inhibition in Huntington's disease. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Generalized brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "skin proteasome inhibition in Huntington's disease."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
Processing 00000000.tx.403: Ann. 

Phrase: "Ann."
Processing 00000000.tx.404: Neurol., 56, 319328.[CrossRef][ISI][Medline] McCaffery, P. and Drager, U.C. 

Phrase: "Neurol.,"

Phrase: "56,"

Phrase: "319328."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McCaffery,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Drager,"

Phrase: "U.C."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0301863:"U" cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.405: (1994) High levels of a retinoic acid-generating dehydrogenase in the meso-telencephalic dopamine system. 

Phrase: "(1994"

Phrase: ")"

Phrase: "High levels of a retinoic acid-generating dehydrogenase"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the meso-telencephalic dopamine system."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   812   C3641135:MESO [Conceptual Entity]
   741 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.406: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.407: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.408: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.409: USA, 91, 77727776.[Abstract/Free FullText] Sirinathsinghji, D.J., Kupsch, A., Mayer, E., Zivin, M., Pufal, D. and Oertel, W.H. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "91,"

Phrase: "77727776."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sirinathsinghji,"

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Kupsch,"

Phrase: "A.,"

Phrase: "Mayer,"

Phrase: "E.,"

Phrase: "Zivin,"

Phrase: "M."

Phrase: ","

Phrase: "Pufal,"

Phrase: "D."

Phrase: "and"

Phrase: "Oertel,"

Phrase: "W.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.410: (1992) Cellular localization of tyrosine hydroxylase mRNA and cholecystokinin mRNA-containing cells in the ventral mesencephalon of the common marmoset: effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Cellular localization of tyrosine hydroxylase mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1660642:cellular localisation [Cell Function]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "cholecystokinin mRNA-containing cells in the ventral mesencephalon of the common marmoset"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   736   C0007634:Cells [Cell]
   736   C3282337:Cells [Cell]
   703 E C1269647:Cell [Cell]
   703 E C1704653:Cell [Medical Device]
   703 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "effects of 1-methyl-4-phenyl-1,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "6-tetrahydropyridine."
Processing 00000000.tx.411: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.412: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.413: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.414: 12, 267274.[ISI][Medline] Seroogy, K.B., Dangaran, K., Lim, S., Haycock, J.W. and Fallon, J.H. 

Phrase: "12,"

Phrase: "267274."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Seroogy,"

Phrase: "K.B.,"

Phrase: "Dangaran,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449205:LIM [Body Location or Region]
  1000   C1538613:LIM [Gene or Genome]

Phrase: "S."

Phrase: ","

Phrase: "Haycock,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348939:Haycock [Occupational Activity]

Phrase: "J.W."

Phrase: "and"

Phrase: "Fallon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551604:Fallon [Population Group]

Phrase: "J.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.415: (1989) Ventral mesencephalic neurons containing both cholecystokinin- and tyrosine hydroxylase-like immunoreactivities project to forebrain regions. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Ventral mesencephalic neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "both cholecystokinin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008328:Cholecystokinin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1413167:CHOLECYSTOKININ [Gene or Genome]

Phrase: "and"

Phrase: "tyrosine hydroxylase-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0041491:Tyrosine Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1420718:TYROSINE HYDROXYLASE [Gene or Genome]
   861   C0020364:Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "like immunoreactivities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0597879:immunoreactivity [Molecular Function]

Phrase: "project to forebrain regions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0085140:Fore-Brain [Body Part, Organ, or Organ Component]
   770   C1709701:Project [Conceptual Entity]
   737   C0017446:Region [Geographic Area]
   737   C0205147:Region [Spatial Concept]
Processing 00000000.tx.416: J. 

Phrase: "J."
Processing 00000000.tx.417: Comp. 

Phrase: "Comp."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0056167:COMP [Therapeutic or Preventive Procedure]
  1000   C1456376:COMP [Gene or Genome]
Processing 00000000.tx.418: Neurol., 279, 397414.[CrossRef][ISI][Medline] Draghici, S., Khatri, P., Martins, R.P., Ostermeier, G.C. and Krawetz, S.A. 

Phrase: "Neurol.,"

Phrase: "279,"

Phrase: "397414."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Draghici,"

Phrase: "S."

Phrase: ","

Phrase: "Khatri,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Martins,"

Phrase: "R.P.,"

Phrase: "Ostermeier,"

Phrase: "G.C."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0524983:G Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0439267:g% [Quantitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "Krawetz,"

Phrase: "S.A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.419: (2003) Global functional profiling of gene expression. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Global functional profiling of gene expression."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   820   C0752248:Gene Expression Profiling [Laboratory Procedure,Molecular Biology Research Technique]
   820   C1449575:Gene Expression Profiling [Laboratory Procedure]
   804 E C1956267:Profile, Gene Expression [Quantitative Concept]
   783   C1513400:Expression Profiling [Molecular Biology Research Technique]
   719   C1979963:Profile [Laboratory Procedure]
   719   C2003903:Profile [Functional Concept]
Processing 00000000.tx.420: Genomics, 81, 98104.[CrossRef][ISI][Medline] Seabra, M.C., Mules, E.H. and Hume, A.N. 

Phrase: "Genomics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: "81,"

Phrase: "98104."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Seabra,"

Phrase: "M.C.,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C0599757:M-cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "Mules,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0324146:Mules [Mammal]
  1000   C0453959:Mules [Manufactured Object]
   966 E C1297110:Mule [Mammal]

Phrase: "E.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Hume,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3476794:Hume [Intellectual Product]

Phrase: "A.N."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1272460:a n [Qualitative Concept]
Processing 00000000.tx.421: (2002) Rab GTPases, intracellular traffic and disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Rab GTPases,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0752065:rab GTPases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0018296:GTPases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "intracellular traffic"

Phrase: "and"

Phrase: "disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.422: Trends Mol. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.423: Med., 8, 2330.[CrossRef][ISI][Medline] O'Connor, L., Strasser, A., O'Reilly, L.A., Hausmann, G., Adams, J.M., Cory, S. and Huang, D.C. 

Phrase: "Med.,"

Phrase: "8,"

Phrase: "2330."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] O'Connor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Strasser,"

Phrase: "A.,"

Phrase: "O'Reilly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "L.A.,"

Phrase: "Hausmann,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Adams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331762:Adams [Health Care Related Organization]

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Cory,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Huang,"

Phrase: "D.C."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0524984:D Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.424: (1998) Bim: a novel member of the Bcl-2 family that promotes apoptosis. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Bim"

Phrase: ":"

Phrase: "a novel member of the Bcl-2 family"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0086282:Family member [Family Group]
   767   C1611821:Family Member [Intellectual Product]
   744   C0680022:member [Population Group]
   744   C2698041:Member [Professional or Occupational Group]

Phrase: "that"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.425: EMBO J., 17, 384395.[Abstract/Free FullText] Tanaka, Y., Engelender, S., Igarashi, S., Rao, R.K., Wanner, T., Tanzi, R.E., Sawa, A., V, L.D., Dawson, T.M. and Ross, C.A. 

Phrase: "EMBO J.,"

Phrase: "17,"

Phrase: "384395."

Phrase: "[Abstract/Free FullText"

Phrase: "] Tanaka,"

Phrase: "Y.,"

Phrase: "Engelender,"

Phrase: "S."

Phrase: ","

Phrase: "Igarashi,"

Phrase: "S."

Phrase: ","

Phrase: "Rao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412430:RAO [Gene or Genome]

Phrase: "R.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Wanner,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tanzi,"

Phrase: "R.E.,"

Phrase: "Sawa,"

Phrase: "A.,"

Phrase: "V,"

Phrase: "L.D.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0475219:L/d [Quantitative Concept]
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "C."

Phrase: "A."
Processing 00000000.tx.426: (2001) Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Inducible expression of mutant alpha-synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "proteasome activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1622946:proteasome activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "sensitivity to mitochondria-dependent apoptosis."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0332324:Sensitive to [Functional Concept]
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C2346484:SENSITIVITY [Phenomenon or Process]
   760   C2349185:Sensitivity [Qualitative Concept]
Processing 00000000.tx.427: Hum. 

Phrase: "Hum."
Processing 00000000.tx.428: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.429: Genet., 10, 919926.[Abstract/Free FullText] Przedborski, S., Tieu, K., Perier, C. and Vila, M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "10,"

Phrase: "919926."

Phrase: "[Abstract/Free FullText"

Phrase: "] Przedborski,"

Phrase: "S."

Phrase: ","

Phrase: "Tieu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Perier,"

Phrase: "C."

Phrase: "and"

Phrase: "Vila,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1061396:Vila [Eukaryote]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.430: (2004) MPTP as a mitochondrial neurotoxic model of Parkinson's disease. 

Phrase: "(2004"

Phrase: ")"

Phrase: "MPTP as a mitochondrial neurotoxic model of Parkinson's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0000097:MPTP [Hazardous or Poisonous Substance,Organic Chemical]
Processing 00000000.tx.431: J. 

Phrase: "J."
Processing 00000000.tx.432: Bioenerg. 

Phrase: "Bioenerg."
Processing 00000000.tx.433: Biomembr., 36, 375379.[CrossRef][ISI][Medline] Bayer, S.A., Triarhou, L.C., Thomas, J.D. and Ghetti, B. 

Phrase: "Biomembr.,"

Phrase: "36,"

Phrase: "375379."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bayer,"

Phrase: "S.A.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Triarhou,"

Phrase: "L.C.,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0022827:L cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "Thomas,"

Phrase: "J.D."

Phrase: "and"

Phrase: "Ghetti,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.434: (1994) Correlated quantitative studies of the neostriatum, nucleus accumbens, substantia nigra, and ventral tegmental area in normal and weaver mutant mice. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Correlated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707520:Correlated [Qualitative Concept]

Phrase: "quantitative studies of the neostriatum,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "nucleus accumbens,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028633:Nucleus Accumbens [Body Part, Organ, or Organ Component]
   861   C0007610:Nucleus [Cell Component]

Phrase: "substantia nigra,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ventral tegmental area in normal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0175405:Ventral Tegmental Area [Body Part, Organ, or Organ Component]
   760   C0017446:Area [Geographic Area]
   760   C0205146:Area [Spatial Concept]
   760   C1704448:Ventral [Spatial Concept]

Phrase: "and"

Phrase: "weaver mutant mice."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0043086:Weaver Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0326812:Weaver [Bird]
   827   C0596988:Mutant [Cell or Molecular Dysfunction]
Processing 00000000.tx.435: J. 

Phrase: "J."
Processing 00000000.tx.436: Neurosci., 14, 69016910.[Abstract] Graybiel, A.M., Ohta, K. and Roffler-Tarlov, S. 

Phrase: "Neurosci.,"

Phrase: "14,"

Phrase: "69016910."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Graybiel,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ohta,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Roffler-Tarlov,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.437: (1990) Patterns of cell and fiber vulnerability in the mesostriatal system of the mutant mouse weaver. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Patterns of cell"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0449774:Patterns [Spatial Concept]

Phrase: "and"

Phrase: "fiber vulnerability in the mesostriatal system of the mutant mouse weaver."
Processing 00000000.tx.438: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.439: Gradients and compartments. 

Phrase: "Gradients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0812409:gradients [Quantitative Concept]
   966 E C0439182:% gradient [Quantitative Concept]

Phrase: "and"

Phrase: "compartments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1185625:Compartments [Body Space or Junction]
  1000   C1382196:Compartments [Natural Phenomenon or Process]
   966 E C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.440: J. 

Phrase: "J."
Processing 00000000.tx.441: Neurosci., 10, 720733.[Abstract] Halestrap, A.P. and Brennerb, C. 

Phrase: "Neurosci.,"

Phrase: "10,"

Phrase: "720733."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Halestrap,"

Phrase: "A.P."

Phrase: "and"

Phrase: "Brennerb,"

Phrase: "C."
Processing 00000000.tx.442: (2003) The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. 

Phrase: "(2003"

Phrase: ")"

Phrase: "The adenine nucleotide translocase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1141015:Adenine Nucleotide Translocase [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1153238:adenine nucleotide translocase [Molecular Function]
   901   C1135982:Nucleotide Translocase [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0582119:Translocase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ":"

Phrase: "a central component of the mitochondrial permeability transition pore"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0449432:Component [Manufactured Object]
   742   C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "key player in cell death."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0007587:Cell Death [Cell Function]
   804   C0011065:Death [Organism Function]
   804   C1306577:Death, NOS [Finding]
Processing 00000000.tx.443: Curr. 

Phrase: "Curr."
Processing 00000000.tx.444: Med. 

Phrase: "Med."
Processing 00000000.tx.445: Chem., 10, 15071525.[CrossRef][ISI][Medline] Marzo, I., Brenner, C., Zamzami, N., Jurgensmeier, J.M., Susin, S.A., Vieira, H.L., Prevost, M.C., Xie, Z., Matsuyama, S., Reed, J.C. etal. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "10,"

Phrase: "15071525."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Marzo,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Brenner,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Zamzami,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Jurgensmeier,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Susin,"

Phrase: "S.A.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Vieira,"

Phrase: "H.L., Prevost,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2346686:h l [Quantitative Concept]

Phrase: "M.C.,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C0599757:M-cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "Xie,"

Phrase: "Z.,"

Phrase: "Matsuyama,"

Phrase: "S."

Phrase: ","

Phrase: "Reed,"

Phrase: "J.C. etal."
Processing 00000000.tx.446: (1998) Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Bax"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812198:BAX [Gene or Genome]

Phrase: "and"

Phrase: "adenine nucleotide translocator"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0001413:adenine nucleotide [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "cooperate in the mitochondrial control of apoptosis."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0026237:Mitochondrial [Cell Component]
   748   C0162638:Apoptosis [Cell Function]
   748   C0243148:control [Qualitative Concept]
   748   C0521451:Mitochondrial [Functional Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.447: Science, 281, 20272031.[Abstract/Free FullText] Lu, T., Pan, Y., Kao, S.Y., Li, C., Kohane, I., Chan, J. and Yankner, B.A. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "281,"

Phrase: "20272031."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Pan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085999:Pan [Mammal]

Phrase: "Y.,"

Phrase: "Kao,"

Phrase: "S."

Phrase: "Y.,"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Kohane,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Chan,"

Phrase: "J."

Phrase: "and"

Phrase: "Yankner,"

Phrase: "B.A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.448: (2004) Gene regulation and DNA damage in the ageing human brain. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Gene regulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017263:Gene Regulation [Genetic Function]
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "DNA damage in the ageing human brain."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   774   C0270611:Brain damage [Injury or Poisoning]
   748   C0010957:Damage [Injury or Poisoning]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C1883709:Damage [Functional Concept]
Processing 00000000.tx.449: Nature, 429, 883891.[CrossRef][ISI][Medline] Quesada, A. and Micevych, P.E. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "429,"

Phrase: "883891."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Quesada,"

Phrase: "A."

Phrase: "and"

Phrase: "Micevych,"

Phrase: "P.E."
Processing 00000000.tx.450: (2004) Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Estrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
  1000   C2936882:Estrogen [Pharmacologic Substance]
   928 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "interacts with the IGF-1 system to"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0220844:growth [Physiologic Function]
   742   C0449913:System [Functional Concept]
   742   C1521761:Factor [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1553451:System [Manufactured Object]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1704459:System [Medical Device]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]

Phrase: "protect"

Phrase: "nigrostriatal dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "motoric behavior after 6-hydroxdopamine lesions."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0026606:Motor behavior [Daily or Recreational Activity]
   753   C0004927:Behavior [Individual Behavior]
   753   C2707008:Behavior [Clinical Attribute]
Processing 00000000.tx.451: J. 

Phrase: "J."
Processing 00000000.tx.452: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.453: Res., 75, 107116.[CrossRef][ISI][Medline] Krishnamurthi, R., Stott, S., Maingay, M., Faull, R.L., McCarthy, D., Gluckman, P. and Guan, J. 

Phrase: "Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]

Phrase: "75,"

Phrase: "107116."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Krishnamurthi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Stott,"

Phrase: "S."

Phrase: ","

Phrase: "Maingay,"

Phrase: "M."

Phrase: ","

Phrase: "Faull,"

Phrase: "R.L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "McCarthy,"

Phrase: "D."

Phrase: ","

Phrase: "Gluckman,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Guan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325602:Guan [Bird]

Phrase: "J."
Processing 00000000.tx.454: (2004) N-terminal tripeptide of IGF-1 improves functional deficits after 6-OHDA lesion in rats. 

Phrase: "(2004"

Phrase: ")"

Phrase: "N-terminal tripeptide of IGF-1"

Phrase: "improves"

Phrase: "functional deficits after 6-OHDA lesion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C2987487:deficits [Qualitative Concept]
   719 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "in rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.455: Neuroreport, 15, 16011604.[CrossRef][ISI][Medline] Wickman, K. and Clapham, D.E. 

Phrase: "Neuroreport,"

Phrase: "15,"

Phrase: "16011604."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wickman,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Clapham,"

Phrase: "D."

Phrase: "E."
Processing 00000000.tx.456: (1995) Ion channel regulation by G proteins. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Ion channel regulation by G proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.457: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.458: Rev., 75, 865885.[Abstract/Free FullText] Slesinger, P.A., Patil, N., Liao, Y.J., Jan, Y.N., Jan, L.Y. and Cox, D.R. 

Phrase: "Rev.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]

Phrase: "75,"

Phrase: "865885."

Phrase: "[Abstract/Free FullText"

Phrase: "] Slesinger,"

Phrase: "P.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Patil,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Liao,"

Phrase: "Y.J.,"

Phrase: "Jan,"

Phrase: "Y.N., Jan,"

Phrase: "L.Y."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551080:l.y. [Temporal Concept]

Phrase: "and"

Phrase: "Cox,"

Phrase: "D.R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.459: (1996) Functional effects of the mouse weaver mutation on G protein-gated inwardly rectifying K+ channels. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Functional effects of the mouse weaver mutation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on G protein-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439267:g% [Quantitative Concept]

Phrase: "gated"

Phrase: "inwardly"

Phrase: "rectifying"

Phrase: "K+ channels."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.460: Neuron, 16, 321331.[CrossRef][ISI][Medline] Palmieri, F. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "16,"

Phrase: "321331."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Palmieri,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.461: (2004) The mitochondrial transporter family (SLC25): physiological and pathological implications. 

Phrase: "(2004"

Phrase: ")"

Phrase: "The mitochondrial transporter family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Family [Family Group]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]

Phrase: "(SLC25"

Phrase: ")"

Phrase: ":"

Phrase: "physiological"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205463:Physiological [Functional Concept]
   928 E C0031842:Physiology [Biomedical Occupation or Discipline]
   928 E C0031843:physiology [Physiologic Function]

Phrase: "and"

Phrase: "pathological implications."
Processing 00000000.tx.462: Pflugers Arch., 447, 689709.[CrossRef][ISI][Medline] Cassarino, D.S., Parks, J.K., Parker, W.D., Jr. and Bennett, J.P., Jr. 

Phrase: "Pflugers Arch.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0230467:arch [Body Location or Region]
   861   C0741204:ARCH [Body Space or Junction]

Phrase: "447,"

Phrase: "689709."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cassarino,"

Phrase: "D.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Parks,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0562547:parks [Manufactured Object]
   966 E C3160718:PARK [Disease or Syndrome]

Phrase: "J.K.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346601:J/K [Quantitative Concept]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Parker,"

Phrase: "W."

Phrase: "D."

Phrase: ","

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "and"

Phrase: "Bennett,"

Phrase: "J.P.,"

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.463: (1999) The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. 

Phrase: "(1999"

Phrase: ")"

Phrase: "The parkinsonian neurotoxin MPP+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0000098:MPP+ [Hazardous or Poisonous Substance,Organic Chemical]
   827   C1417248:MPP [Gene or Genome]

Phrase: "opens"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175566:Open [Spatial Concept]

Phrase: "the mitochondrial permeability transition pore"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
  1000   C0908146:mitochondrial permeability transition pore [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2000322:permeability transition pore, mitochondrial [Amino Acid, Peptide, or Protein]
   923   C3158983:mitochondrial permeability transition [Cell Function]
   812   C0026237:Mitochondrial [Cell Component]
   812   C0031164:Permeability [Natural Phenomenon or Process]
   812   C0521451:Mitochondrial [Functional Concept]
   812   C0599156:Transition [Cell or Molecular Dysfunction]
   812   C1325742:Pore [Cell Component]
   812   C2700061:Transition [Activity]
   741 E C0205326:Permeable [Functional Concept]
   741 E C1182674:Transitional [Spatial Concept]
   741 E C1548597:Transitional [Idea or Concept]

Phrase: "and"

Phrase: "releases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "cytochrome c in isolated mitochondria"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
   806   C1153524:cytochrome c [Molecular Function]
   806   C1426584:CYTOCHROME C [Gene or Genome]
   760   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1325304:cytochrome [Molecular Function]

Phrase: "via an oxidative mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.464: Biochim. 

Phrase: "Biochim."
Processing 00000000.tx.465: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.466: Acta, 1453, 4962.[ISI][Medline] Kiranadi, B., Bangham, J.A. and Smith, P.A. 

Phrase: "Acta,"

Phrase: "1453,"

Phrase: "4962."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kiranadi,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Bangham,"

Phrase: "J."

Phrase: "A."

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "P.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.467: (1991) Inhibition of electrical activity in mouse pancreatic beta-cells by the ATP/ADP translocase inhibitor, bongkrekic acid. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Inhibition of electrical activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "in mouse pancreatic beta-cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   923   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   906   C1522214:Mouse Beta Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C2004068:Beta [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "by the ATP/ADP translocase inhibitor,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1999216:Inhibitor [Qualitative Concept]
   756   C1141015:ATP-ADP Translocase [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           ATP Translocase

Phrase: "bongkrekic acid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005982:Bongkrekic Acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.468: FEBS Lett., 283, 9396.[CrossRef][ISI][Medline] Guan, J., Miller, O.T., Waugh, K.M., McCarthy, D.C. and Gluckman, P.D. 

Phrase: "FEBS Lett.,"

Phrase: "283,"

Phrase: "9396."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Guan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325602:Guan [Bird]

Phrase: "J.,"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "O.T.,"

Phrase: "Waugh,"

Phrase: "K.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "McCarthy,"

Phrase: "D.C."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0524984:D Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "Gluckman,"

Phrase: "P.D."
Processing 00000000.tx.469: (2001) Insulin-like growth factor-1 improves somatosensory function and reduces the extent of cortical infarction and ongoing neuronal loss after hypoxia-ischemia in rats. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Insulin-like growth factor-1"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "improves"

Phrase: "somatosensory function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "reduces"

Phrase: "the extent of cortical infarction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439792:Extent [Spatial Concept]

Phrase: "and"

Phrase: "ongoing neuronal loss after hypoxia-ischemia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1850496:Neuronal loss [Finding]
   754 E C0598940:neuron loss [Finding]
   753   C1517945:Loss [Quantitative Concept]

Phrase: "in rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.470: Neuroscience, 105, 299306.[CrossRef][ISI][Medline] Wang, J.M., Hayashi, T., Zhang, W.R., Sakai, K., Shiro, Y. and Abe, K. 

Phrase: "Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "105,"

Phrase: "299306."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wang,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Hayashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Zhang,"

Phrase: "W.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Sakai,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Shiro,"

Phrase: "Y."

Phrase: "and"

Phrase: "Abe,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0155685:abe [Disease or Syndrome]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.471: (2000) Reduction of ischemic brain injury by topical application of insulin-like growth factor-I after transient middle cerebral artery occlusion in rats. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Reduction of ischemic brain injury"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "by topical application"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0683174:topical application [Therapeutic or Preventive Procedure]
   861   C0185125:Application [Health Care Activity]
   861   C1947919:Application [Intellectual Product]
   861   C2347934:Application [Intellectual Product]
   861   C3539080:APPLICATION [Quantitative Concept]

Phrase: "of insulin-like growth factor-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "after transient middle cerebral artery occlusion"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   937   C0740391:Middle Cerebral Artery Occlusion [Acquired Abnormality]
   884   C0028790:Cerebral artery occlusion [Acquired Abnormality]
   884   C0149566:Middle Cerebral Artery [Body Part, Organ, or Organ Component]
   884   C1269012:Middle cerebral artery [Body Part, Organ, or Organ Component]
   853   C0596298:cerebral occlusion [Disease or Syndrome]
   840   C0007770:Cerebral artery [Body Part, Organ, or Organ Component]
   840   C0264995:artery occlusion [Pathologic Function]
   840   C1278936:Cerebral artery [Body Part, Organ, or Organ Component]
   804   C0003842:Artery [Body Part, Organ, or Organ Component]
   804   C0011382:Occlusion [Organ or Tissue Function]
   804   C0028778:Occlusion [Pathologic Function]
   804   C0226004:artery [Body System]
   804   C0441597:Occlusion [Functional Concept]
   804   C0444598:Middle [Spatial Concept]
   804   C0549183:middle [Spatial Concept]
   804   C1110554:OCCLUSION [Pathologic Function]
   804   C1552826:middle [Idea or Concept]
   804   C1882137:OCCLUSION [Phenomenon or Process]
   804   C1947917:Occlusion, NOS [Functional Concept]
   748 E C0205098:Medial [Spatial Concept]
   733 E C0221464:Arterial [Spatial Concept]

Phrase: "in rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.472: Brain Res., 859, 381385.[CrossRef][ISI][Medline] Kermer, P., Klocker, N., Labes, M. and Bahr, M. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "859,"

Phrase: "381385."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kermer,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Klocker,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Labes,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Bahr,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.473: (2000) Insulin-like growth factor-I protects axotomized rat retinal ganglion cells from secondary death via PI3-K-dependent Akt phosphorylation and inhibition of caspase-3 in vivo. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Insulin-like growth factor-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "protects"

Phrase: "axotomized rat retinal ganglion cells from secondary death"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   800   C0035316:Retinal Ganglion Cells [Cell]
           retinal ganglion
   770   C0228071:Ganglion Cells [Cell]
   767   C0007587:cells death [Cell Function]
   750   C2338017:Retinal cell [Cell]
   744   C0007634:Cells [Cell]
   744   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   744   C0035298:Retinal [Body Part, Organ, or Organ Component]
   744   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "via PI3-K-dependent Akt phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "inhibition of caspase-3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.474: J. 

Phrase: "J."
Processing 00000000.tx.475: Neurosci., 20, 28. 

Phrase: "Neurosci.,"

Phrase: "20,"

Phrase: "28."
Processing 00000000.tx.476: Poe, B.H., Linville, C., Riddle, D.R., Sonntag, W.E. and Brunso-Bechtold, J.K. 

Phrase: "Poe,"

Phrase: "B.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Linville,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Riddle,"

Phrase: "D.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Sonntag,"

Phrase: "W.E."

Phrase: "and"

Phrase: "Brunso-Bechtold,"

Phrase: "J.K."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346601:J/K [Quantitative Concept]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.477: (2001) Effects of age and insulin-like growth factor-1 on neuron and synapse numbers in area CA3 of hippocampus. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Effects of age"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "insulin-like growth factor-1 on neuron"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   897   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   897   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   853   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   853   C1753359:insulin-like growth factor [Molecular Function]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0220844:growth [Physiologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]
   738   C0814002:Neuronal Growth [Cell Function,Organism Function]

Phrase: "and"

Phrase: "synapse numbers in area CA3 of hippocampus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.478: Neuroscience, 107, 231238.[CrossRef][ISI][Medline] Vincent, A.M., Mobley, B.C., Hiller, A. and Feldman, E.L. 

Phrase: "Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "107,"

Phrase: "231238."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Vincent,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Mobley,"

Phrase: "B.C.,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004561:B-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "Hiller,"

Phrase: "A."

Phrase: "and"

Phrase: "Feldman,"

Phrase: "E.L."
Processing 00000000.tx.479: (2004) IGF-I prevents glutamate-induced motor neuron programmed cell death. 

Phrase: "(2004"

Phrase: ")"

Phrase: "IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:IGF I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "glutamate-induced motor neuron programmed cell death."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   852   C2754100:neuron cell death [Cell Function]
           neuron death
   845   C0026609:motor cell [Cell]
   845   C0162638:Programmed Cell Death [Cell Function]
   824   C1660771:programmed cell death, neurons [Cell Function]
   818   C0007587:Cell Death [Cell Function]
   795   C0007634:Cell [Cell]
   795   C0011065:Death [Organism Function]
   795   C1269647:Cell [Cell]
   795   C1306577:Death, NOS [Finding]
   795   C1704653:Cell [Medical Device]
   795   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.480: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.481: Dis., 16, 407416.[CrossRef][ISI][Medline] Zawada, W.M., Kirschman, D.L., Cohen, J.J., Heidenreich, K.A. and Freed, C.R. 

Phrase: "Dis.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]

Phrase: "16,"

Phrase: "407416."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zawada,"

Phrase: "W."

Phrase: "M."

Phrase: ","

Phrase: "Kirschman,"

Phrase: "D."

Phrase: "L., Cohen,"

Phrase: "J.J.,"

Phrase: "Heidenreich,"

Phrase: "K.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Freed,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0332296:free [Functional Concept]
   966   C1880497:Free [Qualitative Concept]
   966   C1996904:Free [Qualitative Concept]

Phrase: "C.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.482: (1996) Growth factors rescue embryonic dopamine neurons from programmed cell death. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "rescue"

Phrase: "embryonic dopamine neurons from programmed cell death."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1660771:programmed cell death, neurons [Cell Function]
   788   C2754100:neuron cell death [Cell Function]
           neuron death
   778   C1512035:dopamine neurons [Cell]
   748   C0027882:Neurons [Cell]
Processing 00000000.tx.483: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.484: Neurol., 140, 6067.[CrossRef][ISI][Medline] Shavali, S., Ren, J. and Ebadi, M. 

Phrase: "Neurol.,"

Phrase: "140,"

Phrase: "6067."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shavali,"

Phrase: "S."

Phrase: ","

Phrase: "Ren,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022646:Ren [Body Part, Organ, or Organ Component]
  1000   C1419338:REN [Gene or Genome]
  1000   C1427479:REN [Gene or Genome]

Phrase: "J."

Phrase: "and"

Phrase: "Ebadi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.485: (2003) Insulin-like growth factor-1 protects human dopaminergic SH-SY5Y cells from salsolinol-induced toxicity. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Insulin-like growth factor-1"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "protects"

Phrase: "human dopaminergic SH-SY5Y cells from salsolinol-induced toxicity."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   762   C0427861:Human cells [Laboratory or Test Result]
   762   C1512035:Dopaminergic cells [Cell]
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.486: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.487: Lett., 340, 7982.[CrossRef][ISI][Medline] Strasburger, C.J., Bidlingmaier, M., Wu, Z. and Morrison, K.M. 

Phrase: "Lett.,"

Phrase: "340,"

Phrase: "7982."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Strasburger,"

Phrase: "C.J.,"

Phrase: "Bidlingmaier,"

Phrase: "M."

Phrase: ","

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Z."

Phrase: "and"

Phrase: "Morrison,"

Phrase: "K.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.488: (2001) Normal values of insulin-like growth factor I and their clinical utility in adults. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Normal values of insulin-like growth factor I"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0086715:Normal Values [Quantitative Concept]
   767   C0018270:normal growth [Organism Function]
   767   C0578019:Normal growth [Finding]
   767   C0858301:insulin normal [Finding]
   744   C0042295:Values [Qualitative Concept]
   744   C0205307:Normal [Qualitative Concept]
   744   C0439166:% normal [Quantitative Concept]
   744   C2347086:% Normal [Quantitative Concept]
   711 E C1522609:Value [Quantitative Concept]
   703   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]

Phrase: "and"

Phrase: "their clinical utility in adults."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0582205:utility [Organization]
Processing 00000000.tx.489: Horm. 

Phrase: "Horm."
Processing 00000000.tx.490: Res., 55(Suppl. 

Phrase: "Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "(Suppl."
Processing 00000000.tx.491: 2), 100105.[CrossRef][ISI][Medline] van Dam, P.S. and Aleman, A. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "100105."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] van Dam,"

Phrase: "P.S."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0234833:P s [Organ or Tissue Function]
  1000   C0722388:P & S [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Aleman,"

Phrase: "A."
Processing 00000000.tx.492: (2004) Insulin-like growth factor-I, cognition and brain aging. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Insulin-like growth factor-I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "cognition"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009240:Cognition [Mental Process]
   916 E C2981149:Intellect [Mental Process]
   907 E C0233698:Noesis [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "brain aging."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0001811:Ageing [Organism Function]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C0001779:Age [Organism Attribute]
Processing 00000000.tx.493: Eur. 

Phrase: "Eur."
Processing 00000000.tx.494: J. 

Phrase: "J."
Processing 00000000.tx.495: Pharmacol., 490, 8795.[CrossRef][ISI][Medline] Yegen, B.C. 

Phrase: "Pharmacol.,"

Phrase: "490,"

Phrase: "8795."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yegen,"

Phrase: "B.C."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004561:B-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.496: (2003) Bombesin-like peptides: candidates as diagnostic and therapeutic tools. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Bombesin-like peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   988   C0596202:bombesin like peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: ":"

Phrase: "candidates as diagnostic"

Phrase: "and"

Phrase: "therapeutic tools."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0336791:Tool [Manufactured Object]
   827   C2827396:Tool [Manufactured Object]
Processing 00000000.tx.497: Curr. 

Phrase: "Curr."
Processing 00000000.tx.498: Pharm. 

Phrase: "Pharm."
Processing 00000000.tx.499: Des., 9, 10131022.[CrossRef][ISI][Medline] Cuttitta, F., Carney, D.N., Mulshine, J., Moody, T.W., Fedorko, J., Fischler, A. and Minna, J.D. 

Phrase: "Des.,"

Phrase: "9,"

Phrase: "10131022."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cuttitta,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Carney,"

Phrase: "D."

Phrase: "N., Mulshine,"

Phrase: "J.,"

Phrase: "Moody,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0554980:Moody [Finding]
   928 E C0026516:Mood [Mental Process]
   928 E C0241999:MOODINESS [Mental Process]
   928 E C2713234:Mood [Clinical Attribute]

Phrase: "T.W., Fedorko,"

Phrase: "J.,"

Phrase: "Fischler,"

Phrase: "A."

Phrase: "and"

Phrase: "Minna,"

Phrase: "J.D."
Processing 00000000.tx.500: (1985) Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Bombesin-like peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   988   C0596202:bombesin like peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "can"

Phrase: "function as autocrine growth factors"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0031843:function [Physiologic Function]
   760   C0220844:growth [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0596138:Autocrine [Organ or Tissue Function]
   760   C0700205:FUNCTION [Classification]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C1705273:Function [Intellectual Product]
   760   C2911660:Growth [Activity]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "in human small-cell lung cancer."
Meta Candidates (Total=22; Excluded=3; Pruned=0; Remaining=19)
   937   C0149925:Small Cell Lung Cancer [Neoplastic Process]
   937   C2984312:Small cell lung cancer [Functional Concept]
   937   C3540630:Small Cell Lung Cancer [Intellectual Product]
   888   C0262584:Small Cell Cancer [Neoplastic Process]
   853   C0427861:human cell [Laboratory or Test Result]
   840   C0242379:Lung Cancer [Neoplastic Process]
   840   C0684249:LUNG CANCER [Neoplastic Process]
   811   C2749705:Small lungs [Finding]
   804   C0006826:Cancer [Neoplastic Process]
   804   C0007634:Cell [Cell]
   804   C0024109:Lung [Body Part, Organ, or Organ Component]
   804   C0700321:Small [Quantitative Concept]
   804   C0819757:LUNG [Tissue]
   804   C0998265:Cancer [Eukaryote]
   804   C1269647:Cell [Cell]
   804   C1278908:Lung [Body Part, Organ, or Organ Component]
   804   C1306459:Cancer [Finding]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   748 E C2707265:Pulmonary [Clinical Attribute]
   748 E C2709248:Pulmonary [Qualitative Concept]
   711 E C0032285:Pneumonia [Disease or Syndrome]
Processing 00000000.tx.501: Nature, 316, 823826.[CrossRef][ISI][Medline] Alexander, R.W., Upp, J.R., Jr., Poston, G.J., Gupta, V., Townsend, C.M., Jr. and Thompson, J.C. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "316,"

Phrase: "823826."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Alexander,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551702:Alexander [Population Group]

Phrase: "R.W., Upp,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0200005:UPP [Diagnostic Procedure]
   827   C1421363:UPP [Gene or Genome]

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Poston,"

Phrase: "G.J.,"

Phrase: "Gupta,"

Phrase: "V.,"

Phrase: "Townsend,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "and"

Phrase: "Thompson,"

Phrase: "J.C."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.502: (1988) Effects of bombesin on growth of human small cell lung carcinoma in vivo. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Effects of bombesin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "on growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "of human small cell lung carcinoma"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   937   C0149925:Small Cell Lung Carcinoma [Neoplastic Process]
           small cell carcinoma
   888   C0262584:Carcinoma, Small Cell [Neoplastic Process]
   853   C0427861:human cell [Laboratory or Test Result]
   840   C0684249:Lung Carcinoma [Neoplastic Process]
   811   C2749705:Small lungs [Finding]
   804   C0007097:Carcinoma [Neoplastic Process]
   804   C0007634:Cell [Cell]
   804   C0024109:Lung [Body Part, Organ, or Organ Component]
   804   C0700321:Small [Quantitative Concept]
   804   C0819757:LUNG [Tissue]
   804   C1269647:Cell [Cell]
   804   C1278908:Lung [Body Part, Organ, or Organ Component]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   748 E C2707265:Pulmonary [Clinical Attribute]
   748 E C2709248:Pulmonary [Qualitative Concept]
   711 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.503: Cancer Res., 48, 14391441.[Abstract] Larsen, P.J., Saermark, T. and Mikkelsen, J.D. 

Phrase: "Cancer Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "48,"

Phrase: "14391441."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Larsen,"

Phrase: "P.J.,"

Phrase: "Saermark,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Mikkelsen,"

Phrase: "J.D."
Processing 00000000.tx.504: (1989) An immunohistochemical demonstration of gastrin-releasing peptide (GRP) in the rat substantia nigra. 

Phrase: "(1989"

Phrase: ")"

Phrase: "An immunohistochemical demonstration of gastrin-releasing peptide"

Phrase: "(GRP"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0061132:Gastrin releasing peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1333714:gastrin-releasing peptide [Gene or Genome]
   827   C0017151:Gastrin [Amino Acid, Peptide, or Protein,Hormone]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0376180:Gastrin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1283071:Releasing [Functional Concept]
   793 E C0030685:Release [Health Care Activity]
   793 E C0391871:Release [Functional Concept]
   793 E C0439180:% release [Quantitative Concept]
   793 E C0680255:release [Health Care Activity]
   793 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "in the rat substantia nigra."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   901   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
Processing 00000000.tx.505: J. 

Phrase: "J."
Processing 00000000.tx.506: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.507: Neuroanat., 2, 8393.[ISI][Medline] Goodman, E.C. and Iversen, L.L. 

Phrase: "Neuroanat.,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "8393."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Goodman,"

Phrase: "E.C."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "Iversen,"

Phrase: "L.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539687:L/L [Quantitative Concept]
Processing 00000000.tx.508: (1986) Calcitonin gene-related peptide: novel neuropeptide. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Calcitonin gene-related peptide"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]
   812   C0006668:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0017337:Gene [Gene or Genome]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   812   C0770558:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1704385:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C2825090:Calcitonin [Pharmacologic Substance]
   812   C3536753:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   779 E C0163712:Relate [Organic Chemical]
   756 E C0115656:Thyrocalcitonin [Organic Chemical,Pharmacologic Substance]
   741 E C0080103:Relation [Family Group]
   741 E C0869014:Relations [Social Behavior]

Phrase: ":"

Phrase: "novel neuropeptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.509: Life Sci., 38, 21692178.[CrossRef][ISI][Medline] Bell, D. and McDermott, B.J. 

Phrase: "Life Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]

Phrase: "38,"

Phrase: "21692178."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706917:Bell [Manufactured Object]

Phrase: "D."

Phrase: "and"

Phrase: "McDermott,"

Phrase: "B.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.510: (1996) Calcitonin gene-related peptide in the cardiovascular system: characterization of receptor populations and their (patho)physiological significance. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Calcitonin gene-related peptide in the cardiovascular system"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   833   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]
   744   C0006668:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0017337:Gene [Gene or Genome]
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C0770558:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1704385:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C2825090:Calcitonin [Pharmacologic Substance]
   744   C3536753:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   711 E C0163712:Relate [Organic Chemical]

Phrase: ":"

Phrase: "characterization of receptor populations and their (patho)physiological significance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880022:Characterization [Activity]
Processing 00000000.tx.511: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.512: Rev., 48, 253288.[ISI][Medline] Burvenich, S., Unsicker, K. and Krieglstein, K. 

Phrase: "Rev.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]

Phrase: "48,"

Phrase: "253288."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Burvenich,"

Phrase: "S."

Phrase: ","

Phrase: "Unsicker,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Krieglstein,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.513: (1998) Calcitonin gene-related peptide promotes differentiation, but not survival, of rat mesencephalic dopaminergic neurons in vitro. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Calcitonin gene-related peptide"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]
   812   C0006668:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0017337:Gene [Gene or Genome]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   812   C0770558:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1704385:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C2825090:Calcitonin [Pharmacologic Substance]
   812   C3536753:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   779 E C0163712:Relate [Organic Chemical]
   756 E C0115656:Thyrocalcitonin [Organic Chemical,Pharmacologic Substance]
   741 E C0080103:Relation [Family Group]
   741 E C0869014:Relations [Social Behavior]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "but"

Phrase: "not survival,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]

Phrase: "of rat mesencephalic dopaminergic neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1512035:Dopaminergic Neurons [Cell]
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.514: Neuroscience, 86, 11651172.[CrossRef][ISI][Medline] Arimura, A. 

Phrase: "Neuroscience,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "86,"

Phrase: "11651172."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Arimura,"

Phrase: "A."
Processing 00000000.tx.515: (1992) Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Pituitary adenylate cyclase activating polypeptide"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0071163:pituitary adenylate cyclase activating polypeptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412228:PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE [Gene or Genome]
   840   C0001492:Adenylate Cyclase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C1382029:Adenylate Cyclase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0032005:Pituitary, NOS [Body Part, Organ, or Organ Component]
   804   C0597765:adenylate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]
   804   C1879547:activating [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "(PACAP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0071163:PACAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412228:PACAP [Gene or Genome]
  1000   C1836172:PACAP [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "discovery"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880355:Discovery [Activity]

Phrase: "and"

Phrase: "current status of research."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449438:Status [Qualitative Concept]
Processing 00000000.tx.516: Regul. 

Phrase: "Regul."
Processing 00000000.tx.517: Pept., 37, 287303.[ISI][Medline] Ogi, K., Kimura, C., Onda, H., Arimura, A. and Fujino, M. 

Phrase: "Pept.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080384:PEPT [Organic Chemical,Pharmacologic Substance]

Phrase: "37,"

Phrase: "287303."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ogi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kimura,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Onda,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Arimura,"

Phrase: "A."

Phrase: "and"

Phrase: "Fujino,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.518: (1990) Molecular cloning and characterization of cDNA for the precursor of rat pituitary adenylate cyclase activating polypeptide (PACAP). 

Phrase: "(1990"

Phrase: ")"

Phrase: "Molecular cloning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "characterization of cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1880022:Characterization [Activity]

Phrase: "for the precursor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709634:Precursor [Idea or Concept]

Phrase: "of rat pituitary adenylate cyclase activating polypeptide"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   947   C0071163:pituitary adenylate cyclase activating polypeptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1412228:PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE [Gene or Genome]
   827   C0001492:Adenylate Cyclase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1382029:Adenylate Cyclase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1882827:Rat Pituitary [Body Part, Organ, or Organ Component]
   799   C0032005:Pituitary, NOS [Body Part, Organ, or Organ Component]
   799   C0597765:adenylate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]
   799   C1879547:activating [Activity]
   766 E C1515877:Activate [Functional Concept]

Phrase: "(PACAP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0071163:PACAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412228:PACAP [Gene or Genome]
  1000   C1836172:PACAP [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.519: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.520: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.521: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.522: Commun., 173, 12711279.[CrossRef][ISI][Medline] Vaudry, D., Gonzalez, B.J., Basille, M., Yon, L., Fournier, A. and Vaudry, H. 

Phrase: "Commun.,"

Phrase: "173,"

Phrase: "12711279."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Vaudry,"

Phrase: "D."

Phrase: ","

Phrase: "Gonzalez,"

Phrase: "B.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Basille,"

Phrase: "M."

Phrase: ","

Phrase: "Yon,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Fournier,"

Phrase: "A."

Phrase: "and"

Phrase: "Vaudry,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.523: (2000) Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Pituitary adenylate cyclase-activating polypeptide"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0071163:pituitary adenylate cyclase activating polypeptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412228:PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE [Gene or Genome]
   840   C0001492:Adenylate Cyclase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C1382029:Adenylate Cyclase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0032005:Pituitary, NOS [Body Part, Organ, or Organ Component]
   804   C0597765:adenylate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]
   804   C1879547:activating [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "its receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ":"

Phrase: "from structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "to functions."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0542341:Functions [Functional Concept]
   966 E C0031843:function [Physiologic Function]
   966 E C0700205:FUNCTION [Classification]
   966 E C1705273:Function [Intellectual Product]
   916 E C0205245:Functional [Functional Concept]
   916 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.524: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.525: Rev., 52, 269324.[Abstract/Free FullText] Arimura, A. 

Phrase: "Rev.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]

Phrase: "52,"

Phrase: "269324."

Phrase: "[Abstract/Free FullText"

Phrase: "] Arimura,"

Phrase: "A."
Processing 00000000.tx.526: (1998) Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Perspectives on pituitary adenylate cyclase activating polypeptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   731   C0071163:pituitary adenylate cyclase activating polypeptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   731   C1412228:PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE [Gene or Genome]

Phrase: "(PACAP) in the neuroendocrine, endocrine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0071163:PACAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1412228:PACAP [Gene or Genome]
   760   C1836172:PACAP [Gene or Genome]

Phrase: "and"

Phrase: "nervous systems."
Meta Candidates (Total=15; Excluded=9; Pruned=0; Remaining=6)
  1000   C0027763:Systems, Nervous [Body System]
   966 E C0422837:NERVOUS SYSTEM [Finding]
   966 E C1269560:Nervous system [Body System]
   928 E C0205494:Neurologic [Qualitative Concept]
   900 E C0027855:Neurology [Biomedical Occupation or Discipline]
   884 E C2707261:Neurological [Clinical Attribute]
   861   C0027769:Nervous [Sign or Symptom]
   861   C0599851:Nervous [Functional Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]
   745 E C0027740:Nerve [Tissue]
   745 E C0027757:NERVE [Tissue]
   745 E C1280541:Nerve [Body Part, Organ, or Organ Component]
Processing 00000000.tx.527: Jpn. 

Phrase: "Jpn."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:JPN [Geographic Area]
Processing 00000000.tx.528: J. 

Phrase: "J."
Processing 00000000.tx.529: Physiol., 48, 301331.[CrossRef][ISI][Medline] Reglodi, D., Lubics, A., Tamas, A., Szalontay, L. and Lengvari, I. 

Phrase: "Physiol.,"

Phrase: "48,"

Phrase: "301331."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Reglodi,"

Phrase: "D."

Phrase: ","

Phrase: "Lubics,"

Phrase: "A.,"

Phrase: "Tamas,"

Phrase: "A.,"

Phrase: "Szalontay,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Lengvari,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.530: (2004) Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Pituitary adenylate cyclase activating polypeptide"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0071163:pituitary adenylate cyclase activating polypeptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412228:PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE [Gene or Genome]
   840   C0001492:Adenylate Cyclase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C1382029:Adenylate Cyclase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0032005:Pituitary, NOS [Body Part, Organ, or Organ Component]
   804   C0597765:adenylate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]
   804   C1879547:activating [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "protects"

Phrase: "dopaminergic neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1512035:Dopaminergic Neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "improves"

Phrase: "behavioral deficits in a rat model of Parkinson's disease."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C2987487:deficits [Qualitative Concept]
   708 E C0162429:Deficit, NOS [Disease or Syndrome]
Processing 00000000.tx.531: Behav Brain. 

Phrase: "Behav Brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.532: Res., 151, 303312.[CrossRef][ISI][Medline] Takei, N., Skoglosa, Y. and Lindholm, D. 

Phrase: "Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]

Phrase: "151,"

Phrase: "303312."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Takei,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Skoglosa,"

Phrase: "Y."

Phrase: "and"

Phrase: "Lindholm,"

Phrase: "D."
Processing 00000000.tx.533: (1998) Neurotrophic and neuroprotective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on mesencephalic dopaminergic neurons. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neurotrophic"

Phrase: "and"

Phrase: "neuroprotective effects of pituitary adenylate cyclase-activating polypeptide"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0815279:Neuroprotective Effects [Functional Concept]
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]
   703   C0071163:pituitary adenylate cyclase activating polypeptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1412228:PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE [Gene or Genome]

Phrase: "(PACAP) on mesencephalic dopaminergic neurons."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0071163:PACAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1412228:PACAP [Gene or Genome]
   760   C1836172:PACAP [Gene or Genome]
Processing 00000000.tx.534: J. 

Phrase: "J."
Processing 00000000.tx.535: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.536: Res., 54, 698706.[CrossRef][ISI][Medline] Delgado, M. and Ganea, D. 

Phrase: "Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]

Phrase: "54,"

Phrase: "698706."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Delgado,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Ganea,"

Phrase: "D."
Processing 00000000.tx.537: (2003) Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Neuroprotective effect of vasoactive intestinal peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0815279:Neuroprotective Effect [Functional Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "(VIP"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0042395:Vasoactive Intestinal Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1366646:VASOACTIVE INTESTINAL PEPTIDE [Gene or Genome]
   827   C0021853:Intestinal [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C1980011:Vasoactive [Qualitative Concept]
   755 E C1708548:INTESTINE [Tissue]

Phrase: ")"

Phrase: "in a mouse model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2986594:Mouse Model [Experimental Model of Disease]
   861   C3161035:Model [Intellectual Product]

Phrase: "of Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "by blocking microglial activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]
Processing 00000000.tx.538: FASEB J., 17, 944946.[Abstract/Free FullText] Dogrukol-Ak, D., Tore, F. and Tuncel, N. 

Phrase: "FASEB J.,"

Phrase: "17,"

Phrase: "944946."

Phrase: "[Abstract/Free FullText"

Phrase: "] Dogrukol-Ak,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]

Phrase: "D."

Phrase: ","

Phrase: "Tore,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0039409:Tear [Body Substance]
   966   C0043246:Tear [Injury or Poisoning]
   966   C1704633:Tear [Spatial Concept]
   966   C3203359:tear [Injury or Poisoning]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Tuncel,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.539: (2004) Passage of VIP/PACAP/secretin family across the blood-brain barrier: therapeutic effects. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Passage of VIP/PACAP/secretin family"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439799:Passage [Spatial Concept]

Phrase: "across the blood-brain barrier"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
  1000   C1305865:Blood-brain barrier [Organ or Tissue Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0229664:Blood [Body Substance]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1706912:BARRIER [Medical Device]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "therapeutic effects."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1527144:Therapeutic Effect [Health Care Activity]
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.540: Curr. 

Phrase: "Curr."
Processing 00000000.tx.541: Pharm. 

Phrase: "Pharm."
Processing 00000000.tx.542: Des., 10, 13251340.[CrossRef][ISI][Medline] Greenamyre, J.T., Sherer, T.B., Betarbet, R. and Panov, A.V. 

Phrase: "Des.,"

Phrase: "10,"

Phrase: "13251340."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Greenamyre,"

Phrase: "J.T.,"

Phrase: "Sherer,"

Phrase: "T.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "Betarbet,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Panov,"

Phrase: "A.V."
Processing 00000000.tx.543: (2001) Complex I and Parkinson's disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Complex I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2245017:Complex I [Cell Component]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.544: IUBMB Life, 52, 135141.[ISI][Medline] Betarbet, R., Sherer, T.B., MacKenzie, G., Garcia-Osuna, M., Panov, A.V. and Greenamyre, J.T. 

Phrase: "IUBMB Life,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0376558:Life [Idea or Concept]
   777 E C0595998:lives [Finding]

Phrase: "52,"

Phrase: "135141."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Betarbet,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Sherer,"

Phrase: "T.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "MacKenzie,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Garcia-Osuna,"

Phrase: "M."

Phrase: ","

Phrase: "Panov,"

Phrase: "A.V."

Phrase: "and"

Phrase: "Greenamyre,"

Phrase: "J.T."
Processing 00000000.tx.545: (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Chronic systemic pesticide exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0274281:Exposure, NOS [Injury or Poisoning]
   812   C0332157:Exposure [Clinical Attribute]

Phrase: "reproduces"

Phrase: "features of Parkinson's disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C1521970:Feature [Qualitative Concept]
   737   C1706388:Feature [Conceptual Entity]
   737   C2346469:Feature [Qualitative Concept]
   737   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.546: Nat. 

Phrase: "Nat."
Processing 00000000.tx.547: Neurosci., 3, 13011306.[CrossRef][ISI][Medline] Beal, M.F. 

Phrase: "Neurosci.,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "13011306."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Beal,"

Phrase: "M."

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.548: (2004) Commentary on alpha-synuclein and mitochondria: a tangled skein. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Commentary on alpha-synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0282411:Commentary [Intellectual Product]

Phrase: "and"

Phrase: "mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: ":"

Phrase: "a tangled skein."
Processing 00000000.tx.549: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.550: Neurol., 186, 109111.[CrossRef][ISI][Medline] Hsu, L.J., Sagara, Y., Arroyo, A., Rockenstein, E., Sisk, A., Mallory, M., Wong, J., Takenouchi, T., Hashimoto, M. and Masliah, E. 

Phrase: "Neurol.,"

Phrase: "186,"

Phrase: "109111."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hsu,"

Phrase: "L.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Sagara,"

Phrase: "Y.,"

Phrase: "Arroyo,"

Phrase: "A.,"

Phrase: "Rockenstein,"

Phrase: "E.,"

Phrase: "Sisk,"

Phrase: "A.,"

Phrase: "Mallory,"

Phrase: "M."

Phrase: ","

Phrase: "Wong,"

Phrase: "J.,"

Phrase: "Takenouchi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hashimoto,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Masliah,"

Phrase: "E."
Processing 00000000.tx.551: (2000) alpha-synuclein promotes mitochondrial deficit and oxidative stress. 

Phrase: "(2000"

Phrase: ")"

Phrase: "alpha-synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "mitochondrial deficit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0162429:Deficit, NOS [Disease or Syndrome]
   861   C2987487:Deficit [Qualitative Concept]

Phrase: "and"

Phrase: "oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.552: Am. 

Phrase: "Am."
Processing 00000000.tx.553: J. 

Phrase: "J."
Processing 00000000.tx.554: Pathol., 157, 401410.[Abstract/Free FullText] Palacino, J.J., Sagi, D., Goldberg, M.S., Krauss, S., Motz, C., Wacker, M., Klose, J. and Shen, J. 

Phrase: "Pathol.,"

Phrase: "157,"

Phrase: "401410."

Phrase: "[Abstract/Free FullText"

Phrase: "] Palacino,"

Phrase: "J.J.,"

Phrase: "Sagi,"

Phrase: "D."

Phrase: ","

Phrase: "Goldberg,"

Phrase: "M.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Krauss,"

Phrase: "S."

Phrase: ","

Phrase: "Motz,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Wacker,"

Phrase: "M."

Phrase: ","

Phrase: "Klose,"

Phrase: "J."

Phrase: "and"

Phrase: "Shen,"

Phrase: "J."
Processing 00000000.tx.555: (2004) Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Mitochondrial dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "oxidative damage in parkin-deficient mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0010957:Damage [Injury or Poisoning]
   753   C1883709:Damage [Functional Concept]
Processing 00000000.tx.556: J. 

Phrase: "J."
Processing 00000000.tx.557: Biol. 

Phrase: "Biol."
Processing 00000000.tx.558: Chem., 279, 1861418622.[Abstract/Free FullText] Graham, D.G. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "279,"

Phrase: "1861418622."

Phrase: "[Abstract/Free FullText"

Phrase: "] Graham,"

Phrase: "D."

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.559: (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. 

Phrase: "(1978"

Phrase: ")"

Phrase: "Oxidative pathways for catecholamines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1704259:Pathways [Molecular Function]
   770   C1705987:Pathways [Conceptual Entity]

Phrase: "in the genesis"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1414672:Genesis [Gene or Genome]
  1000   C2984892:Genesis [Gene or Genome]
   907 E C0079411:Generation [Temporal Concept]
   907 E C3146294:Generation [Activity]

Phrase: "of neuromelanin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0068608:neuromelanin [Organic Chemical]

Phrase: "and"

Phrase: "cytotoxic quinones."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0034435:Quinones [Organic Chemical]
   827 E C0053241:Quinone [Organic Chemical]
   827 E C1096793:Quinone [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.560: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.561: Pharmacol., 14, 633643.[Abstract] Ciliax, B.J., Drash, G.W., Staley, J.K., Haber, S., Mobley, C.J., Miller, G.W., Mufson, E.J., Mash, D.C. and Levey, A.I. 

Phrase: "Pharmacol.,"

Phrase: "14,"

Phrase: "633643."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ciliax,"

Phrase: "B.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Drash,"

Phrase: "G.W., Staley,"

Phrase: "J.K.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346601:J/K [Quantitative Concept]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Haber,"

Phrase: "S."

Phrase: ","

Phrase: "Mobley,"

Phrase: "C.J.,"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "G.W., Mufson,"

Phrase: "E.J.,"

Phrase: "Mash,"

Phrase: "D.C."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0524984:D Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "Levey,"

Phrase: "A.I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.562: (1999) Immunocytochemical localization of the dopamine transporter in human brain. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Immunocytochemical localization of the dopamine transporter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "in human brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.563: J. 

Phrase: "J."
Processing 00000000.tx.564: Comp. 

Phrase: "Comp."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0056167:COMP [Therapeutic or Preventive Procedure]
  1000   C1456376:COMP [Gene or Genome]
Processing 00000000.tx.565: Neurol., 409, 3856.[CrossRef][ISI][Medline] Haber, S.N., Ryoo, H., Cox, C. and Lu, W. 

Phrase: "Neurol.,"

Phrase: "409,"

Phrase: "3856."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Haber,"

Phrase: "S."

Phrase: "N., Ryoo,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Cox,"

Phrase: "C."

Phrase: "and"

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "W."
Processing 00000000.tx.566: (1995) Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Subsets of midbrain dopaminergic neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1515021:Subset [Classification]

Phrase: "in monkeys"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026447:Monkeys [Mammal]

Phrase: "are"

Phrase: "distinguished by different levels of mRNA"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0441889:Levels [Qualitative Concept]
   753   C1705242:Different [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "for the dopamine transporter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0114838:dopamine transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420213:DOPAMINE TRANSPORTER [Gene or Genome]
   861   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   861   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "comparison with the mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "for the D2 receptor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0058698:D2 receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "tyrosine hydroxylase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0041491:Tyrosine Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1420718:TYROSINE HYDROXYLASE [Gene or Genome]
   861   C0020364:Hydroxylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "calbindin immunoreactivity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]
Processing 00000000.tx.567: J. 

Phrase: "J."
Processing 00000000.tx.568: Comp. 

Phrase: "Comp."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0056167:COMP [Therapeutic or Preventive Procedure]
  1000   C1456376:COMP [Gene or Genome]
Processing 00000000.tx.569: Neurol., 362, 400410.[CrossRef][ISI][Medline] Uhl, G.R., Walther, D., Mash, D., Faucheux, B. and Javoy-Agid, F. 

Phrase: "Neurol.,"

Phrase: "362,"

Phrase: "400410."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Uhl,"

Phrase: "G.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Walther,"

Phrase: "D."

Phrase: ","

Phrase: "Mash,"

Phrase: "D."

Phrase: ","

Phrase: "Faucheux,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Javoy-Agid,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.570: (1994) Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Dopamine transporter messenger RNA in Parkinson's disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0035696:RNA, Messenger [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0335218:Messenger [Professional or Occupational Group]

Phrase: "and"

Phrase: "control substantia nigra neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.571: Ann. 

Phrase: "Ann."
Processing 00000000.tx.572: Neurol., 35, 494498.[CrossRef][ISI][Medline] Aubert, I., Brana, C., Pellevoisin, C., Giros, B., Caille, I., Carles, D., Vital, C. and Bloch, B. 

Phrase: "Neurol.,"

Phrase: "35,"

Phrase: "494498."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Aubert,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Brana,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0054050:BRANA [Pharmacologic Substance]

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Pellevoisin,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Giros,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Caille,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Carles,"

Phrase: "D."

Phrase: ","

Phrase: "Vital,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442732:Vital [Qualitative Concept]
  1000   C1875856:VITAL [Food]

Phrase: "C."

Phrase: "and"

Phrase: "Bloch,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.573: (1997) Molecular anatomy of the development of the human substantia nigra. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Molecular anatomy of the development of the human substantia nigra."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0868920:Anatomy, Human [Functional Concept]
   739   C0002808:Anatomy [Biomedical Occupation or Discipline]
   739   C0700276:anatomy [Anatomical Structure]
   739   C1384516:anatomy [Qualitative Concept]
   722   C1511798:Developmental Anatomy [Biomedical Occupation or Discipline]
Processing 00000000.tx.574: J. 

Phrase: "J."
Processing 00000000.tx.575: Comp. 

Phrase: "Comp."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0056167:COMP [Therapeutic or Preventive Procedure]
  1000   C1456376:COMP [Gene or Genome]
Processing 00000000.tx.576: Neurol., 379, 7287.[CrossRef][ISI][Medline] Willingham, S., Outeiro, T.F., DeVit, M.J., Lindquist, S.L. and Muchowski, P.J. 

Phrase: "Neurol.,"

Phrase: "379,"

Phrase: "7287."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Willingham,"

Phrase: "S."

Phrase: ","

Phrase: "Outeiro,"

Phrase: "T.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "DeVit,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Lindquist,"

Phrase: "S.L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Muchowski,"

Phrase: "P.J."
Processing 00000000.tx.577: (2003) Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Yeast genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "that"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the toxicity of a mutant huntingtin fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0040539:toxicity [Qualitative Concept]
   748   C0600688:Toxicity [Injury or Poisoning]

Phrase: "or"

Phrase: "alpha-synuclein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]
Processing 00000000.tx.578: Science, 302, 17691772.[Abstract/Free FullText] Hauser, M.A., Li, Y.J., Takeuchi, S., Walters, R., Noureddine, M., Maready, M., Darden, T., Hulette, C., Martin, E., Hauser, E. etal. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "302,"

Phrase: "17691772."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hauser,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Y.J.,"

Phrase: "Takeuchi,"

Phrase: "S."

Phrase: ","

Phrase: "Walters,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Noureddine,"

Phrase: "M."

Phrase: ","

Phrase: "Maready,"

Phrase: "M."

Phrase: ","

Phrase: "Darden,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hulette,"

Phrase: "C.,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "Martin,"

Phrase: "E.,"

Phrase: "Hauser,"

Phrase: "E. etal."
Processing 00000000.tx.579: (2003) Genomic convergence: identifying candidate genes for Parkinson's disease by combining serial analysis of gene expression and genetic linkage. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Genomic convergence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0443193:Convergence [Spatial Concept]
   861   C1446614:Convergence [Finding]
   861   C2700387:Convergence [Activity]

Phrase: ":"

Phrase: "identifying"

Phrase: "candidate genes for Parkinson's disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   824   C1332838:Candidate Disease Gene [Gene or Genome]
           Candidate Genes
   760   C0017337:Genes [Gene or Genome]
   753   C1416989:MAL gene [Gene or Genome]

Phrase: "by combining serial analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "of gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "genetic linkage."
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
  1000   C0023745:genetic linkage [Molecular Function]
           linkage
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]
Processing 00000000.tx.580: Hum. 

Phrase: "Hum."
Processing 00000000.tx.581: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.582: Genet., 12, 671677.[Abstract/Free FullText] Grimm, J., Mueller, A., Hefti, F. and Rosenthal, A. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "12,"

Phrase: "671677."

Phrase: "[Abstract/Free FullText"

Phrase: "] Grimm,"

Phrase: "J.,"

Phrase: "Mueller,"

Phrase: "A.,"

Phrase: "Hefti,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Rosenthal,"

Phrase: "A."
Processing 00000000.tx.583: (2004) Molecular basis for catecholaminergic neuron diversity. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Molecular basis for catecholaminergic neuron diversity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1853126:MOLECULAR BASIS [Idea or Concept]
   753   C1527178:Basis [Functional Concept]
   753   C1874451:Basis [Pharmacologic Substance]
Processing 00000000.tx.584: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.585: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.586: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.587: USA, 101, 1389113896.[Abstract/Free FullText] Livak, K.J. and Schmittgen, T.D. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "101,"

Phrase: "1389113896."

Phrase: "[Abstract/Free FullText"

Phrase: "] Livak,"

Phrase: "K.J."

Phrase: "and"

Phrase: "Schmittgen,"

Phrase: "T.D."
Processing 00000000.tx.588: (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(Delta Delta C(T)) method. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Analysis of relative gene expression data"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   820   C1880945:Gene Expression Analysis [Molecular Biology Research Technique]
   783   C0010992:Data Analysis [Occupational Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "real-time quantitative PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0677874:pCR [Finding]

Phrase: "and"

Phrase: "the 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(Delta Delta C"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0524984:delta Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(T)) method."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.589: Methods, 25, 402408.[CrossRef][ISI][Medline] Zufferey, R., Dull, T., Mandel, R.J., Bukovsky, A., Quiroz, D., Naldini, L. and Trono, D. 

Phrase: "Methods,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "25,"

Phrase: "402408."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zufferey,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Dull,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0443208:Dull [Qualitative Concept]
  1000   C1455762:Dull [Qualitative Concept]
  1000   C1880427:DULL [Phenomenon or Process]
   928 E C0541911:Dullness [Finding]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mandel,"

Phrase: "R.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bukovsky,"

Phrase: "A.,"

Phrase: "Quiroz,"

Phrase: "D."

Phrase: ","

Phrase: "Naldini,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Trono,"

Phrase: "D."
Processing 00000000.tx.590: (1998) Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Self-inactivating"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036588:Self [Idea or Concept]
   861   C1551994:self [Intellectual Product]
   861   C3244295:Self [Intellectual Product]

Phrase: "lentivirus vector for safe"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]

Phrase: "and"

Phrase: "efficient in vivo gene delivery."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0872177:gene delivery [Genetic Function]
   840   C1524066:Gene Delivery [Conceptual Entity]
   804   C0011209:Delivery [Therapeutic or Preventive Procedure]
   804   C0559563:delivery [Finding]
   804   C1705822:Delivery [Activity]
Processing 00000000.tx.591: J. 

Phrase: "J."
Processing 00000000.tx.592: Virol., 72, 98739880.[Abstract/Free FullText]

Phrase: "Virol.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0965991:virol [Lipid]

Phrase: "72,"

Phrase: "98739880."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

